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ABSTRACT 
 
 
Short-chain dehydrogenases/reductases (SDR) and glutaredoxins (Grx) are large protein families playing 
diverse roles in prokaryotic, viral and eukaryotic functions. These critical roles, from detoxification and 
coping with cellular stress to modulating signaling pathways, are highlighted by a vast presence in nearly 
every life form. 
 
With the access to an exponentially growing number of genome sequences, protein:protein alignments 
allow the detection of outliers within the well established SDR and Grx families. In this thesis, we have 
focused on SDRs and Grxs in general, and on two proteins from an operon within the second chromosome 
of the Gram-negative pathogen Vibrio vulnificus in particular. As revealed by bioinformatics, these 
proteins –rebaptized as SDRvv and VvGrx2- can indeed be categorized as atypical: SDRvv because it 
misses the characteristic active site signature and some structural elements of short-chain 
dehydrogenases, and VvGrx2 being twice the size of classical glutaredoxins by the peculiar addition of a 
C-terminal glutathione S-transferase-like domain. 
 
Until now, the research on SDRs and glutaredoxins was dedicated to a large extent to its classical 
members. Yet, the study of proteins categorized as outliers offers the possibility to confirm or reconsider 
the present knowledge on a protein family. Data on atypical members can lead for instance to adjustments 
in the current classification system, the discovery of different mechanistic routes or the establishment of 
evolutionary relationships with other protein families.  
 
In this thesis, we hope to contribute to the current state of the art in the SDR- and Grx-field, by a 
thorough biochemical characterization of atypical enzymes. At the same time, this study can bring 
insights in their functional contribution in the cell. Indeed, while a growing number of in vivo 
functions were successfully attributed to many classical SDRs and glutaredoxins, no physiological roles 
could be assigned to the closest homologues of SDRvv and VvGrx2, nor to any other gene product of the 
VVA1598-VVA1599-VVA1600-VVA1601 operon.  
 
Based on the principle that genes from the same operon encode functionally related proteins, this 
approach could at the same time be a lead for the in vivo role of VvOYE in particular and all OYEs in 
general. While these NAD(P)H-dependent enzymes can be strongly upregulated under oxidative stress 
conditions, and despite the fact that many tight-binding ligands as phenols and steroids were identified, 
their exact physiological function is unknown. Note that the research on VvOYE is not part of this thesis, 
and was restricted to the determination of the coenzyme as being NADPH, the same cofactor as SDRvv. 
 
 
 
The facilities at L-ProBE allow a broad-spectrum characterization of the atypical SDR and Grx under 
study. Among the techniques used during this PhD, we distinguish: 
- Cloning of the coding sequences, followed by expression and purification of the tested proteins 
- Biochemical analyses by fluorescence-based thermal shift assays, measurement of intrinsic 
fluorescence, electromobility shift assays and steady-state kinetics. 
- Biophysical techniques (ITC) and structural analysis 
- Mass spectrometry 
 
The general outline of this thesis is as follows: 
 
While the first chapter introduces the reader to the biology of Vibrio’s, the second chapter focuses on the 
short-chain dehydrogenases and SDRvv. Here, we wanted to address the following question: how can 
SDRvv retain the capacity to coordinate a cofactor and eventually be catalytically active while it 
shows important truncations in protein regions associated with cofactor stabilization or substrate 
binding? The results of our research are bundled into two manuscripts. One of them describes the 
successful crystallization of the protein in its apo- and NADPH-bound form, of which the crystals 
diffracted to 2.35 and 1.80 Å, respectively. The other is dedicated to the analysis of the high-resolution 
structure and the parameters making cofactor coordination possible. We found that the SDRvv-bound 
NADPH is essentially coordinated by the same functional groups as in other SDR-members, although 
they originate from different secondary elements. Reducing power towards a substrate is even likely, as 
the coordination distances between the residues of the so-called catalytic tetrad are respected. 
 
In the third chapter, we investigate the possibility that SDRvv operates as a redox-sensor, 
communicating the NADPH-status of the cell to a transcriptional regulator. This presumption is 
based on the close association between SDRvv-like proteins and upstream-located LysR-type 
transcriptional regulators (LTTRs) and the remarkable ability of SDRvv to strongly discriminate between 
NADPH and its oxidized counterpart. Based on electromobility shift assays in the presence of SDRvv, we 
found no indication that a ternary complex is formed. 
 
The fourth and last chapter gives an overview of the present knowledge on glutaredoxins. It shows among 
others that scientific reports remain remarkably silent concerning atypical glutaredoxins such as 
VvGrx2. Nonetheless, these proteins are strongly upregulated during the stationary phase and can make 
up to 1% of the total protein content. Here, we aimed to provide a kinetic-based framework, giving a 
better understanding of the mechanistic properties of atypical and classical glutaredoxins. 
Different kinetic profiles between classical and atypical glutaredoxins could point towards different 
fields of action. To achieve this goal, a fluorescence-based assay was optimized and the mode of data-
analysis was fine-tuned. The achievements and the experimental results obtained by characterizing a 
protagonist of the classical Grx-subgroup and one of the atypical subgroup, are discussed in the third 
manuscript. While data fitting remains problematic, this research brings new insights. First, we showed 
that both representatives have comparable IC50-values for GSSG. Secondly, we demonstrated that, 
contrary to classical Grx, atypical Grx exhibits a covalently bound glutathione in the active site instead of 
an intramolecular disulphide bridge when exposed to an excess of GSSG. This finding has important 
repercussions at the physiological level and allows the proposal that atypical glutaredoxins are crucial in 
the first moments after overt oxidative stress, i.e. when the free glutathione concentrations are still low. 
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1. 
VIBRIO VULNIFICUS 
1. INTRODUCTION 
 
Vibrios are important inhabitants of riverine, estuarine and marine aquatic environments. They represent a 
family of Gram-negative, slightly curved rod-shaped bacteria that depend on 1 to 3% (wt/vol) NaCl for 
optimal growth. Vibrios are fermentative in their metabolism and, having a single polar flagellum, all 
members are motile (Fig1).  
Many species are bioluminescent. In the well-studied Vibrio fisheri, bioluminescence is owed to the Lux 
operon, where the product of luxA and luxB -known as bacterial luciferase- converts FMNH2, O2 and an 
aliphatic aldehyde (RCHO) to FMN, water, an aliphatic acid ,and light. Living in symbiosis with the 
Hawaiian bobtail squid (Eupryma scolopes) by colonizing its specifically adapted light organs, the 
bioluminescence produced by V. fisheri is used as an antipredatory mechanism(Lopes Thompson et al., 
2006).  
 
In contrast to this intriguing partnership, other Vibrios can 
cause disease or vibriosis in marine animals. Pathogens like 
Vibrio harveyi and Vibrio anguillarium were shown to lead 
to a rapid reduction of the fish population and are considered 
to be responsible for the majority of all fish diseases.  
V. anguillarium is even regarded as the major obstacle for the 
marine culture of salmonid fish (Lopes Thompson et al., 
2006). The marine life, however, is not the only victim of the 
Vibrio virulence. Some of the species are human pathogens 
and played a consequent role in human history.  
 
2. VIBRIOS, A DANGER FOR MANKIND 
 
Vibrio cholerae, the causative agent of an acute intestinal infection called cholera, is probably the most 
notorious among them. The bacterium colonizes the small intestine, producing an enterotoxin (CT or 
cholera toxin), which causes severe watery diarrhea (10 to 20L/day), in many cases accompanied by vomiting 
which can lead to severe dehydration. If untreated, death can occur within hours in 30 to 50% of the cases. 
 
Fig 1.  The comma-shaped morphology of 
a V. vulnificus bacterium  
 !
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Since the incubation period is very short (2 hours to 5 days), the number of cholera-victims can rise 
extremely rapidly. Treatment, however, is very simple and is based on the concept of replacing fluids as fast 
as they are being lost, with fluids having the same electrolyte composition (www.who.org). 
 
Outbreaks of cholera sporadically affected the world. Writings of the ancient 
Greeks, like those of Hippocrates of Cos (ca. 460BC-ca. 350BC) and Galen of 
Pergamon (129AD-199AD), describe an illness that might have been cholera 
(Kousoulis, 2012). The disease, however, has his roots in South-Asia, 
especially around the Ganges delta region in India. The 19th century, with its 
growing network of trade routes, saw the disease spreading rapidly to Russia, 
Europe and North America, making millions of deaths on its way. Since then 
(1817), seven pandemics or global epidemics were recorded (Faruque et al., 
1998).  
 
It was the British physician John Snow, who first identified the fecal-oral 
route to infection (1849) and showed the importance of contaminated water in 
its cause even before bacteria were known to exist (Fig. 2). His ‘germ theory’ 
led to many advances in the prevention and treatment of infectious diseases. 
The bacillus Vibrio cholerae was first studied by Pacini (1854) and further 
described in detail by Robert Koch (1884) (Sack et al., 2004). 
 
As the bacterium is contracted by contaminated food or water, the disease is now rare in industrialized 
nations. Cholera, however, remains a global threat. Where water supplies, sanitation, food safety and hygiene 
are inadequate (e.g. natural disasters, refugee camps,… ), cholera gets a chance to strike. Since 2000, the 
cholera-incidence increased steadily. The WHO reports about 300.000 cases worldwide, of which there are 
7500 deaths. In 2010, the high number of cholera-cases is explained by the massive cholera outbreak after the 
earthquake in Haiti (www.who.org). 
 
Like Vibrio parahaemolyticus, another significant human pathogenic species of the genus is Vibrio 
vulnificus. Since they occur in shrimps, in fish, and especially in high numbers in bivalve mollusks like 
oysters and clams, they constitute a high risk for persons consuming raw or undercooked seafood. Once 
ingested, the proliferating bacteria can trigger symptoms like fever, chills, a hypotensive septic shock, and 
the formation of secondary lesions on the extremities of patients. Primary septicemia provoked by an 
infection of Vibrio vulnificus is lethal in more than 50% of the cases, and in the United States it is the number 
one cause of seafood-borne deaths. Furthermore, this pathogen can infect preexisting wounds or those 
contracted during seawater-associated activities (swimming, cleaning fish,…). These wound infections can 
rapidly progress, leading to necrosis of the tissues and often to amputation. The mortality rate, however, is 
much lower (25%). Based on their biochemical features three biotypes of Vibrio vulnificus are known, of 
which only biotype 1 is relevant in the context of human disease (Jones & Oliver, 2009). 
 
Fig 2.  19th century picture: 
“Death comes through the 
water” 
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The major virulence factor for Vibrio vulnificus is its capsular polysaccharide (CPS). The formation of a 
protecting capsule will camouflage the pathogen for the complement system of the host and avoid 
phagocytosis by defense cells. Secondly, Vibrio vulnificus depends on high levels of iron to infect its host. 
The acquisition of the metal is achieved through iron-scavenging siderophores (e.g. vulnibactin) and 
proteins that bind iron-containing proteins of the host. Some researchers suggest that iron enhances the 
growth of the pathogen (Starks et al., 2006), while others found that iron-excess decreases the neutrophil 
activity and thus compromises the immune system (Hor et al., 2000). Other virulence factors are proposed to 
play a role in pathogenesis: (i) a cytolysin/hemolysin (vvhA) and a metalloprotease (vvpE) whose role is still 
enigmatic, (ii) an RTX toxin which causes depolymerization and aggregation of actin fibers and leads to 
rearrangements of the cytoskeleton, and (iii) the flagella, for its possible involvement in cell adherence 
(Gulig et al., 2005). 
3. VIBRIO VULNIFICUS YJ016 
 
Different Vibrio vulnificus strains may demonstrate significant 
heterogeneity at the genetic level, which may also lead to 
differences in virulence among those strains. The complete 
genomic sequence of Vibrio vulnificus YJ016, a biotype 1 clinical 
isolate from Taiwan, was determined by whole-genome shotgun 
sequencing and revealed the presence of two chromosomes (Chen 
et al., 2003). The reason for the presence of two chromosomes is 
not clear. But, as the genes on chromosome 1 encode mostly for housekeeping functions and those on 
chromosome 2 for functions associated with the environmental adaptation, the second chromosome may 
provide some selective advantages for survival in a particular niche (Thompson et al., 2004). 
 
The proteins studied in this thesis are encoded by an operon structure on the second chromosome (Fig 3). 
Transcription and translation of VVA1599, VVA1600 and VVA1601 respectively leads to a FabG-
ressembling short-chain dehydrogenase, a glutaredoxin similar to Grx2 of E. coli, and an Old Yellow 
Enzyme. All three genes are under control of a LysR-type transcriptional regulator, the product of the 
divergently transcribed VVA1598 gene. In the following chapters, the LysR transcriptional regulator, the 
short-chain dehydrogenase and the atypical glutaredoxin from this operon will be described in further detail. 
The Old Yellow enzyme representative is the only protein not discussed in this thesis. 
 
 
Scientific classification 
Kingdom: Bacteria 
Phylum: Proteobacteria 
Class: γ-Proteobacteria 
Order: Vibrionales 
Family: Vibrionaceae 
Genus: Vibrio 
Species: Vibrio vulnificus 
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Fig 3. Schematic representation of the operon constituted by VVA1598, VVA1599, VVA1600 and 
VVA1601, encoding respectively a LysR-type transcriptional regulator, a short-chain 
dehydrogenase/reductase, an E.coli Grx2 homologue, and an Old Yellow Enzyme. Cartoon representation of 
(i) the LysR transcriptional regulator CbnR from Ralstonia eutropha (pdb-code: 1IZ1) (Muraoka et al., 2003), 
(ii) SDRvv (pdb-code: 3UCE) (Buysschaert et al., 2012), (iii) Grx2 from Salmonella typhimurium  (pdb-code: 
3IR4) and (iv) an Old Yellow Enzyme from Saccharomyces pastorianus (pdb-code: 10YA) (Fox & Karplus, 
1994). The α-helices are depicted in blue and β-strands in red. 
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1. INTRODUCTION 
When Negelein and Wulff purified and crystallized an alcohol dehydrogenase from baker’s yeast in 1937, 
they described the first member of a large family (E.C.1.1.1.1) catalyzing the reversible oxidation of alcohols 
to their corresponding acetaldehyde or ketone, using NAD(P)+/NAD(P)H as electron acceptor or donor. 
Playing a crucial role for cell survival in the removal of the otherwise toxic ethanol, alcohol dehydrogenases 
were since then extensively studied. Especially horse liver alcohol dehydrogenase, a mammalian variant, 
received much attention. The catalytic mechanism was disentangled in many aspects by Theorell and 
coworkers (Theorell & Mc, 1961), and a few years later the same protein was the first oligomeric enzyme of 
which the primary structure and three-dimensional structure was resolved (Jornvall & Harris, 1970).  
The growing number of available annotated sequences and structures of alcohol dehydrogenases showed 
distinct features among those enzymes and led to a subdivision of structurally and catalytically different 
types of alcohol dehydrogenases. Today, we differentiate three superfamilies, especially by the length of the 
protein chain: short-chain dehydrogenase/reductases (SDR; ± 250 aa) (Jornvall et al., 1995)), medium-chain 
dehydrogenase/reductases (MDR; ±350 aa) (Persson et al., 1994)) and long-chain dehydrogenase/reductases 
(LDR; 350-550 aa)  (Persson et al., 1991). 
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Common to all three types of oxidoreductases, is the presence of a coenzyme binding domain, the  
‘Rossmann-fold’ (Rossmann et al., 1974). Named after Michael Rossmann, who was the first to show that this 
3D-organisation is recurrent in nucleotide binding proteins, the Rossmann-topology (Fig 4) typically 
consists of a sequence of alternating α-helices and β-strands. The latter form a slightly twisted, parallel β-
sheet, flanked on both sides by two or three α-helices. The fold is further hallmarked by a highly variable 
Gly-rich motif, enabling the accommodation and binding of the nucleotide cofactor. The Rossmann fold was 
originally discovered in lactate, alcohol, malate, and glyceraldehyde-3-phosphate dehydrogenase. Later, 
crystallographic studies demonstrated that this canonical fold is also present in kinases, synthetases and 
many other proteins using ATP, GTP or other high-energy nucleotide analogues. 
 
 
 
 
 
 
Fig 4: A topology diagram for the Rossmann-fold. Cylinders represent α-helices and arrows β-strands. 
2. LONG-CHAIN DEHYDROGENASES 
From the three described dehydrogenase/reductase families, the large long-chain group is probably the least 
well characterized. Long-chain dehydrogenases act mainly on polyols, sugars such as D-mannitol or 
glycerol. These enzymes are between 350 and 560 amino acids long and show a great heterogeneity, which is 
reflected by a very low conservation of the primary structure. LDRs are typified by a two-domain 
architecture, forming a cleft wherein the active site resides. While the N-terminal domain is involved in 
cofactor binding, the C-terminal part provides the active site groups and the residues conferring substrate 
specificity.  
Some of these polyol-utilizing LDRs, mainly prokaryotic ADH’s, are metal-independent. These members 
fall into 5 subfamilies: the D-mannitol 2-dehydrogenases (EC 1.1.1.67), D-mannonate 5-oxidoreductases 
(EC 1.1.1.57), D-altronate 5-oxidoreductases (EC 1.1.1.58), D-arabinitol 4-dehydrogenases (EC 1.1.1.11) 
and D-mannitol-1-phosphate 5-dehydrogenases (EC 1.1.1.17). Upon protein sequence alignment, only three 
amino acids are found to be invariant, among them a conserved catalytic Lys residue (Klimacek & Nidetzky, 
2002).  
LDRs further comprise metal-dependent enzymes. Originally called ‘iron-containing’ alcohol 
dehydrogenases due to the dependence of these enzymes on Fe2+, the nomenclature was found to be 
inappropriate when enzymes using divalent metal ions oher than iron were discovered (e.g. B. methanolicus 
methanol dehydrogenase (de Vries et al., 1992)). 
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3. MEDIUM-CHAIN DEHYDROGENASES 
Since the discovery of the first medium-chain dehydrogenase, known as the class I type mammalian alcohol 
dehydrogenase (Jornvall, 1970), this enzyme superfamily grew spectacularly. Having reached today over 
15.000 entries in the UniProt KB database (Hedlund et al., 2010) and distributed over all kingdoms of life 
(with at least 25 forms in human), MDRs can be clustered in close to 500 families. The larger part of these is 
purely of bacterial origin, contrasting with only 14% of pure eukaryotic origin. Among the largest MDR 
families, we account the classical Zn-containing alcohol dehydrogenases, the NADP-binding prostaglandin 
reductases, the multidomain fatty acid synthases, quinone reductases, sorbitol/xylitol dehydrogenases and 
D-xylulose reductases (Hedlund et al., 2010). 
MDRs contain 350 to 400 amino acids and typically have a two-domain architecture, in which the C-
terminal subunit binds the coenzyme using the Rossmann-fold.  The N-terminal domain accommodates the 
substrate with a scaffold showing homology with the GroES-chaperon structure (Taneja & Mande, 1999) 
and which consists of antiparallel β-strands and surface-positioned α-helices. Most MDRs form 
homodimers or homotetramers; however, exceptions of monomers (Stoop et al., 1995) are known. 
MDRs can have none to two Zn2+ ions per subunit. In the case where one Zn2+ ion resides in the active site -
referred to as the catalytic Zn2+-ion- the metal is usually liganded by three residues, often two Cys residues 
and one His. The coordinated metal ion plays a dual role: apart from catalysis, Zn2+ contributes to maintain 
the architecture for coenzyme binding and allows conformational changes for the formation of a substrate 
binding pocket (Eklund & Ramaswamy, 2008). In proteins such as mammalian ADH, where two Zn2+ atoms 
are bound, a second Zn2+ ion, designated in literature as the structural Zn-ion, is kept in place by four nearby 
protein ligands. Having a stabilizing action on subunit interactions, the structural Zn2+ can modulate the 
quaternary structure of the protein (Jornvall, 1994, Eklund & Ramaswamy, 2008). 
Interestingly, there is a strong correlation between Zn2+ content and coenzyme preference. Despite 
exceptions to this rule, it was observed that MDRs bearing no Zn2+-atoms have a preference for NADP and 
usually act as reductases, while MDRs with two Zn2+-ions -functioning mainly as dehydrogenases- utilize 
NAD as a cofactor (Hedlund et al., 2010). 
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4. SHORT-CHAIN DEHYDROGENASES 
4.1. Introduction 
After the isolation of the first alcohol dehydrogenase from Drosophila melanogaster (the fruit fly) (Schwartz 
& Jornvall, 1976), structure analyses immediately showed distinct properties from the thus far studied yeast 
and mammalian dehydrogenases. To distinguish this enzyme from the other characterized ADHs, a novel 
superfamily originally called ‘insect-type alcohol dehydrogenases’ was introduced. Later, as all members 
shared a smaller protein chain length compared to other ADHs, the superfamily was rebaptized as short-
chain dehydrogenases/reductases (Jornvall et al., 1981, Kavanagh et al., 2008). While research in the 
seventies focused primarily on the Zn-containing liver and yeast ADHs, this superfamily came back into the 
spotlights when similarities were found with hydroxyprostaglandin from the human placenta, rat liver 11β-
hydroxysteroid dehydrogenase type I and other mammalian dehydrogenases (Kavanagh et al., 2008).  
Growing exponentially, today more than 47.000 primary structures of SDRs are annotated in sequence 
databases (Kallberg et al., 2010), representing 25% of all known dehydrogenases (Kallberg and Persson, 
2006). With sequencing projects on the way, these numbers are expected to increase further in the coming 
years.  
 
Within the human genome only, 202 SDR forms encoded by at least 82 genes have been discovered. Beside a 
role in the detoxification of xenobiotics, they appear to play pivotal roles in cell signaling, due to their 
involvement in steroid hormone, prostaglandin and retinoid metabolism (Kallberg et al., 2010). Not 
surprisingly, mutations paralyzing these important functions lead to diseases. As resumed in Table 1, 
several genetic defects in SDR enzymes were discovered and linked to human pathologies.  
Much under the attention today are the hydroxysteroid dehydrogenases, a family of enzymes responsible 
for the reduction and oxidation of hormones, fatty acids and bile acids in vivo. An excellent example to 
illustrate the physiological importance of SDRs in human is the case of 11β-hydroxysteroid dehydrogenase, 
of which two isoforms catalyse the interconversion of the principal circulating glucocorticoid: the 
hormonally inactive cortisone and active cortisol. Both glucocorticoid hormones can also bind aldosterone 
(mineralocorticoid) receptors, for which the inactive cortisone demonstrates much lower affinity than for 
cortisol. With glucocorticoids being secreted in far higher amounts compared to aldosterone (cortisol 
15mg/d versus aldosterone 150μg/d), 11β-HSD protects the body against excess stimulation of aldosterone 
receptors by regulating the cortisone/cortisol levels. Deficiencies in these isozymes thus lead to 
malfunctions in steroid signaling, a pathology referred to as ‘mineralocorticoid excess syndrome’ (AME) 
and which is characterized by symptoms such as high blood pressure, sodium retention and hypokalemia 
(Tomlinson et al., 2004). 
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Gene Associated pathologies Reference 
UDP-galactose-4-epimerase Type III galactosemia Timson, 2006 
Retinol dehydrogenase 5 (9cis/11cis) Retinitis punctata albescencs (RPA) Yamamoto, 1999 
Dihydropterine reductase Phenylketonuria Varughese, 1994 
2,4-dienoyl-CoA reductase Neonatal hypotonia and respiratory acidosis Roe, 1990 
Sepiapterin reductase Tetrahydrobiopterin (BH4) deficiency 
Parkinson’s disease-3 
Bonafe, 2001 
Sharma, 2006 
17β-hydroxysteroid dehydrogenase type 1 
17β-hydroxysteroid dehydrogenase type 3 
17β-hydroxysteroid dehydrogenase type 10 
Breast cancer 
Pseudohermaphroditism 
Alzheimer’s disease 
Gunnarsson, 2005 
Geissler, 1994 
Yan, 1997 
11β-hydroxysteroid dehydrogenase Apparent Mineralocorticoid Excess 
Obesity, hypertension and insulin resistance 
Osteoporosis 
White, 2001 
Wake, 2004 
Cooper, 2000 
3β-hydroxysteroid dehydrogenase type 2 Congenital Adrenal Hyperplasia Rheaume, 1992 
WWOX Carcinogenesis Bednarek, 2001 
Table 1: Single nucleotide polymorphisms in human SDR enzymes associated with diseases. 
 
On the other hand, some SDR members could be regarded as promising targets for medical or 
biotechnological applications. A review evaluating target selection for potential drug design indicates that 
the targets of the top 100 pharmaceutical drugs are not human genes that directly cause disease, but are key 
biochemical switches that produce a desirable change in the physiological state of the organism, which in 
turn alter or abrogate an ongoing disease process (Zambrowicz & Sands, 2003). Several pharmaceutical 
companies, like Innventis (www.innventis-pharma.com), develop drugs aiming for the inhibition of specific 
short-chain dehydrogenases. Targets can be of microbial origin, such as the enoyl-ACP reductases from 
E.coli (Sivaraman et al., 2004, Ward et al., 1999), M.tuberculosis (Luckner et al., 2010) and S.aureus (Xu et al., 
2008), which are readily inactivated by inhibitors such as triclosan and other diphenyl ethers.  
Others focus on human proteins, especially on hydroxysteroid dehydrogenases. In endometriosis and 
hormone-dependent cancers such as breast and prostate cancer, 17β-HSDs have a crucial role in supporting 
cell proliferation. In this field, the development of specific inhibitors tackling 17β-HSD type 1, whose levels 
are increased in tumors of patients with hormone-dependent breast cancer and which thus lead to increased 
conversion of estrone to the biologically active estradiol, is the most advanced (Day et al., 2008). 
4.2. General architecture and typical sequence motifs in SDRs 
Consisting of enzymes between 250 and 350 amino acids in length, SDRs are not dependent on metal 
cofactors as medium-chain dehydrogenases/reductases are. 3α,20β-Hydroxysteroid dehydrogenase (Ghosh 
et al., 1991, Ghosh et al., 1994) and dihydropteridine reductase (Varughese et al., 1992) were among the first 
short-chain dehydrogenases whose crystal structure was resolved. At present, approximately 300 SDR 
structures are deposited in PDB. In spite of the low pairwise sequence identity –balancing between 15% and 
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30% (Oppermann et al., 2003) between SDR members- this divergence in primary structure is not seen at the 
tertiary level. Superposition of the α-carbon traces of several SDRs indeed reveals that the three-
dimensional organization of these enzymes is strongly conserved (Fig 5). 
 
 
Fig 5. Superposition of the α-carbon traces 
of 5 SDRs shows the overall conservation of 
the tertiary structure despite low pair-wise 
sequence identity. A monomer of the crystal 
structures of E. coli β-ketoacyl-ACP 
reductase (FabG; PDB-code: 1Q7B - green), C. 
testosteroni 3β/17β hydroxysteroid 
dehydrogenase (PDB-code: 1HXH - blue), D. 
melanogaster alcohol dehydrogenase (PDB-
code: 1MG5 - pink), C. lunatus 17β 
hydroxysteroid dehydrogenase (PDB-code: 
3QWH - grey), M. musculus carbonyl 
reductase (PDB-code: 1CYD - orange) are 
represented as ribbons. The overlap also 
demonstrates the identical locations of the 
bound coenzymes (circle), and the variability 
around the substrate-binding loop (top). 
 
 
 
Short-chain dehydrogenases/reductases exist mostly as soluble proteins; however, membrane-bound SDRs 
were also reported. While SDRs are in most cases active as dimers or tetramers, examples are known of 
monomeric variants. Based on their oligomeric behavior only, three groups are thus observed in the SDR 
superfamily: 
• monomeric SDRs: e.g. human carbonyl reductase CBR1 (Wermuth, 1981), pig testicular carbonyl 
reductase PTCR (Ghosh et al., 2001) 
• homodimeric SDRs: e.g. Sniffer (Sgraja et al., 2004), Drosophila ADH (Benach et al., 2000), 
dihydropterine reductase (Varughese et al., 1992) 
• homotetrameric SDRs: e.g. 3α/20β-HSD (Ghosh et al., 1994), mouse lung carbonyl reductase 
MLCR (Tanaka et al., 1996)  
Within the homodimeric and homotetrameric SDRs (the most frequently observed oligomeric states in the 
SDR superfamily), interactions between structural elements occur around the mutually perpendicular P- and 
Q-symmetry axes. Q-interfacial dimer contacts are seen in both homotetrameric and homodimeric SDRs, 
but are particularly important for the latter (Fig 6). Here, the respective α5- and α6-helices from each 
monomer come in close contact to form a four-helical bundle. As the Q-dimer interface is not distantly 
located from the catalytic binding site and as the amino acids surrounding the catalytic triad are probably 
interacting with the α6 helix, the formed helical bundle motif provides stability to the active site cleft 
(Tsigelny & Baker, 1995), a requirement for normal enzyme function. Indeed, amino acid substitutions 
leading to a disrupted four-helix arrangement results in inactive protein aggregates (Ghosh et al., 2001, 
Puranen et al., 1997). From this point of view, proteins such as human CBR1, which have an additional 
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extraloop-domain between strand β5 and helix α6, are restricted in the formation of a four-helical bundle, 
which explains their monomeric state. Furthermore, homotetrameric SDRs attain their quaternary structure 
by inter-subunit contacts along the P-axis interface, provided by antiparallel interactions between strand β7 
and helix α7 of each monomer. Nonetheless, the P-axis interface involves a smaller surface area of 
association, is less conserved and less critical to enzyme function than the Q-axis interface (Ghosh et al., 
1994). 
 
 
 
 
 
Fig 6. The quaternary structure of E. coli FabG 
(PDB-code: 1Q7B) with the molecular axes P 
and Q. Along the Q-axis, the interface between 
both monomers is hallmarked by 4 helices (blue 
and purple), building up an important structural 
motif. 
 
 
 
 
 
 
Beside the general α/β folding pattern of the Rossmann-fold signature, SDR membership is defined by few, 
but distinct sequence motifs (Table 2 and Fig 7). Amongst them, (i) an N-terminal Gly-rich region to 
facilitate cofactor binding, (ii) an active site tetrad formed by the conserved Asn-Ser-Tyr-Lys residues, (iii) 
the NNAG motif involved in β-sheet stabilization, and (iv) single residues coordinating and orienting the 
coenzyme (Oppermann et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
P 
Q 
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Table 2. Sequence motifs found in SDR enzymes -Based on (Oppermann et al., 2003) 
Motif Function 
GxxxGxG Coenzyme binding region 
Maintenance of the central β-sheet 
D or R Stabilization of adenine ring pocket 
NNAG Stabilization of central β-sheet 
N Active Site 
S-Y-K Active Site 
N Connection of substrate binding loop and active site 
PG Reaction direction 
T Hydrogen bonding to carboxamide of nicotinamide ring 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7. Schematic diagram with the positions of the most conserved residues in SDRs (> 70% sequence 
identity; orange). !-Helices are shown as circles, "-strands as squares. X can be any amino acid. Based on 
(Duax et al., 2003). 
4.3.  Classification 
The fact that various SDRs can be found in nearly every species annotated so far and that the structure-
function relationships of these enzymes are well conserved point towards a very early evolutionary origin. It 
is now recognized that SDRs form one of the oldest protein families. Their presence in high numbers in 
early life forms, such as in viruses where lateral gene transfer is known to commonly occur, may explain the 
widespread nature and diverse types of activity observed in the SDR superfamily. Indeed, SDRs demonstrate 
half of all activity types (dehydrogenase/reductase (EC 1), lyase (EC 4) and isomerase (EC 5) activity), a 
great divergence that is rarely observed in protein superfamilies (Jornvall et al., 1995, Kavanagh et al., 2008).  
At present, 47.000 sequences in protein databases are linked to the SDR superfamily, of which about 68% can 
be assigned to one of the 314 families defined by Hidden Markov Models (HMMs). The species distribution 
of these families is analogous to that of MDRs: the greater part (57%) is unique to bacteria, with only 13% 
being solely eukaryotic (Kallberg et al., 2010). 
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SDR proteins (table 3) can roughly be categorized into five classes: the ‘classical’, ‘divergent’, ‘extended’, 
‘complex’ and ‘intermediate’ SDRs. At the second level, members of the classical and extended families can be 
subdivided into 7 and 3 subfamilies, respectively, based upon coenzyme-binding residue patterns (Persson 
et al., 2003). The first defined families, the classical and extended SDRs (Jornvall et al., 1995), comprise more 
than 75% of all short-chain dehydrogenases (Persson et al., 2003) and are both defined by an YxxxK active 
site, in which the tyrosine serves as the critical catalytic residue. In most cases, a serine and asparagine 
residue precedes this highly conserved signature. Differences between both classes are mainly situated 
around the overall length of the SDRs, their enzymatic properties and the N-terminal Gly-rich motif. 
Classical SDRs, like steroid dehydrogenase and carbonyl reductase, are mainly oxidoreductases of about 
250 residues long and with a TGxxxA/GxG sequence for nucleotide cofactor binding. With a typical length 
of 350 residues, the extended SDRs naturally have additional elements in the C-terminal region and are 
further characterized by a TGxxGxxG motif. Besides oxidoreductions, members of this family can perform 
isomerase or lyase reactions. The class of intermediate SDRs is formed by a group of alcohol 
dehydrogenases found only in insects, of which Drosophila melanogaster ADH is a member. The large size 
of this class can be explained by very extensive research on the genome of the fruit fly. Several resemblances, 
in overall size and sequence motifs, are found between intermediate and classical SDRs. However, a 
frequently occurring alanine residue in the G/AxxGxxG/A Gly-motif and a NGAG instead of NNAG motif 
generally characterizes intermediate SDRs. The NADH-binding divergent SDRs, including enoyl 
reductases from plant and bacteria, do not have the classical catalytic tetrad and the typical glycine-rich 
motif found in classical SDRs. Instead, they are hallmarked by a GxxxxxSxA cofactor binding sequence and a 
YxxMxxxK (or YxxxMxxxK) active site motif. Being differently organized at the primary structure level, 
divergent SDRs nevertheless have the catalytically important tyrosine and lysine residues in close 
conformation. The last class, the complex SDRs, encompasses multifunctional enzyme complexes such as 
the ketoreductase domains of fatty acid synthase. This group has the unique GGxGxxG NAD(P)-binding 
motif and an altered active site, YxxxN, rather than the for SDRs common YxxxK (Persson et al., 2003). 
 
Table 3. Features of the five SDR families – Based on (Hoffmann & Maser, 2007). 
x, any amino acid residue. Brackets denote alternatives. 
 
 Classical Extended Intermediate Divergent Complex 
Monomer size ≈ 250 aa ≈ 350 aa ≈ 250 aa   
Cofactor NAD(P)(H) NAD(P)(H)  NADH NADP(H) 
Cofactor binding motif TGxxx(A/G)xG (S/T)GxxGxxG (G/A)xxGxx(G/A) GxxxxxSxA GGxGxxG 
Active site motif YxxxK YxxxK YxxxK YxxMxxxK YxxxN 
Sequence identity 
(according to Swissprot) 
8-99% 10-99% 27-99% 28-99% 20-74% 
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4.4. Commonalities of SDRs with the Aldo-Keto Reductase family 
Since hydroxyl-groups are less toxic and easier to eliminate from the cell than the reactive ketone and 
aldehyde moieties of certain substances, carbonyl reduction is regarded as an important part of the phase I 
detoxification machinery. The cell is continuously confronted with the threat of carbonyl-bearing 
compounds which are common in the environment, but which can also be produced endogenously as part of 
normal cell processes such as lipid peroxidation or hormone metabolism (Hoffmann & Maser, 2007). It is 
thus not surprising that enzymes catalyzing these steps are ubiquitous in nature and found in all life forms, 
from bacteria and yeast to plants and mammals. Based on their amino acid sequence, carbonyl-reducing 
enzymes were initially split in three groups and got corresponding EC-numbers: the aldehyde reductases 
(EC 1.1.1.2), the aldose reductases (EC 1.1.1.21), and the carbonyl reductases (EC 1.1.1.184) (Bohren et al., 
1989, Wermuth et al., 1988). A decade later, further research revealed that these enzymes can be assigned to 
one of two large protein superfamilies: the aldo-keto reductases enclosing the aldehyde and aldose 
reductases (Jez et al., 1997), and the short-chain dehydrogenases/reductases (Jornvall et al., 1995) 
comprising the members of the carbonyl reductase group. 
  
Found in eukaryotes and prokaryotes, aldo-keto reductases are a growing family of mainly monomeric 
(multimeric forms are known in the AKR6 and AKR7 families) NADPH-dependent oxidoreductases with 
an overall length of approximately 320 amino acids. The conserved fold consists of an (α/β)8 –barrel (or TIM 
barrel), but clearly misses a Rossmann-fold motif for coenzyme binding. In this case, binding of the cofactor 
is achieved through important conformational changes leading to the reorientation of a loop. Their active 
site is built up by four conserved amino acids: Tyr, His, Asp and Lys. Aldo-keto reductases metabolize a 
wide range of substrates, including steroids and prostaglandins, xenobiotic ketones and aldehydes, sugars 
and bile acids (Jez et al., 1997). Despite overlapping substrate specificities with SDRs, there are thus no 
structural similarities between both superfamilies. 
 
5. COENZYME POSITIONING AND PREFERENCE 
5.1. Specific motifs for coenzyme binding in SDRs 
Kallberg and coworkers (2006) demonstrated that, over all kingdoms, NAD-coenzymes are the most 
preferred ones, while FAD are the least. Several studies identified the residues allowing cofactor binding. In 
most dehydrogenases, the top of the β1α2β2 region in the Rossmann fold is typified by three conserved 
glycines surrounded by hydrophobic residues. These Gly residues form the so-called Gly-rich N-terminal 
motif, which in a large group of SDR proteins can be found as the sequence TGxxxGIG (Duax et al., 2003). 
While the second Gly takes part in dinucleotide binding, the first and third Gly participate in the packing of 
the β-strands and α-helix (Wierenga et al., 1986).  
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Except for this motif, two other conserved signature sequences are implicated in the coordination of the 
cofactor: the NAG site in the connecting loop between β4 and α5, and the PG motif in strand β6. The backbone 
atoms of the NAG residues -which are conserved at levels of 72% or more- make all water-mediated 
contacts with the cofactor, while in the IxVNxxxPG-sequence the interactions with the cofactor are direct. 
The Pro in the PG-motif is highly conserved (occurring >90%) and participates, together with a nearby Gly, 
in a network of short contacts with the nicotinamide ring. One of them is an essential and strong hydrogen 
bond between the Gly carbonyl group and the hydride transfer site (NC4) of the cofactor. Influencing the 
transfer, this and other H-bonds of the network are likely indispensable for normal catalytic efficiency 
(Duax et al., 2003). High resolution crystal structures also demonstrate the importance of three conserved 
water molecules, found on identical positions in NAD(H)- and NADP(H)-binding SDRs, which appear to 
link the cofactor to the enzyme. One of them is found in all Rossmann-fold containing proteins and is now 
considered to be an inherent feature of this scaffold (Bottoms et al., 2002). 
 
Furthermore, the chemical properties of some of the highly conserved amino acids predestine SDRs to bind 
either NADP(H) or NAD(H). These determining regions, allowing cofactor binding and differentiation 
between NADP(H) and NAD(H), are largely authenticated to (i) the connecting turn between strand β1 and 
helix α2 containing the N-terminal GxxxGxG motif, (ii) the connecting loop between strand β2 and helix α3, 
and in some cases (iii) a flexible loop covering the substrate binding pocket when substrate is bound.   
The nature of the residues at the end of the β2 strand is one of the elements determining coenzyme preference. 
Generally, NAD- and FAD-preferring enzymes carry an acidic residue in this position. In the latter case, 
the phosphate group in NADP would confer steric hindrance. The presence of an Asp residue at this 
position, forming hydrogen bonds with the 2’ and 3’ hydroxyl groups on the adenine ribose, seems to 
determine the preference for of NAD(H) over NADP(H) (Fig 8).  
 
Fig 8. The association between Asp and NAD in the 
overlaid structures of 3!, 20" hydroxysteroid 
dehydrogenase (PDB-code: 2HSD - green), 7! 
hydroxysteroid dehydrogenase (PDB-code: 1FMC -
cyan) and rat liver dihydropteridine reductase (PDB-
code: 1DHR - magenta). The bifurcated hydrogen 
bonds to both the 2’ and 3’ hydroxylgroups of the 
ribose are shown as dashed lines. -Based on (Duax et 
al., 2003) 
 
 
NADP-binding SDRs, instead, typically have two positively charged residues to interact with the 
coenzyme, one located at the C-terminal end of β2, the other positioned before the second glycine of the Gly-
motif (see further). In most cases, a strong correlation exists between the presence of an Arg residue in the 
β2α3 turn and NADPH binding. The guanidinium moiety of the Arg side chain forms two hydrogen bonds 
with the 2’-phosphate group of NADPH, thereby assisting in the compensation of its intrinsic negative 
charge. Secondly, the Arg also provide cation-pi stacking interactions with the adenylyl heterocycle (Fig 9).  
 
NAD 
D 
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Fig 9. The association between Arg and NADP in the 
overlaid structures of mouse lung carbonyl reductase 
(PDB-code: 1CYD - green)  and mouse 
sepiapterin reductase (PDB-code: 1OAA -blue). 
Hydrogen bonds are shown as dashed lines. -Based on 
(Duax et al., 2003) 
 
 
 
Mutation of a residue such as Arg, crucial to cofactor binding, can dramatically alter enzymatic activity. It 
were the naturally occurring mutations R80Q (Geissler et al., 1994) and R80W (Bilbao et al., 1998) of 17β-
HSD-3 which due to a compromised testosterone production led to pseudohermaphroditism in men, that 
indicated that the absence of Arg in this position completely abolishes SDR activity. Site-directed 
mutagenesis experiments (McKeever et al., 2002) demonstrated that the lack of activity relates directly to an 
aberrant binding of the NADPH cofactor. This stabilizing action of arginine appears to occur not only in 
SDRs, but also in other NADPH-binding enzymes, such as glutathione reductase, 6-phosphogluconate 
dehydrogenase and trypanothione reductase (Tanaka et al., 1996). 
 NADPH-binding SDRs usually count on a second basic residue, located at the 4th position of the GxxxGxG 
consensus sequence, to further neutralize the negative charge of the 2’ phosphate of the dinucleotide cofactor. 
Such a residue is conserved in approximately 50% of the NADP(H)-preferring enzymes (Mazza et al., 1998). 
5.2. Substrate binding loop 
The crystal structures of a mutated 17β-HSD-1 revealed that the residues from a distorted loop between 
strand β6 and helix α7 -the so-called substrate binding loop- can also participate in cofactor-binding (Mazza 
et al., 1998). In this case, charge compensation of the 2’ phosphate group of NADP(H) is further provided by 
an unusual interaction with a Lys side-chain from this loop region. Comparison of several 3D-structures of 
SDRs revealed that the substrate binding loop is very flexible when cofactor and substrate are not bound. 
Most SDRs are supposed to follow a compulsory ordered mechanism, whereby binding of the coenzyme is 
followed by the substrate. Upon complex formation, the substrate binding loop becomes well ordered, 
usually as a helix (Grimm et al., 2000). The stabilization of this loop is mediated by direct interactions with 
cofactor and substrate. The loop contains a number of hydrophobic residues such as Phe and Met, whose 
character will help to shield the substrate binding pocket from the aqueous environment and to stabilize the 
transition state (Mazza et al., 1998). 
The substrate binding loop is often delineated by two prolines: one at the C-terminal end of β6 and part of the 
PG-motif, the other at the N-terminal side of the α7 helix. Both are thought to prevent the propagation of 
NADP 
R 
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conformational changes to the rest of the protein (Tanaka et al., 1996). Except for the catalytic triad Ser-Tyr-
Lys, no conserved amino acids can be pointed at in the substrate-binding site (Duax et al., 2000).  
Conserved residues identified within SDR structures are primarily located in the core of the Rossmann-fold 
and around the cofactor binding pocket, respectively playing a role in stabilization of the overall fold and in 
cofactor binding. The lack of conservation and the great flexibility observed in this region is assumed to be 
responsible for the broad substrate spectrum of these proteins (Grimm et al., 2000). 
6.  ON THE MODUS OPERANDI OF SDRS   
6.1.  Substrate specificity 
The boom in annotated SDR-enzymes in the last decades is accompanied by the discovery of a plethora of 
functions and associated substrates. Figure 10 illustrates the broad substrate specificities of SDR enzymes, 
including different steroids, retinoids, sugars and several xenobiotics. Remarkably, the depicted SDR 
substrates display very divergent structures, from large to small, with a few or many polar groups. As the 
overall fold is largely conserved in the SDR superfamily, it is assumed that substrate specificity evolved 
later than the dehydrogenase function. From this point of view it is not surprising that several SDR enzymes 
showing activity with a same substrate can nonetheless have different cellular localizations, cofactor 
specificities, substrate affinities, tissue distributions or directions of reaction.  
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Fig 10. SDR family members display an enormous substrate specificity spread, regulating diverse 
biological processes. (a) Hydroxysteroid dehydrogenases play a crucial role in the biosynthesis and 
inactivation of steroid hormones. By catalyzing the interconversion between receptor-active and receptor-
inactive forms of the hormone, they control the signaling pathway leading to transcriptional regulation 
(Duax et al., 2000). (b) SDRs are also key players in the sugar metabolism. One of its representatives, UDP-
galactose-4-epimerase, or GALE, catalyses the last step of the Leloir pathway of galactose metabolism where 
UDP-galactose is converted to UDP-glucose. (c) Other SDRs are implicated in the metabolism of lipids and 
amino acids. As an example, a bacterial L-threonine dehydrogenase catalyses the NAD-dependent 
dehydrogenation of L-threonine, to form a product that will lead to glycine and acetyl-CoA. (d) SDRs can 
also provide the biosynthesis of certain important cofactors. Sepiapterin reductase triggers the synthesis 
of tetrahydropterin (BH4), the cofactor needed by nitric oxide synthase and aromatic amino acid 
hydroxylases. The latter are involved in signaling pathways, since they produce molecules such as nitric 
oxide and precursors of the catecholamine neurotransmitter, respectively. e) SDRs participate in the first-
line defense against xenobiotics and endogenously produced toxic metabolites. Among these, we account 
the reactive aldehydes derived from lipid peroxidation (acrolein, 4-hydroxynonenal,…) (Hoffmann & 
Maser, 2007), as well as quinones which play pivotal roles as redox catalysts in biological processes (e.g. 
coenzyme Q in the respiratory chain, or vit E, protecting lipids of biological membranes against lipid 
peroxidation), but which also may be toxic to the cell by a number of mechanisms. From this perspective, 
human CBR1 is crucial in detoxification, as quinones are one of the best substrates of these enzymes 
(Wermuth, 1981). Furthermore, many keto-drugs and even the aliphatic keto side chain of anthracycline 
anticancer drugs, like DRC and DOXO, can be reduced by SDRs (Felsted & Bachur, 1982). Similarly, the 
presence of 3α-hydroxysteroid dehydrogenase in the bacterium Comamonas testosteroni provides 
resistance to the antibiotic fusidic acid (Oppermann, 2006).  
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6.2. The active site residues 
According to the original studies on SDRs, the highly preserved Ser-Tyr-Lys triad constitutes the active site 
(Jornvall et al., 1995). However, since a couple of years, the importance of a fourth conserved residue, Asn, 
can not anymore be overlooked and, when referring to the active site residues, the triad is now extended to a 
tetrad (Filling et al., 2002). These four amino acids, critical for enzyme function, are conserved with 94, 94, 
96 and 97% sequence identity respectively (Duax et al., 2003) and appear to maintain a conserved position 
relative to the scaffolding of the βαβ-folding and the position of the cofactor (Hoffmann & Maser, 2007). 
 
Table 4. Overview of the reported mutations of active site residues in SDR and their observed effect on 
activity 
 
SDR enzymes are thought to work through a general acid-base mechanism where a highly conserved Tyr-
residue acts as a catalytic acid or base. Briefly, deprotonation of the hydroxyl functional group is facilitated 
by a nearby Lys. Together with an adjacent Asn and the 2’-hydroxyl group of the nicotinamide ribose, the 
former participates in a stabilizing hydrogen network. The serine residue of the catalytic tetrad keeps the 
substrate in position, close to the catalytic acid/base, to ease a proton relay between the substrate and the 
coenzyme (Fig 11).  
Much of the research on the catalytic reaction mechanism of SDRs was achieved using 3β/17β 
hydroxysteroid dehydrogenase (E.C.1.1.1.51) from the Gram-negative bacterium Comamonas testosteroni 
as a model system (Jornvall et al., 1995, Oppermann et al., 1997, Filling et al., 2002). This member of the 
SDR-family catalyzes oxo-reductase and beta-dehydrogenase reactions at positions C3 and C17 of several 
steroids, including hormones and isobile acids. A combination of techniques such as chemical 
modifications, site-directed mutagenesis, and structural and kinetic analyses revealed the importance and the 
role of some residues in SDRs. In the following paragraphs we will give an overview of these functions. 
Mutation Protein Observed phenotype Reference 
S38A 15-Hydroxyprostaglandin dehydrogenase (Human) Loss of function Ensor & Tai, 1996 
S138A 3β/17β-Hydroxysteroid dehydrogenase (Comamonas) Loss of function Oppermann, 1997 
S138T 3β/17β-Hydroxysteroid dehydrogenase (Comamonas) Similar activity Oppermann, 1997 
S179C, T or V Retinol dehydrogenase 10 (Human) Loss of function Takahashi, 2009 
S139A or C Alcohol dehydrogenase ( Drosophila) Loss of function Cols et al., 1997 
Y151F or S 15-Hydroxyprostaglandin dehydrogenase (Human) Loss of function Ensor & Tai, 1991 & 1994 
Y151F 3β/17β-Hydroxysteroid dehydrogenase (Comamonas) Loss of function Filling, 2002 
Y179F or S 11β-Hydroxysteroid dehydrogenase (Human) Loss of function Obeid & White, 1992 
Y152F, H or E Alcohol dehydrogenase ( Drosophila) Loss of function Chen, 1993 
K155Q or L 15-Hydroxyprostaglandin dehydrogenase (Human) Loss of function Ensor & Tai, 1994 
K183R 11β-Hydroxysteroid dehydrogenase (Human) Loss of function Obeid & White, 1992 
K156I Alcohol dehydrogenase (Drosophila) Loss of function Chen, 1993 
N111L 3β/17β-Hydroxysteroid dehydrogenase (Comamonas) Loss of function Filling, 2002 
N179A 3β/17β-Hydroxysteroid dehydrogenase (Comamonas) Loss of function Filling, 2001 
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Fig 11. NADPH and key residues in the active site of E.coli FabG. The N110, Y151, and K155 residues 
interact with the cofactor as shown (PDB-code: 1Q7B). Hydrogen bonds are indicated as dashed lines, the 
connecting water molecule as a red sphere. Labels indicate distances in Å.  
 
The hydroxyl-group of Tyr was easily identified to be crucial for enzymatic reactions as it is the only 
residue almost completely conserved in SDR enzymes. Not surprisingly, it probably is the most frequently 
mutated amino acid in this family. Site directed-mutagenesis, replacing this Tyr by another residue, e.g. Phe, 
completely abolishes the activity (Jornvall et al., 1995). The pKa of the hydroxyl moiety of Tyr varies 
between 9.7 and 10.2 in solution. However, in the cofactor-bound local environment of the active site of 
short-chain dehydrogenases, the pKa of the functional group is much lower. According to some 
investigators (Hwang et al., 2005), the side chain of the catalytic tyrosine in 3α-hydroxysteroid 
dehydrogenase has a value of 7.2. As such, the deprotonated phenolic group of tyrosine can act as a general 
acid and donate a proton to the carbonyl group of the substrate in reduction reactions.  
Since the pKa of tyrosine shifts to 9.1 when the neighboring Lys is mutated to Ala, the latter is irrevocably 
implicated in priming the catalytic Tyr for the enzymatic reaction. This phenomenon is explained by 
electrostatic interactions occurring between the positive charge of the ε-aminium ion of Lys and the 
hydroxyl group of Tyr, leading to deprotonation of the hydroxyl group. Replacement of Lys with Ala 
evidently abolishes these electrostatic interactions and the concomitant pKa-lowering. Furthermore, the Lys 
residue demonstrates bifunctionality, forming also hydrogen bonds with the two hydroxyl groups of the 
nicotinamide ribose moiety (Hwang et al., 2005).  
 
The serine residue preceding the YxxxK signature appears to support the catalytic mechanism by direct 
hydrogen bonding with the substrate, the reaction intermediate and the product (Grimm et al., 2000). The 
hydroxyl side chain of serine has thus a stabilizing and polarizing function. This ability to form hydrogen 
bonds probably explains why the measured activities are similar to those recorded for the wild-type when 
NADPH 
Y151 
S138 
N110
 ! "#$%!
K155 
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serine is mutated to threonine (Oppermann et al., 1997). Alternately, since its pKa can also be lowered by the 
nearby Lys, the same residue was found to act as a general base to rescue in part the catalytic oxidation 
mechanism in the Y155F mutant of 3β/17β-hydroxysteroid dehydrogenase (Hwang et al., 2005). 
 
The fourth residue involved in catalysis, Asn, was identified to be important in maintaining an active site 
configuration due to its role in the building up of a proton relay network during catalysis. The connection 
with the other residues involved in the first steps of the proton shuttle is based on the presence of a shared 
hydrogen-bonded water molecule between the Lys and Asn of the catalytic tetrad. Remarkably, the Asn 
residue is nearly invariably located within the α5-helix, at a position where the helix is sharply twisted. This 
kink presumably forces the Asn to connect its backbone carbonyl group to a water molecule instead of the 
amide group of a nearby amino acid. Except for its contribution to the hydrogen network, the latter in this 
way also stabilizes the position of the active site Lys (Chang et al., 2010). Such a traffic of protons through 
the protein scaffold, along a route of hydrogen-bound amino acid side chains and water molecules, is 
elementary for catalysis in many enzymes. Here, the proton will thus be shuttled from the the bulk solvent 
to the substrate between the following essential participants: a water-molecule hydrogen-bonded to the 
backbone carbonyl of the Asn, the active site Lys, the ribose 2’-hydroxyl group, and the catalytic tyrosine 
(Benach et al., 1998, Filling et al., 2002, Filling et al., 2001, Chang et al., 2007) 
The way leading the protons to the solvent or vice versa is further paved with two to five water molecules. 
Forming a temporary proton reservoir, they reside in a largely hydrophobic cavity, lined by some well-
conserved amino acids whose side chains stabilize the water molecules and allow mutual proton transfer 
(Filling et al., 2002). 
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Fig 12. The reductive reaction of a steroid substrate by the NADPH-dependent 3!/20"  
hydroxysteroid dehydrogenase. First, the hydroxyl-group of the catalytic tyrosine forms a hydrogen bond 
with the carbonyl group of the substrate to form a ternary complex. The serine residue positions and 
stabilizes the substrate, while Lysine orients the cofactor by hydrogen bonding and lowers the pKa of the 
catalytic Tyr. In the following step, the tyrosine acts as a general acid that will donate a proton to the 
substrate. Consequently, the cofactor transfers a hydride, liberated from the C4 position at the S-face of the 
nicotinamide ring to the substrate, followed by dismissal of product and oxidized cofactor. Finally the 
hydroxyl-group of tyrosine takes up a proton from the solution, using a proton relay formed by the 
hydroxyl groups of the ribose, the Lys side chain, and water molecules. 
 
6.3.  Stereospecificity of the reaction 
In not a single known dehydrogenase, the hydride transfer to or from the pro-chiral carbon at the pyridine 
C4 position of the nicotinamide ring of NAD(H) or NADP(H) is stereorandom. Either the pro-R hydrogen 
atthe A-side of the ring or the pro-S hydrogen at the B-side of the ring is involved in the transfer. The 
number of dehydrogenases showing pro-S or pro-R specificity is comparable and depends totally on how 
the nicotinamide ring is positioned in the active site with respect to the bound substrate. It was shown that 
MDRs and AKRs utilize the pro-R hydrogen, while SDRs and LDRs solely use the pro-S hydrogen of 
NADPH in their reactions (Di Costanzo et al., 2009). In the case of short-chain dehydrogenases, the bound 
cofactor assumes an extended conformation, with the adenine ring in an anti- and the nicotinamide ring in a 
syn-conformation. 
6.4. SDRs with aberrant active sites 
While nearly all known SDRs to date display the highly conserved Asn-Ser-Tyr-Lys tetrad to perform their 
catalytic functions, a few examples in the literature are known of members missing this typical signature. 
These proteins demonstrate the versatility of the Rossmann fold to bear different active site configurations 
and to acquire other functions than the predominant oxidoreductions. 
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One of the best-studied short-chain dehydrogenases lacking the distinctive YxxxK active site motif is 
NmrA, a monomeric protein involved in the regulation of the nitrogen metabolism in the fungus Aspergillus 
nidulans. With MxxxK as active site residues, where methionine replaces the key catalytic tyrosine, it is 
unlikely that NmrA demonstrates any conventional SDR activity (Stammers et al., 2001). However, NmrA 
is able to efficiently discriminate between oxidized and reduced forms of the NAD(P)+ and NAD(P)H 
dinucleotide cofactors. Furthermore, ITC experiments revealed that NmrA could be complexed with a C-
terminal fragment of AreA, the first and only protein-protein interaction involving an SDR described to 
date. Since AreA is an essential GATA-type transcriptional regulator, stimulating the transcription of genes 
controlled by nitrogen metabolite repression, NmrA can link the redox status of the cell to transcriptional 
regulation through the interaction with AreA (Stammers et al., 2001, Lamb et al., 2003). 
 
The crystal structure is known of an unusual short-chain dehydrogenase from the hyperthermophilic 
archaea Aeropyrum pernix K1, where the Ser-Tyr-Lys catalytic triad is replaced by a unique Ser-Ser-Arg 
active site. Till now, no physiological function or catalytic activity could be assigned to this protein 
(Yamamura et al., 2008). 
 
The Q9HYA2 protein from Pseudomonas aeruginosa possesses all the hallmarks of the SDR protein family 
except one: the active center is built up by the sequence Lys-Ser-Thr-Arg. Orthologs carrying the same 
residues were found in 27 other organisms, all being β- or γ-Proteobacteria. The authors hypothesize that 
the Arg or Lys residue will reduce the normally high pKa of the adjacent Thr, thereby deprotonating and 
priming it for proton/hydride transfer. Since the substrate of this atypical SDR is still unknown, it is 
currently not possible to validate the proposed reaction mechanism (Huether et al., 2010). 
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Manuscript 1:  
 
Crystallization of an atypical short-chain dehydrogenase from Vibrio 
vulnificus missing the conserved catalytic tetrad 
Buysschaert G., Verstraete K., Savvides S.N., Vergauwen B. 
 
The manuscript was reviewed and published in Acta Crystallographica Section F as “Crystallization of an 
atypical short-chain dehydrogenase from Vibrio vulnificus lacking the conserved catalytic tetrad” 
Buysschaert G., Verstraete K., Savvides S, Vergauwen B. (2012)  F68, 771-774 
GB expressed and purified the recombinant protein. With contributions from KV, GB carried out all 
crystallographic studies. KV carried out the preliminary structural studies. 
 
 
ABSTRACT 
Short-chain dehydrogenases/reductases (SDR) are a rapidly expanding superfamily of enzymes found in all 
kingdoms of life.  Hallmarked by a highly conserved Asn-Ser-Tyr-Lys catalytic tetrad, SDRs have a broad 
substrate spectrum and play diverse roles in key metabolic processes. Locus tag VVA1599 encodes a short-
chain dehydrogenase in Vibrio vulnificus, hereafter referred to as SDRvv, which lacks the signature catalytic 
tetrad of SDR members. Structure-based protein sequence alignments have suggested that SDRvv may 
harbor a unique binding site for its nicotinamide cofactor. To date, structural studies of SDRs with altered 
catalytic centers are underrepresented in the scientific literature thus limiting our understanding of the 
spectrum of their substrate and cofactor preferences. Here, we present the expression, purification and 
crystallization of recombinant SDRvv. Two well-diffracting crystal forms could be obtained by co-
crystallization in the presence of the reduced form of the phosphorylated nicotinamide cofactor, NADPH. 
The collected data were of sufficient quality for successful structure determination by molecular 
replacement and subsequent refinement. This work sets the stage for deriving the identity of the natural 
substrate of SDRvv and the structure-function landscape of typical and atypical SDR.  
 
INTRODUCTION 
Vibrio vulnificus is a naturally occurring Gram-negative bacterium, colonizing coastal marine 
environments.  Ingestion of raw contaminated seafood such as oysters and clams or exposure of open 
wounds with infected water can lead to rapidly progressing fatal septicemia and necrotizing tissues, 
respectively. Being closely related to the causative agent of cholera, Vibrio vulnificus is responsible for the 
greater part of reported seafood-related deaths in the United States (Jones & Oliver, 2009).   
 
Genome analysis of this human pathogen revealed the presence of 25 genes coding for short-chain 
dehydrogenases (abbreviated as SDR). SDRs form an omnipresent and increasingly growing family of 
NAD(P)-dependent oxidoreductases distinct from the functionally related medium-chain 
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dehydrogenases/reductases (MDR) and aldo-ketoreductases by sequence length and characteristic sequence 
motifs (Filling et al., 2002). SDRs are functionally diverse and have been linked to a multitude of substrates 
involving them in many important cellular processes as diverse as sugar and nucleotide metabolism, steroid 
and hormone metabolism, redox sensing and phase I metabolism of many endogenous (biogenic aldehydes, 
reactive lipid peroxidation products) and xenobiotic (pharmacologic drugs, carcinogens, toxicants) 
compounds (Oppermann & Maser, 2000, Kavanagh et al., 2008, Hoffmann & Maser, 2007). Despite rather 
low pairwise sequence identities between members of the superfamily - typically ranging between 15 and 
30% - SDRs demonstrate a well-conserved tertiary architecture (Kallberg et al., 2002). The overall structure 
of the SDR superfamily members is built up of a sequence of alternating α-helices and β-strands. This 
dinucleotide-binding motif composed of βαβ units is called the Rossmann fold (Rossmann et al., 1974). 
Consistent with the observed weak mutual sequence similarity, classical SDRs only have a handful of 
strictly conserved residues, which appear at the core of the structure and in the Rossmann-fold to aid 
catalysis and cofactor stabilization respectively. Nearly all classical SDRs use the conserved Asn-Tyr-Lys-
Ser motif as catalytic residues, whereas a Gly-X-X-X-Gly-X-Gly motif is retained in the Rossmann-fold to 
accommodate the cofactors’ adenine nucleotide diphosphate.  
 
The product of the V. vulnificus YJ016 locus tag VVA1599, SDRvv, clusters within the “classical” SDR 
family, like the top-homolog identified by BLAST analysis of structurally resolved SDRs: the E. coli enoyl 
reductase FabG. Based on protein sequence alignments, SDRvv however, clearly misses the active site 
residues facilitating hydride transfer in this family of oxidoreductases. Among them, the catalytic tetrad Tyr 
and Lys residues which are also crucial for cofactor binding as they engage in hydrogen bonding with the 
nicotineamide ribose hydroxyl groups. The Y->K and K->N substitutions seen in SDRvv therefore have to 
abrogate catalytic proficiency. In addition to the absence of the catalytic tetrad, well-conserved amino acids 
shown by mutagenesis studies to be important for catalysis such as a Thr and the NNAG-motif at e.g. 
positions 10 and 85-88 respectively for the E. coli FabG (PDB accession number 1q7b), are also not retained 
in SDRvv (Filling et al., 2002). Furthermore, the Rossmann fold of SDRvv appears to be truncated, missing a 
large piece of the loop that joins helices α2 and α3.  
 
Here, we report the expression, isolation and preliminary crystallographic studies of recombinant SDRvv in 
the apo form and in complex with its cofactor NADPH. Crystals were obtained in cocrystallization 
experiments with NADPH, and one crystal form showed unbiased difference density that clearly 
demonstrated the presence of the bound NADPH cofactor at full occupancy. Therefore, this work identifies 
and delineates the reducing cofactor conformation of the “classical” family outlier SDRvv from Vibrio 
vulnificus. 
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EXPERIMENTAL PROCEDURES 
2.1. Cloning and expression 
The open reading frame VVA1599 encoding SDRvv from Vibrio vulnificus YJ016 (accession number 
NC_005140) was synthesized and inserted in the pUC18 plasmid by GenScript Corporation (Piscataway, 
New Jersey, USA). To facilitate the cloning procedures into the T7-inducible expression vector 
pACYCDuet-I (Novagen), unique NdeI and KpnI restriction sites were introduced at the N- and C-termini 
by PCR-amplification using 5’-CATATGATGGGATCAGACAAAACCG-3’ and 5’-
GGTACCCTAACCCAGCAGCGCGCC-3’ as sense and antisense primers respectively. Since the native 
stop codon is retained, SDRvv will be recombinantly expressed in its native state, i.e. without affinity tag. 
Electrocompetent BL21(DE3) E. coli cells were transformed with pACYCDUet-I-VVA1599 and cultured 
under continuous shaking at 37°C in Luria-Bertani (LB) medium supplemented with chloramphenicol. Full-
grown overnight precultures were subsequently diluted (ratio 1/100) in fresh medium and induced for 
expression by addition of a final concentration of 1mM IPTG when an optical density (OD600) of 0.6 was 
reached. After induction, cells were grown during minimally 4 hours in a rotary shaker at 37°C and 
harvested by centrifugation at 4000g for 30 min at 4°C. Cell pellets were resuspended in Buffer A (50mM 
Tris pH 8.5), and subsequently broken by sonication. 
 
2.2. Protein purification 
SDRvv was purified to homogeneity following a three-step procedure. First, the SDRvv-enriched lysate was 
loaded on a manual Q-Sepharose Fast Flow column, pre-equilibrated with Buffer A (50mM Tris pH 8.5). 
The protein was eluted with increasing concentrations of NaCl, using step gradients of 100mM. Fractions 
containing the recombinant protein were pooled and buffer-exchanged by dialysis against Buffer B (50mM 
Tris, pH 7.2). A second round of anion exchange chromatography was applied using a SourceQ column 
connected to an ÄKTA-system (GE Healthcare). Bound protein was eluted using a linear NaCl gradient and 
concentrated prior to size-exclusion chromatography (SEC, HiLoad 26/60 Superdex200 column [GE 
Healthcare]). SEC was performed using 50mM Tris, pH 8.0 and 150mM NaCl as the eluting buffer. The 
observed elution volume of the single SDRvv peak coincided with the predicted molecular weight of a 
tetramer (94 616 Da). At every stage, the purity of SDRvv was monitored using SDS-PAGE. The molecular 
weight and identity of the purified protein was further confirmed by MALDI-TOF mass spectrometry using 
peptide mass fingerprinting. 
 
2.3. Crystallization and data collection 
Purified SDRvv was concentrated to 8 mg ml-1 using centrifugal microconcentrators (10kDa MWCO; 
Centricon) and complexed with its corresponding nucleotide cofactor by addition of a molar excess of 
NADPH (1mM). This particular ligand was chosen on the basis of fluorescence-based thermal shift assays 
(probing oxidized and reduced forms of NAD and NADP; data not shown), and because of the presence of an 
Arg in the putative β2α3 turn which has already been shown in previous studies to be involved in NADP(H) 
binding (Geissler et al., 1994, Nakanishi et al., 1996, Tanaka et al., 1996). Interestingly, concentrating SDRvv 
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above 10 mg ml-1 initiated aggregation of the protein into easily visible flocks, which could be solubilized 
instantly by addition of NADPH. Notably, addition of up to 1mM of NAD+, NADH, or NADP+ proved 
inadequate for solubilizing the SDRvv aggregates.   
Prior to setting up crystallization drops, the protein solutions were centrifuged for 30 minutes at 20.000 x g 
(at 4 °C). Initial crystallization trials were performed at 293K in 96-well dual-drop MRC crystallization 
plates (Jena Bioscience) using the following commercially available sparse-matrix screens: Hampton 
Crystal Screen 1 & 2, Hampton Index Screen and Hampton PEG/Ion Screen 1 & 2 (Hampton Research). Each 
well was filled with 70μl of the corresponding reservoir solution, while the drops were set up using a 
Mosquito crystallization robot (TTP Labtech) by mixing equal volumes (100 nL) of protein and precipitant 
solution. The initial screens identified 15 crystallization hits that were characterized by the presence of 20-
25% (wt/vol) of low-molecular weight polyethylene glycols. Of these, two promising leads, 0.2 M 
ammonium acetate, 0.1 M Bis-Tris pH 6.5, 25% PEG3350 (A; Fig. 1a) and 0.1 M Bis-Tris pH 6.5, 20% 
PEG5000 (B), already producing suitably-sized crystals within 2 days, were further optimized by varying 
pH values as function PEG concentration and vice versa. For crystal morphology A, this approach did not 
improve crystal growth nor the X-ray diffraction quality of the collected crystals. Optimization of condition 
B led to growth of some well-defined triangular crystals besides the generally observed lamelliform beam-
shaped crystals (Fig. 1b). The triangular-shaped SDRvv-B crystals obtained from 0.1 M Bis-Tris pH 6.5, 
18% PEG5000 exhibited the better diffraction capacity and generally diffracted to Bragg spacings of 4 Å to 
2.5 Å. However, a single crystal diffracted to 1.80 Å and led to the reported dataset. 
 
 
Fig. 1. Single crystals of SDRvv from Vibrio vulnificus, co-crystallized with NADPH using the sitting-
drop vapour-diffusion method, belonging to the primitive monoclinic space group P21. (a) Crystals 
that appeared in 0.2 M ammonium acetate, 0.1 M Bis-Tris pH 6.5, 25% PEG3350 and referred to as crystals 
of morphology A (SDRvv-A). (b) Typical crystals grown in 0.1 M Bis-Tris pH 6.5, 18% PEG5000 for two 
days. The triangular-shaped crystal depicted with an arrow is referred to as a crystal with morphology B 
(SDRvv-B). Scale bars are 50 µm in length.  
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a. Data collection 
Crystals were transferred to a drop of mother liquor using of a nylon loop (Hampton Research) mounted 
onto SPINE standard cryocaps (Molecular dimensions, cat. No. MD7-406). Subsequently, crystals were 
cryoprotected by gradually adding an equal volume of mother liquor supplemented with 40% (v/v) PEG 
400. Crystals were then flash-cooled directly into liquid nitrogen and loaded into SPINE/ESRF pucks for 
storage and transport. Data sets were collected for two different crystal forms, SDRvv-A and SDSRvv-B to 
2.35 and 1.80 Å resolution, respectively. The corresponding data set statistics are summarized in Table 1.  
 
Table 1: Crystal data and data-collection statistics#  
!
# Values in parentheses refer to the highest resolution shell. 
a Rmeas = ∑h√nh/(nh-1) ∑h∑i|I(h,i)-‹I(h)›| / ∑h∑iI(h,i), where nh is the multiplicity, I(h,i) is the intensity of 
the ith   measurement of reflection h,  and ‹I(h)› is the average value over multiple measurements 
(Diederichs & Karplus, 1997).  
b Estimates of solvent content and Matthews coefficients were calculated via 
www.ruppweb.org/mattprob/ (Matthews Probability Calculator) (Kantardjieff & Rupp, 2003, 
Matthews, 1968). 
 
b. Data analysis 
Both crystal forms belonged to the monoclinic space group P21 and both were predicted to contain 1 
SDRvv tetramer per asymmetric unit on basis of their calculated Matthews coefficients (Table 1), resulting 
in a solvent content of 46 and 50 %, for crystal form SDRvv-A and SDRvv-B, respectively. The structure of 
SDRvv could be determined by maximum-likelihood molecular replacement (MR) as implemented in 
 SDRvv-A SDRvv-B 
     Date 
      
June 12, 2011 
 
July 18, 2011 
      Beamline PROXIMA1 (SOLEIL) X06SA (SLS) 
     Detector ADSC Q315 
 
Pilatus 6M 
      Temperature (K) 100 100 
     Wavelength (Å) 0.98011 0.99993 
     Number of crystals 1 1 
     Oscillation range per image (°) 0.5 0.2 
     Total oscillation range (°) 180 180 
     Resolution range (Å) 45.0 – 2.35 (2.49 – 2.35) 40.0 – 1.80 (1.91 – 1.80) 
     Space group P21 P21 
     Unit cell parameters (Å, °) a = 59.37, b = 122.89, 
c = 63.14, β = 111.09 
a = 69.63, b = 96.26,  
c = 72.11, β = 103.99 
     No. of observed relections 127 883 (19 059) 288 963 (45 106) 
     No. of unique reflections 34 318 (5 346) 84 971 (13 354) 
     Multiplicity 3.7 (3.6) 3.4 (3.4) 
     Data completeness (%) 97.0 (94.3) 
. 
99.1 (97.0) 
     aRmeas (%) 13.1 (68.4) 9.5 (56.1) 
     Mean I/σ(I)     10.6 (2.7) 10.5 (2.4) 
     Mosaicity (°) 
 
      
0.39 0.19 
      Wilson B (Å2) 29.17 18.78 
      No. of molecules in ASU 4 4 
     Solvent content (%) 45.8 50.4 
     bMatthews coefficient (Å3/Da) 2.3 2.5 
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Phaser (McCoy et al., 2007). A monomeric search model based on the structure of 3-oxoacyl-(acyl carrier 
protein) reductase from Thermotoga maritima (pdb 1O5I; Joint Center for Structural Genomics (JCSG), 
2003) was created by CHAINSAW (Stein, 2008) by pruning non-conserved residues to the C-gamma 
atom. An ensuing MR-search for crystal form A resulted in the consecutive placement of four copies of 
the search model creating a tetrameric assembly as in the homologous T. maritima structure. The 
reported Z-scores for the translation function (TFZ) were 3.8 (TFZ1), 8.0 (TFZ2), 7.6 (TFZ3) and 10.1 
(TFZ4). Subsequently, using the MR solution of crystal form A, a solution for crystal form B was easily 
obtained. Analyzing the crystal packing and the quality of calculated electron density maps indicated that 
the found MR-solutions were correct. Initial rigid body and coordinate refinement in Phenix (Adams et 
al., 2010) showed that contrary to crystal form SDRvv-A, crystal form SDRvv-B displayed strong and 
contiguous unbiased difference density for the cofactor at the active site of SDRvv (Fig. 2). SDRvv-A crystals 
therefore appear to contain protein crystallized in a unbound state despite the fact that SDRvv:NADPH–
complexed molecules prevail at the beginning of the crystallization experiment. Therefore, empty crystals 
strongly suggest a crystal packing in which the flexible motif (i.e. “the substrate binding loop”), shielding 
the cofactor binding site from the solvent in SDR family members, is not restrained as to allow mass action 
driven cofactor exchange. As NADPH oxidizes spontaneously and rapidly to NADP+, crystal growth takes 
place in a continuously changing environment containing increasing amounts of NADP+ at the expense of 
NADPH. Hence, SDRvv-active sites in crystal form A become empty only when the developing amounts of 
NADP+ (up to 1 mM) are not high enough to saturate the proteins, i.e. implicating a significant (> 10-fold) 
difference in affinity of SDRvv for NADPH compared to NADP+. Such a scenario implies that crystal 
contacts fix the substrate binding loop in the cofactor binding-proficient conformation in SDRvv-B crystals, 
and that the bound cofactor therefore retains its reduced form during crystal growth. 
While it remains uncertain whether SDRvv represents a catalytically competent reductase, the co-occurrence 
of SDRvv-homologues with divergently transcribed lysR-type transcriptional regulators in Vibrio species 
and other bacterial pathogens (Szklarczyk et al., 2010) establishes the possibility that SDRvv-like proteins 
fulfill a role in redox control of transcription. 
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Fig 2. Unbiased difference density map (Fo-Fc) in the vicinity of the NADP(H) cofactor, contoured at 
+3σ, confirms the presence of a bound cofactor in SDRvv-B. 
An NADPH molecule was manually docked in the positive difference density using COOT. The figure 
was generated by carving the map by a radius of 3.0 Å around the NADPH molecule in Pymol 
(Schrödinger). 
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Manuscript 2:  
 
Structural and biochemical characterization of an atypical short-chain 
dehydrogenase reveals an unusual cofactor preference 
Buysschaert G., Verstraete K., Savvides S.N., Vergauwen B. 
 
 
The manuscript is currently under review with FEBS Journal.  
GB expressed and purified the recombinant SDRvv. With contributions of KV, GB carried out all 
crystallographic studies. KV carried out the preliminary structural studies. KV and SNS solved the 
crystal structure. GB carried out the mutagenesis and ITC studies, with contributions from BV. GB 
performed the fluorescence assays and thermofluor experiments, with contributions from BV. 
 
 
ABSTRACT 
Short–chain dehydrogenases (SDR) encompass a large and functionally diverse family of enzymes with 
representative members in all kingdoms of life. Despite the wealth of reactions catalyzed by SDR, they 
operate through a well-conserved and efficient reaction mechanism centered in a conserved catalytic 
tetrad  (Asn-Ser-Tyr-Lys), and the employment of an appropriate cofactor. In recent years SDR that lack 
the signature catalytic tetrad have been identified, thus adding a perplexing twist to SDR functionality. 
Here, we present the crystal structure of SDRvv, a short-chain dehydrogenase from Vibrio vulnificus 
devoid of the catalytic tetrad, thereby defining the structural signature of this apparent SDR family 
outlier. Further structural analysis of SDRvv in complex with its putative cofactor NADPH, site-directed 
mutagenesis and binding studies via isothermal titration calorimetry and further biochemical 
characterization, have allowed us to dissect the cofactor preferences of SDRvv. The retained capacity to 
bind the NADPH cofactor, the conceivable existence of a proton relay and the conservation of the 
coordination distances between the key residues in the cofactor binding pocket, define a first set of rules 
towards catalytic activity for SDRvv. This work sets the stage for deriving the identity of the natural 
substrate of SDRvv and the structure-function landscape of typical and atypical SDR.  
 
INTRODUCTION 
Short-chain dehydrogenases/reductases (SDR) form an evolutionarily ancient and ubiquitous enzyme 
family found across a broad spectrum of life forms (Kallberg et al., 2002). Currently, more than 47,000 
primary sequences are annotated as SDR (Kallberg et al., 2010) which have been functionally linked to a 
host of metabolic functions based on a chemically diverse substrate repertoire, including the sugar and 
nucleotide metabolism, the detoxification of xenobiotics, the biosynthesis of hormones and cofactors, 
and the control of the cellular redox status (Lamb et al., 2003, Kavanagh et al., 2008).  Given such a 
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central role in cellular physiology, it is not surprising that inherited single-nucleotide polymorphisms in 
human SDR genes lead to altered SDR proteins that are closely associated with disease (Oppermann et 
al., 2001). In addition, a number of SDR proteins, such as the bacterial enoyl-acyl carrier protein (ACP) 
reductases involved in fatty acid biosynthesis (FAS-II pathway), have emerged as validated clinical drug 
targets (Lu & Tonge, 2008). Isoniazid for instance, one of the frontline drugs against tuberculosis 
(Rozwarski et al., 1998), is a potent inhibitor of InhA, a short-chain dehydrogenase from 
Mycobacterium tuberculosis participating in the production of the pathogen’s cell wall. 
 
Based on their sequence length on one hand and the presence of unique signature motifs on the other 
hand, SDRs cluster away from the closely related medium-chain dehydrogenases/reductases and the 
aldo-keto reductases respectively (Filling et al., 2002). SDR sequences are typically !250 residues long 
and adopt a conserved Rossmann fold (Kallberg & Persson, 2006), despite often low sequence identities 
(15-30%). Nevertheless, several sequence signature motifs can be identified, such as the glycine-rich 
dinucleotide binding motif TGXXXGhG (where h = hydrophobic residue) that delineates the bottom of 
the NAD(P)-binding site in oxidoreductases adopting the Rossmann fold. Another example is the 
NNAG motif stabilizing the central β-sheet of the Rossmann fold (Filling et al., 2002, Jornvall et al., 
1995). 
 
Nearly all SDRs rely for their activity on a set of four highly conserved active site residues, referred to as 
the catalytic tetrad: a YXXXK motif positioned on helix α6, a serine positioned on the loop following 
strand β5, and an asparagine located on helix α5. Numerous studies have attributed a key role to the 
tyrosine residue, operating as the central acid-base catalyst in SDRs thereby donating or abstracting a 
proton to or from the substrate. The ability of this Tyr residue to act as a catalytic acid/base is facilitated 
by an adjacent Lys residue that together with an oxidized, positively charged cofactor nicotinamide 
lowers the tyrosine hydroxyl pKa (Hwang et al., 2005). The active site Ser residue is believed to stabilize 
and polarize the carbonyl groups of the substrates/products, while the active site Asn stabilizes a water 
molecule that is in hydrogen-bonding distance to the active site lysine to form a proton relay system 
connecting bulk solvent to the active site Tyr residue (Filling et al., 2002). Furthermore, the active site 
lysine "-amino and tyrosine hydroxyl groups (Price et al., 2004) are involved in binding the 
nicotinamide ribose group, as point mutations at these positions disrupts or attenuates cofactor binding. 
 
Vibrio vulnificus, a Gram-negative bacterium colonizing marine and estuarine environments, is an 
emerging pathogen in humans causing wound infections, gastroenteritis or primary septicemia (Jones & 
Oliver, 2009). Analysis of the SDR repertoire of this organism by alignment of the primary amino acid 
sequences of these proteins, revealed the existence of an outlier within the SDR family. Although the 
product of locus tag VVA1599 (GenBank ID: BAC97625.1) - designated as SDRvv throughout this 
article – features the Rossmann-fold and conserved XGXXXGhG motif, the protein lacks all of the active 
site residues common to short-chain dehydrogenases. Moreover, the predicted Rossmann-fold of 
SDRvv appears to be functionally impaired due to a deletion of the residues that join strand β2 and helix 
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α3. Given such drastic deviations from canonical SDR sequence, SDRvv would appear to be functionally 
impaired with respect to catalytic activity and cofactor binding. To shed light into these questions and to 
understand the evolutionary traits of the SDR superfamily, we undertook structure-function studies of 
the SDRvv. Here, we reveal the structural and molecular basis of cofactor preferences in SDRvv and 
uncover a unique interaction landscape never seen before in SDR family members.  
 
RESULTS AND DISCUSSION 
 
SDRvv is an outlier within the classical SDR family 
Preliminary sequence alignments of SDRvv against other members of the SDR family had already 
suggested that with its 223 residues, SDRvv would probably approach a “minimal” core Rossmann-fold 
SDR structure. Indeed, 96% of all structurally characterized classical SDR homologues (more than 200 
structures were retrieved from the Protein Data Bank via FATCAT database searching 
(http://fatcat.burnham.org/)) are slightly larger proteins (the typical SDR monomer size is about 250 
residues (Kallberg et al., 2002, Jornvall et al., 1995)). A multiple amino acid sequence alignment 
comparing two well-studied prototypes of the classical SDR family, beta-ketoacyl-acyl carrier protein 
reductase (FabGEc) from the prokaryote E. coli (Price et al., 2004) and 17beta-hydroxysteroid 
dehydrogenase (17β-HSD) (Cassetta et al., 2011) from the eukaryote Cochliobolus lunatus, with the 
atypical SDRvv offers an explanation for the smaller size of SDRvv (Fig. 1). Although SDRvv shares a 
rather low 25% sequence identity with the two classical SDRs, which in turn are also 26% identical, the 
sequences align well globally with a notable exception around the region spanning helix α2 and strand β3. 
This region, has been shown to be important for accommodating the cofactor’s adenosine (2’-
phosphate) moiety in classical SDRs, but is conspicuously missing in SDRvv. Interestingly, the beta-
ketoacyl-acyl carrier protein reductase MabA from Mycobacterium tuberculosis ((Cohen-Gonsaud et al., 
2005) (pdb code:1uzn)) was also shown to carry a deletion in this region, albeit shorter by 7 residues and 
involving only helix α2 (Fig. 1). In fact, by also loosing strand β3, SDRvv appears to have adopted 
features reminiscent of the distantly related flavodoxin-topology that has evolved to bind FMN instead 
of NAD(P).  
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Fig 1. Multiple sequence alignment of canonical and atypical SDR homologs. The amino acid 
sequences of three classical SDRs (17β-HSD of Cochliobolus lunatus, FabG of Escherichia coli, and 
MabA from Mycobacterium tuberculosis) and three atypical SDRs (SDRrs from Roseobacter sp SK209-2-
6, SDRsp from Shewanella piezotolerans, and SDRvv from Vibrio vulnificus) were aligned using Multalin 
(http://multalin.toulouse.inra.fr/multalin). Top and bottom secondary structures were defined from the 
PDB coordinates for NADPH-complexed FabG and -SDRvv, respectively, using ESPript 
(http://espript.ibcp.fr/).The conserved Gly-rich patch for cofactor binding and the TXT-motif are 
shown in blue. A red circle depicts the 310 helices involved in NADPH coordination in SDRvv. The 
active site Asn-Tyr-Lys-Asn tetrad of canonical SDRs is colored in purple. 
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NADPH is the preferred ligand of SDRvv 
Given the fact that FMN lacks the nucleotide moiety found in NAD(P) and given the importance of the 
tyrosine and lysine catalytic tetrad residues in stabilizing the nicotinamide ribose hydroxyl groups, we 
wondered whether SDRvv would show any affinity for such a cofactor. To explore SDRvv’s capacity to 
bind a nicotinamide coenzyme, purified recombinant SDRvv was subjected to various binding studies. 
According to its predicted molecular weight, recombinant SDRvv runs as a ~24 kDa protein on SDS-
PAGE but elutes as a homotetramer during size exclusion chromatography (SEC) (Fig. 2A) in 
accordance with the quaternary structure of classical SDR family members (Kavanagh et al., 2008). 
 
 
Fig 2. Biochemical characterization of SDRvv and exploration of cofactor preferences. A) SDRvv 
eluted as a predicted homotetramer from a superdex 200 gel sizing column. The calibration standards 
used were: aldolase (158kDa), conalbumin (75 kDa), ovalbumin (43 kDa) and carbonic anhydrase (29 
kDa) respectively. B) Thermal shift assays for the initial screening of SDRvv’s cofactor preference. Apo-
SDRvv without (blue) or in the presence of – 1 mM each - NADPH (dark green), NADP+ (cyan), 
NADH (pink), or NAD+ (orange) was heated from 25 to 80 °C, and unfolding was monitored as 
described in Materials and Methods. C) & D) The emission spectra of apo-SDRvv (pink), free NADPH 
(blue) and NADPH-complexed SDRvv (orange) were recorded using excitation at 295 nm (panel C), or 
excitation at 340 nm (panel D).  
 
 
We employed two complementary lines of experimentation to probe cofactor binding. In the first 
instance, we used thermal denaturation assays using the well-established Thermofluor protocol (Niesen 
et al., 2007) to first probe cofactor preferences. Figure 2B shows the temperature-induced changes in 
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relative fluorescence of 50μM SDRvv as a function of oxidized and reduced NAD(P) cofactors at 1 mM. 
Only the 2’-phosphorylated coenzymes increased the melting temperature of the apo-form. NADPH 
brought forth the largest transition, which suggested that NADPH is preferred over NADP+. On the 
other hand neither NADH nor NAD+ appeared to interact at all or do so with non-physiologically 
relevant affinities. In case NADPH is a good SDRvv ligand, reciprocal effects on the intrinsic 
fluorescence of SDRvv and NADPH upon binary complex formation would be expected as already 
reported for a number of dehydrogenases/reductases. Figures 2C and 2D show that the intrinsic SDRvv 
fluorescence at 355 nm is quenched when NADPH is proffered to the protein (Fig. 2C), while the 
NADPH fluorescence at 462 nm simultaneously increases (Fig. 2D), in line with Förster resonance 
energy transfer (FRET)-effects between the indole functional group of SDRvv’s single tryptophan and 
the nicotinamide ring of NADPH. However, the FRET in SDRvv was rather small as the fluorescence 
intensity ratio of the 462 nm-emission peak between same concentrations of NADPH-complexed and 
free SDRvv (excitation wavelength set at 340 nm) is only 2.2, which is four- and tenfold lower than the 
reported values for human 17b-dehydrogenase (Li & Lin, 1996, Chang et al., 2004) and the Vibrio 
vulnificus broad spectrum reductase BfgV (Chang et al., 2004) respectively. While these latter enzymes 
blue-shifted the wavelength of maximal emission, no such change was seen for NADPH-complexed 
SDRvv. 
 
We subsequently employed isothermal titration calorimetry (ITC) to quantify the affinity of SDRvv 
towards NADPH and NADP+ (Fig. 3). The NADPH:SDRvv binding isotherm could be fitted readily to a 
1:1 binding stoichiometry (n = 0.783 ± 0.009) to yield a Kd of ± 3.5µM that is enthalpically-driven (ΔH° 
of  -2.12x104 cal/mol) and entropically-disfavored by -1.37x104 cal/mol of apparent TΔS° (Fig. 3A). Also 
the NADP+:SDRvv binding isotherm fitted to the simple Langmuir model but, consistent with the 
predicted lower affinity from the thermofluor assays, a lot more ligand was required to saturate the 
protein and a Wiseman ‘c’ parameter (the product of receptor concentration and the binding constant 
Ka) regime well below 1 was obtained. Therefore, the fitting routine required to fix the stoichiometry, n 
– for which we choose 0.783, consistent with the active protein fraction as determined by the NADPH 
direct titration experiment - which then yielded a Kd for NADP+-binding of 242 µM, 73-fold lower 
compared to the Kd for NADPH binding (Fig. 3B). From a thermodynamic point of view, the observed 
2.4 kcal/mol lower Gibbs-free energy for SDRvv:NADP+ binary complex formation is dictated by a 50% 
reduction in enthalpy compared to NADPH-binding (note that the associated entropy is actually less 
unfavorable for NADP+ compared to NADPH-binding). Therefore, this analysis suggests that at least 
one polar contact within the binding site is lost upon oxidation of NADPH towards NADP+. 
 
To obtain a more reliable estimate of the strength of the SDRvv/NADP+-complex – after all, the low 
Wiseman ‘c’ parameter is assumed to be prohibitive to reliably determine equilibrium dissociation 
constants using ITC - we set up a competition ITC experiment (Velazquez-Campoy & Freire, 2006) 
probing NADPH binding to SDRvv in the presence of 1 mM NADP+. The apparent Kd shifted to 31 µM 
from which a Kd of 240 µM for the SDRvv:NADP+-interaction could be calculated consistent with the Kd 
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from the direct titration experiment. The validity of the NADP+ direct titration is corroborated by 
accounting for the enthalpy-changes, since the apparent ΔH° in the competition titration experiment is 
lower by the amount corresponding to the heat that is absorbed by the release of the NADP+ competing 
ligand (0.9x104 cal/mol). This almost two orders of magnitude difference in affinity between NADPH 
and NADP+ for SDRvv binding is a peculiar observation as generally dehydrogenases/reductases 
catalyze reversible reactions thereby displaying similar Kd or Km values, typically 1-50μM, for both 
reduced and oxidized forms of the cofactor (http://www.brenda-enzymes.info). (Note that in terms of 
cofactor binding/catalysis, when both Kd or Km values were measured for this family of enzymes, Km’s 
were generally only slightly higher than Kd’s implying Km’s are good estimates for affinity.) 
 
Fig 3. Characterization of cofactor binding to SDRvv by isothermal titration calorimetry. ITC data 
for NADPH-binding (panel A) and NADP+-binding (panel B) to apo-SDRvv. The upper panels depict 
the respective background-corrected thermograms, while the lower panels show the integrated heats 
plotted against the molar ratio of ligand versus SDRvv (squares) and the best-fit of these data to the 1:1 
binding model (solid lines). From these fits, the stoichiometry and thermodynamic constants were 
calculated which are provided as text.   
 
Given the overall reduced NADPH:NADP+-ratio of about 200 in the bacterial cytoplasm, our binding 
experiments suggest that SDRvv fulfills a reductive function in the cell. Because intracellular NADPH-
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pools are in excess over NADH-pools, NADPH-dependent Rossmann-folds may be biologically specific 
for NADPH while they do not exhibit a much higher affinity for the 2’-phosphorylated cofactor over the 
non-phosphorylated counterpart. Indeed, Michaelis or dissociation constants for naturally NADPH-
dependent SDRs are generally within two orders of magnitude for the phosphorylated and non-
phosphorylated coenzyme as shown in reducing Chinese hamster monomeric carbonyl reductases (Km, 
NADPH = 2.2 µM; Km, NADH = 300 µM (Miura et al., 2009)), the Papaver somniferum salutaridine 
reductase (Km, NADPH = 3.5 µM; Km, NADH = 1190 µM (Geissler et al., 2007)), or the human 
oestrogenic 17-HSD1 reductase (Km, NADPH = 70 µM; Km, NADH = 420 µM (Gangloff et al., 2001)). 
However, our thermofluor analysis shown in Fig. 2B suggests a much bigger difference in affinity for 
SDRvv between NADPH and NADH. By using competition ITC, titrating NADPH into a mixture of 
SDRvv and 20 mM of NADH, we sought to determine the affinity of SDRvv for NADH. Surprisingly, 
the presence of NADH did not change at all the thermodynamic parameters of NADPH binding in the 
competition ITC experiment suggesting that the affinity for NADH is extremely weak (Kd >> 100 mM) 
(data not shown). 
 
In an effort to identify a substrate for SDRvv, we sought to exploit the general propensity of SDRs to 
exhibit residual activity on substrates that are analogous to their preferred ligands (Polizzi et al., 2007). 
We therefore subjected SDRvv to activity assays against a diverse test panel covering the broad chemical 
space of SDR activity: hexoses (D-glucose, D-galactose, D-fructose, D-glucuronate, glucono-1,5-lactone, 
glucuronolactone), pentoses (D-ribose, D-xylulose), aldehydes (p-nitrobenzaldehyde, hexanal, 
butyraldehyde, acetoacetyl-CoA, methylglyoxal, p-anisaldehyde), aromatic aldehydes (pyridine-4-
aldehyde, pyridine-3-aldehyde), ketones (acetoacetone, cyclohexenen-on, aceton, 3-deoxyglucosone, 
ethyl 4,4,4-trifluoro-3-oxobutanoate) and alcohols (ethanol, propanol, butanol, 2,3-butanediol). Our 
experimental set up was based on reaction mixtures containing 2 µM of SDRvv, 200 µM of NADPH, 
and 2 mM of test panel compound that were spectrophotometrically monitored at 340 nm, and aimed to 
monitor the decrease in absorption at 340 nm resulting from disappearance of NADPH. None of the 
analyzed substrates affected the NADPH levels suggesting that SDRvv is catalytically paralyzed or has a 
biological function that is clearly distinct from those of classical SDRs. 
 
Structure of the SDRvv-NADP(H) complex 
Our binding studies had already indicated that the deduced truncation of the α2/β3 secondary structure 
region and the substitutions of the catalytic tetrad Tyr and Lys residues do not compromise cofactor 
binding to SDRvv. To obtain better insights into the molecular details underlying cofactor binding in 
SDRvv we grew crystals in the presence of NADPH and determined the crystal structure by maximum-
likelihood molecular replacement using a search model derived from the homologous 3-oxoacyl-(acyl 
carrier protein) reductase from Thermotoga maritima (PDB accession code 1o5i) (Buysschaert et al., 
2012) (Table 1). 
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Table 1. Data Collection and Refinement Statistics 
 apoSDRvv SDRvv-NADPH 
Crystal   
     Space group P21 P21 
     Unit cell parameters (Å, °) a = 59.37, b = 122.89, 
c = 63.14, β = 111.09 
a = 69.63, b = 96.26,  
c = 72.11, β = 103.99 
Data collection   
     Beamline PROXIMA1 (SOLEIL) X06SA (SLS) 
     Resolution range (Å) 45.0 – 2.35 (2.49 – 2.35) 40.0 – 1.80 (1.91 – 1.80) 
     No. of observed reflections 127 883 (19 059) 288 963 (45 106) 
     No. of unique reflections 34 318 (5 346) 84 971 (13 354) 
     Multiplicity 3.72 (3.57) 3.4 (3.38) 
     Data completeness (%) 97.0 (94.3) 99.1 (97.0) 
     Rmeas (%) 13.1 (68.4) 9.5 (56.1) 
     Mean I/σ(I)     10.57 (2.74) 10.54 (2.41) 
     Wilson B overall 29.17 18.78 
Refinement   
     Resolution range (Å) 45.0 - 2.35 (2.42 – 2.35) 40.0  - 1.80 (1.82 – 1.80) 
     No. of work / test reflections 
      
32 600 / 1 712 
(2 594 / 133) 
80 671 / 4 243 
(2 332 / 125) 
     Rwork  / Rfree  
 
     No. of atoms 
0.1808 / 0.2099  
(0.2495 / 0.2879) 
5 888 
0.1752 / 0.2190 
(0.2725 / 0.3042) 
7 612 
     r.m.s. deviation bonds 0.002 0.007 
     r.m.s. deviation angles 0.7 1.1 
Mean B values (Å2)   
      Overall 36.6 24.1 
      Protein 36.7 23.6 
      Water molecules 34.4 31.9 
      NADPH n.a. 19.5 
 
Although both of our crystal forms grew in the presence of NADPH, structure determination revealed 
that we crystallized a binary NADPH:SDRvv complex (SDRvv-B) as well as a ligand-free apo-structure 
(SDRvv-A). Cofactor-bound and apo-SDRvv adopt very similar structures (r.m.s.d 0.4Å) and are 
organized as tetramers obeying 222 symmetry with P, Q, and R dyads, whereby the Q interface features 
the four helical bundle topology responsible for oligomerization in classical SDR proteins (Fig. 4A-C). 
Even though SDRvv subunits adopt the classical SDR Rossmann-fold, they lack almost the entire α2 and 
the β3 secondary structure elements (Tanaka et al., 2001) (Fig. 4C and Fig. 5D),  in agreement with our 
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multiple amino acid sequence alignments (Fig. 1). Besides this deletion, the SDR family topology is fully 
retained and we will hereafter adopt the SDR topology nomenclature for comparative reasons (i.e. from 
strand β3 on, strand βi of SDRvv is referred to as strand βi+1).  
A key finding from our crystal structures is the elucidation of NADPH binding with full-occupancy in 
each of the four binding sites. As seen for other NADPH co-complexes at the same resolution, the 
nicotinamide ring of the cofactor adopts the nonplanar, nonaromatic state consistent with the reduced 
form. Interestingly, helix α8 and its associated N- and C-terminal loops (residues 163-185), a region 
harboring the substrate binding motif in catalytically competent SDRs, exhibited flexibility in two of the 
four subunits as evidenced by in average higher B-factors which is consistent with the behavior of this 
structural element in canonical SDR (Paithankar et al., 2007, Cassetta et al., 2011) (Fig. 4B).  
 
 
 
 
 
 
 
 
 
 
 
Fig 4. Structure of SDRvv in complex 
with NADPH. A) Overall structure of 
the SDRvv tetramer in complex with 
NADPH. For one chain, which is 
colored according to secondary-
structure elements, the NADPH 
cofactor is depicted in black sticks. B) 
A 90° rotated view of panel A colored 
according to their encoded thermal 
factors in (hot) ROYGBIV (cold) 
gradient. Note the on average higher 
B-factors of helix α8. C) A 
superposition of the α-carbon traces of 
SDRvv (green) on top of 17β-HSD 
(pink) from Cochliobolus lunatus 
reveal similarities in terms of fold 
(r.m.s.d. of around 1.1 Å) and cofactor 
accommodation, despite the rather low 
pairwise sequence identity of 24%, 
while, on the other hand, confidently 
showing the absence of the α2/β3 motif 
in favor of a small 310-helix in SDRvv.  
 
 
Structural basis of cofactor binding in SDRvv  
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Each monomer in the SDRvv-B:NADPH complex accommodates a single NADPH molecule in an 
identical manner. The NADPH cofactor is bound in an extended conformation at the C-terminal ends 
of the central β sheet in a manner commonly seen in the known structures of the SDR family with the 
adenine moiety in an anti conformation and the nicotinamide portion in a syn conformation with 
respect to the ribose (Gourley et al., 2001, Ghosh et al., 1991, Shi & Lin, 2004). Nonetheless, the SDRvv 
NADPH binding site differs from canonical SDR family members in two main ways: the residues 37 to 
41 which form a 3-10 helix instead of the extended helix α2 in classical SDRs and the residues E164, 
A165, Y166, and K167, which also form a 3-10 helix instead of the first turns of the substrate binding 
helix α7 in classical SDRs (see Fig. 1, Fig. 4C and Fig. 5A and D). Both conformations have clear 
implications for cofactor binding. Figure 5A and B compares NADP-cofactor binding in the classical 
reducing SDR, 17β-HSD and the atypical SDRvv. Apart from the stabilization of the adenine ring (i.e. 
the D43-I44-dyad that hydrogen bonds respectively the adenine ring N1 and N6 groups), the 
coordination of the nicotinamide amide group(s) via Thr161, and the binding of the pyrophosphate via 
the backbone nitrogen of I18, all other interactions are variations on the classical SDR’s theme (Fig. 5C).  
 
The 3-10 helix formed by R38, Q39, and T40 in SDRvv donates an arginine that i) forms cation-pi and 
Van der Waals interactions with the adenine base of NADPH, and ii) stabilizes the 2’-phosphate of 
NADPH together the hydroxyl of S37, and the side chain amino group and the main chain amide of 
Q39 (Fig. 5D). These interactions are functionally homologous to those provided by the positively 
charged cushion seen in flavin-adenine dinucleotide disulfide reductases or 6-phosphogluconate 
reductases (Adams et al., 1994) for which for example R199 in glutathione reductase (pdb, 1GET) is 
identically positioned compared to R38 in SDRvv. Such cation-pi interactions are also found in a 
subfamily of classical SDRs, the so-called cP2 family, however, the way in which the 3-10 helix triad 
SRQ wraps around the ribose 2’-phosphate is to the best of our knowledge unprecedented in the 
available classical SDR structures. Interestingly, the structure of M. tuberculosis MabA, which also 
carries a truncated helix α2 (Fig. 1), also shows the equivalent of SDRvv’s R38, however not enclosed in a 
stabilizing secondary structural unit but lying on a loop connecting strands β2 and β3 (Cohen-Gonsaud 
et al., 2002). Extra stabilization in this cofactor binding site is provided by an arginine residue at the base 
of helix α1 - which is conserved in the cP1 and cP3 subfamilies of classical SDRs - in concert with the 
side chain of the non-conserved preceding asparagine residue. In other words, the α2/β3 truncation in 
SDRvv gives rise to a completely novel adenine ribose 2’phosphate interaction landscape in SDR family 
member proteins. We thus propose that the observed weak affinity of SDRvv for NADH can be traced 
to the novel 3-10 SRQ helix structural element which looses its conformation and its involvement in 
cofactor stabilization in case a hydroxyl group takes the place of the 2’ phosphate. Given the observed 
drastic effect on cofactor preference, we envisage the use of this information in protein design initiatives, 
for example to engineer a highly specific NADPH-dependent catalyst for use in reaction conditions that 
also contain vast amounts of NADH.  
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In classical SDRs, the nicotinamide and its associated ribose are located at the base of a hydrophobic 
cleft where the two ribose hydroxyl groups are engaged in four H-bond interactions with the active site 
residues that are substituted in SDRvv. The 2’-hydroxyl binds to the hydroxyl of the catalytic Tyr and to 
the NZ atom of the catalytic Lys, and the 3’-hydroxyl binds to the main chain carbonyl of the catalytic 
Asn and to the NZ atom of the catalytic Lys. The nicotinamide amide is furthermore secured by a TXT 
motif. Apart from the latter motif, the residues involved in stabilizing the nicotinamide-ribose portion 
in SDRvv originate from different regions in the protein. The amino headgroup of a Lys also H-bonds 
the ribose hydroxyls in SDRvv, however, this K91 is positioned in the middle of helix α4 while in 
classical SDRs the catalytic lysine originates from helix α6. Nonetheless, the NZ atoms end up at 
analogous positions in the crystal structures (Fig. 5A and B). In SDRvv, the nicotinamide amide 
function is additionally stabilized by the side chain of Y166 originating from the anomalous 3-10 helix 
connecting strand β6 with the substrate binding helices. Interestingly, the catalytic tyrosine of classical 
SDRs is replaced by a lysine (K130) in SDRvv which is forced to the solvent due to charge 
incompatibility with K91, stabilizing the ribose hydroxyls and thereby shielding the cofactor binding 
cleft from the solvent in a combined action with Y166, with which its hydroxyl group forms an 
interaction through a bridging water molecule (Fig 5B). In fact, that water molecule is part of an 
elaborate water network residing in a volume of 98 Å3 (calculated with CASTp, 
http://sts.bioengr.uic.edu/castp, (Dundas et al., 2006) that accommodates another six waters and that 
reaches out towards the side chain of K91 (Fig. 5B). 
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Fig 5. Structural analysis of the NADPH binding site of SDRvv. Comparison of NADPH binding 
between canonical short-chain SDRs and the atypical SDRvv: A) selected interactions of the NADPH-
riboside of NADPH with residues belonging to the active site pocket of SDRvv (orange; pdb-code 
3UCE) and 17b-HSD (grey; pdb-code 3QWI) B) selected interactions of the nicotinamide riboside 
moiety of NADPH and active site residues of SDRvv also showing the structured water network (waters 
are colored according to their thermal factors) C) LIGPLOT representation of the hydrogen-bonding 
network involving the NADPH coenzyme in the 17b-HSD or the SDRvv holo form. Conserved 
coordinating residues are boxed green. The catalytic triad of 17b-HSD and the putative functionally 
analogous residues in SDRvv are boxed orange. D) Side-to-side comparison of the accommodation of 
NADPH’s 2’-monophosphoadenosine by the cP2 SDR representative 11-beta-hydroxysteroid 
dehydrogenase Type 1 (left panel; pdb-code: 2BEL) and SDRvv (right panel). 
 
Mechanistic implications 
The general mechanism for carbonyl reduction with the SDR enzymes involves proton transfer from the 
catalytic tyrosine residue to the carbonyl oxygen, coupled with hydride transfer from the nicotinamide 
ring to the C(sp²) of the carbonyl group. This general mechanism requires a tyrosine residue as a proton 
donor/acceptor, a lysine residue to lower the pKa of the neighboring catalytic tyrosine, and a proton 
shuttle to the bulk solvent to re-establish the catalytically competent state. Notably, although coming 
from different regions of the protein, SDRvv places a lysine (K130) and a tyrosine (Y166) residue at 
positions for which the coordination distances between these amino acid functional groups and the 
NADPH cofactor nicotinamide C4 position were found to be in excellent agreement with those seen in 
classical SDR enzymes (Table 2). The water network observed between these two residues could 
establish a proton relay to reprotonate Y166. This intriguing observation therefore warrants further 
research towards a substrate for this novel class of SDR enzymes.  
 
Table 2. Comparison of active site inter-atomic coordination distances between NADPH-complexed 
SDRvv and 2 closely related well-studied canonical SDRs, 17β-HSD from Cochliobolus lunatus (pdb 
entry of the NADPH-complex: 3QWI) and FabG from E. coli (pdb entry of the NADPH-complex: 
1Q7B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Residue 1 Atom 
1 
Atom 
2 
Residue 2 d (Å) 
SDRvv 
d (Å) 
17β-HSD 
d (Å) 
FabG 
Tyr166 OH NZ Lys130 4.7 3.4 4.3 
Tyr166 OH O Water547 3.3 - - 
Lys130 NZ O Water547 2.9 - - 
Water547 O O Water90 2.3 - - 
Water90 O O2D Ribose 2.7 2.5* 2.5* 
Water90 O O Ser69 2.9 - - 
Lys91 NZ O2D Ribose 2.8 2.7 3.0 
Lys91 NZ O3D Ribose 3.1 3.2 3.0 
Ribose OD3 O Water189 2.6 - - 
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The almost two orders of magnitude difference in NADPH versus NADP+ binding affinity to SDRvv is 
unseen among SDR enzymes. Even for the highly reducing flavin disulfide oxidoreductases such as 
glutathione reductase and thioredoxin reductase, Km values for NADPH and NADP+ do not differ more 
than 10-fold from each other. To our knowledge, the only oxidoreductase that does show a significant 
affinity difference (>102) for the oxidized and reduced cofactor is the lipoamide dehydrogenase of E. coli, 
although in that particular case the competitive inhibition constant of the competing non-cycled 
cofactor is not the result of product inhibition only, but rather a consequence of the formation of an 
inactive reaction coordinate intermediate (Schmincke-Ott & Bisswanger, 1981). Because in our SDRvv-
NADPH structure the positively charged K130 shields the cofactor binding cleft from the surrounding 
water by a water-bridged interaction with the phenolic hydroxyl group of Y166, we hypothesized that 
this interaction network would lose interaction strength in the nearby presence of the oxidized, 
positively charged cofactor, thereby lowering the activation barrier for NADP+ dissociation. To test this 
hypothesis, we expressed proteins carrying K130A, Y166F, or K91A substitutions and analyzed their 
affinity for either NADPH or NADP+ by direct titration and competition ITC, respectively (Table 3).  
 
Table 3. Determined affinities of native SDRvv and three single amino acid mutants (Y166F, K91A, and 
K130A) for candidate cofactors using either direct ITC (NADPH binding) or competition ITC (NADP+ 
binding) 
 
Enzyme 
NADPH 
Kd (μM) 
NADP+ 
Kd (μM)a 
NADPH in presence of 1mM NADP+ 
Kd,app (μM)a 
SDRvv wild-type 3.5 240 31 
SDRvv Y166F 50.7 250 389 
SDRvv K91A 416 NDb NDb 
SDRvv K130A 4.4 700 11 
aApparent Kd-values for NADPH binding to native and mutated SDRvv batches in the presence of 1 mM 
NADP+ were obtained to calculate NADP+-cofactor affinity as described under Materials and Methods. 
bND: not determined 
 
First of all, as to be expected, K91 is essential for stabilizing the nicotinamide associated ribose as its 
substitution to an alanine causes a 100-fold lower affinity for NADPH and no measurable affinity for 
NADP+. Herewith, although originating from a non-analogous secondary structural element, K91 of 
SDRvv is functionally homologous with the active site lysine of classical SDRs with respect to cofactor 
stabilization. The supposedly opening of the cofactor binding cleft for surrounding water due to the 
K130A substitution has apparently no affect on NADPH binding while lowering the affinity for NADP+ 
almost three-fold. On the other hand, the removal of the Y166 phenolic hydroxyl group mediated 
interactions with the cofactor’s amide function and the water bridged K130 amino group leaves the 
binding of NADP+ unchanged, while lowering the affinity for NADPH by a factor ten. So contrary to 
expectation, K130 and the water network underneath are not critically involved in product release. On 
the contrary, in case they do not move position in the Y166F mutant, these functional groups even 
preferentially stabilize NADP+.  Our mutational analysis thus confirms the importance for NADP(H) 
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binding of certain cofactor binding cleft capping residues lying at positions imaginably posed for 
catalysis, but does not enable us to formulate a conclusive answer for the observed 100-fold difference in 
affinity between oxidized and reduced cofactor binding to SDRvv.  
 
The explosive growth of SDR-family members over the last two decades necessitated the development of 
a classification system of this protein family to facilitate functional annotations. Using Hidden Markov 
models (HMM), Kallberg and coworkers (Kallberg et al., 2010) assigned 334 SDR subfamilies which are 
searchable via www.sdr-enzymes.org. SDRvv is absent from the library as the Hidden Markov model 
identifies the positions of amino acids which describe the conserved primary structure of the family 
(Karplus et al., 1998). Apart from some other γ-proteobacteria such as other Vibrionaceae (V. orientalis, 
V. harveyi, V. tubiashii, V. brasiliensis, V. shilonii, V. splendidus), Photobacterium profundum and 
Shewanella piezotolerans, also some Alphaproteobacteria such as Phaeobacter gallaeciensis, Silicibacter 
sp., and Roseobacter sp. contain the genetic information for an SDRvv homologue in their genomes. 
They share between 53 and 57 % sequence identities and also share the residues shown by our structural 
studies to interact with the NADPH cofactor (see Fig. 1). Notably, phylogenetic analysis separates the 
sequences from the gamma- and the alphaproteobacteria in two clades suggesting that a SDRvv 
homologue was already present in a common ancestor of both bacterial classes. Together, our structural 
work should aid the process of structure-based motif fingerprinting to delineate the SDR classification 
towards a new branch of putative SDR catalysts. 
 
MATERIALS AND METHODS 
 
Expression and purification of SDRvv 
The VVA1599-coding sequence for Vibrio vulnificus SDRvv was recombinantly expressed in E. coli and 
purified as described in ref. (Buysschaert et al., 2012). Protein concentrations were determined 
according to Bradford with BSA as a standard (Bradford, 1976) or more accurately by 
spectrophotometry at 280nm (MW = 23,654 Da; e = 21,890 M-1cm-1) using a Nanodrop 
spectrophotometer (Isogen Life Science). 
 
Protein thermal shift assay 
To identify ligands that stabilize SDRvv’s native state, thermal shift assays (Thermofluor) were 
performed with 20 µl-solutions containing 50 μM apo protein mixed with 2x SYPRO Orange dye and 
either - 1mM each - NADPH, NADP+, NADH, or NAD+, in 10 mM Tris-HCl, pH 7.5. Samples loaded 
on a 96-well microplate were covered with microseal B film (Biorad) to prevent evaporation, and 
gradually heat-denatured (2°C/min) from room temperature to 90°C using a C1000 thermal cycler (Bio-
Rad). Changes in the fluorescence intensity of Sypro Orange, due to binding of the dye on hydrophobic 
patches of the unfolded protein, were monitored by a CFX96 optical module (Bio-Rad) working under 
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FRET-modus (excitation, emission). The fluorescence signal was plotted versus temperature and 
derived to the first order to obtain the corresponding melting temperatures (Tm). 
 
Fluorescence spectroscopy 
Fluorescence spectra of SDRvv, NADPH and the SDRvv-NADPH complex were collected at room 
temperature using a Varian Cary Eclipse Fluorescence spectrophotometer. Measurements were 
performed in a 500 μL-quartz cuvette, with excitation and emission slit widths set at 2.5 nm and 20 nm 
respectively.  Enzyme (20 μM) and cofactor (10 μM) concentrations were chosen to provide an adequate 
signal to noise ratio. Under these conditions, and considering a Kd of 3.5 µM as measured with ITC, 
77.7 % of the proffered NADPH forms a complex with SDRvv. All reactions were performed in 50 mM 
Tris-HCl, pH 8.0.  
 
Crystallization of the SDRvv-NADPH complex, Data collection and Structure Determination 
The crystallization and subsequent X-ray analysis of the SDRvv-NADPH complex has been described in 
detail elsewhere (Buysschaert et al., 2012). Those diffraction experiments, conducted on beamlines 
Proxima-1 at SOLEIL (Gif-sur-Yvette) and PXI at the Swiss Light Source (Villigen), led to data-
collection to a resolution of 1.8 Å. After integration and scaling of the diffraction datasets using XDS 
(Kabsch, 2010), the initial phases were obtained by maximum-likelihood molecular replacement using 
the program suite PHASER (McCoy et al., 2007). Based on sequence comparison with structurally 
characterized SDRs, the structure of Thermotoga Maritima 3-oxoacyl-(Acyl Carrier Protein) reductase 
(PDB 1O5I), demonstrating 28 % sequence identity to SDRvv, was chosen as a search model. Starting 
from this model, where all nonconserved residues were pruned to the gamma atom using the CCP4 
program CHAINSAW (Stein, 2008), the structure was further refined with PHENIX (Adams et al., 
2010) and autoBUSTER 2.8.0 (Blanc et al., 2004). After each round of refinement, the structure was built 
manually using the graphics program COOT (Emsley & Cowtan, 2004). The correctness of the 
molecular-replacement was inspected by MolProbity (Chen et al., 2010), indicating that 97.7 % of the 
residues have their ϕ,ψ angles in the favored regions of the Ramachandran plot, 2.3 % of all residues in 
the allowed region and no residues in the disallowed regions. These results reflect the high quality of the 
geometry of the final model. Data collection and refinement statistics are listed in Table 1. Coordinates 
and structure factors for the SDRvv-NADP(H) complex have been deposited in the Protein Data Bank 
(www.rcsb.org) and are accessible trough accession number 3UCE. 
 
Determination of enzyme activity 
The SDRvv enzyme activity was assayed spectrophotometrically, following the oxidation of NADPH at 
340nm and using a molar absorption coefficient (e) of 6220 M-1cm-1. A typical assay contained in a final 
volume of 1 ml: 200 μM NADPH, 1 mM of a carbonyl-containing test substrate, 100 mM Tris-HCl, pH 
7.0, and 2 μM SDRvv which was added last to start the reaction.  
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Site-directed mutagenesis of SDRvv 
The QuickChange site-directed mutagenesis kit (Stratagene) was used to make amino acid mutations of 
putative active site residues of SDRvv: K91, K130 and Y166. The mutations were introduced into the 
pACYCDuet-1-SDRvv construct by PCR (PfuTurbo DNA polymerase) using the following mutagenesis 
primers: 5’- GCCTTTGATACCGCATTCTGGGGTGCCG-3’ (K91A), 5’-
ACACCTATGTGGCAGCCGCCATCAATG-3’ (K130A) and 5’- 
ACCAAAACCGAGGCGTTTAAAGGCATGAAT-3’ (Y166F). All constructs were sequence-verified. 
The mutant variants were expressed and purified as for native SDRvv (Buysschaert et al., 2012). 
 
 
Isothermal titration calorimetry 
Measurements of affinity (Kd), stoichiometry (n) and apparent enthalpy (ΔH°) were conducted at 25°C 
using an isothermal titration calorimeter (VP-ITC, MicroCal Inc., Northampton, MA, USA). Prior to 
the experiment, protein samples (25 μM) were extensively dialyzed at 4°C against 50 mM Tris-HCl, pH 
8.0, 150 mM NaCl, and degassed under vacuum. Ligands were dissolved in dialysis buffer and titrated 25 
times (10 μl injections every 200s) into the cell. The solution was constantly stirred by syringe rotation 
fixed at 300 rpm. Control experiments, injecting the ligand into the buffer, revealed heat of dilutions 
that were negligible for each nucleotide cofactor tested. Several titrations were performed to evaluate 
reproducibility. For low affinity binders or zero-enthalpy binders competition ITC could prove useful in 
which a thermodynamically characterized ligand (NADPH) is titrated in the sample cell containing a 
mixture of target (SDRvv) and low affinity or zero-enthalpy binder (NADP+). Displacement binding 
isotherms can then be fitted to the expression for a direct titration, whereby the apparent binding 
constant relates to the real Kd as is given by the single site competitive inhibition equation: Kd,NADPH,app 
= Kd,NADPH (1+[NADP+]/Kd,NADP+), in which Kd,NADPH,app is the apparent dissociation constant 
for NADPH, calculated from the displacement titration; Kd,NADPH, the dissociation constant for 
NADPH, calculated from direct titration; [NADP+], the concentration of NADP+ included in the sample 
cell in the displacement titration; and Kd, NADP+, the dissociation constant for NADP+. Data were 
analyzed with the Microcal Origin 7.0 software. 
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3. 
SDRs AND TRANSCRIPTIONAL REGULATION 
 
 
The progress in the SDR field and the growing contribution of crystallographic studies on this enzyme family 
reveals how nature can use a highly conserved fold for diverse functions. Today, more and more examples 
emerge of SDR proteins having other functions than the established role of these proteins in 
dehydrogenase/reductase reactions. Since the dehydrogenase of Vibrio vulnificus under study in this thesis  
(SDRvv) is closely associated with a divergently transcribed LysR-type transcriptional regulator, the 
following paragraphs will focus on the role of SDRs in the adaptive response of the cell to external stimuli 
such as oxidative stress, nutrient depletion or availability. 
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1. SDRs IN RELATION TO LYS R-TRANSCRIPTIONAL REGULATORS 
The literature on SDRs reflects the vast implication of these proteins in signaling pathways while exerting 
their essential reductase/dehydrogenase function. Among these, some NADPH-dependent SDR enzymes are 
known to be involved in the biosynthesis of quorum sensing molecules, thereby regulating important 
processes such as biofilm formation or virulence factor production (Wei et al., 2011, Bijtenhoorn et al., 2011). 
Similarly, plant SDR-homologues participate in the production of abscisic acid, an essential plant hormone 
for growth and development, stress response and glucose signaling (Cheng et al., 2002). Evidently, all the 
hydroxysteroid dehydrogenases, responsible for fine-tuning the steroid hormone response, belong to this 
category of signal-mediating SDRs. 
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1.1. The case of NmrA 
The EMBO-publication on the fungal protein NmrA (Stammers et al., 2001) illustrates how SDRs can be 
involved in transcriptional regulation. The monomeric NmrA shows close homology to the short-chain 
dehydrogenase protein superfamily and was discovered to be a regulating partner in the nitrogen utilization 
pathway. 
Ascomycetous fungi, like Aspergillus nidulans, are known to repress alternative nitrogen utilization pathways 
when ammonium or glutamine is present in the growth medium. In absence of these preferred N-sources, a 
complex signal transduction pathway will lead to the binding of GATA-binding proteins to induce the 
expression of genes involved in the acquisition of nitrogen from alternative nutrient sources. GATA-binding 
proteins like AreA form a class of positive transcriptional regulators in eukaryotes, depending on Zn-finger 
motifs to bind promotor DNA. 
 
The high-resolution structure of NmrA revealed an SDR-like fold. Yet, typical key features of the SDR-family 
appear to differ: (i) a monomeric structure substituting the prevailing tetrameric SDR-organization, (ii) an 
AsnxxGlyxxAla motif instead of the widespread GlyxxGlyxxGly cofactor binding sequence and, last but not 
least, (iii) an MetxxxLys active site signature replacing the well-conserved TyrxxxLys motif (Stammers et al., 
2001).  
Given the active site Met residue, it is very unlikely that NmrA is catalytically active. Nonetheless, 
crystallization (Stammers et al., 2001) and ITC (Lamb et al., 2003) studies demonstrated that the protein 
retained the ability to bind both NADP+ and NAD+ cofactors. Remarkably, the protein can accurately 
discriminate between oxidized and reduced forms of the dinucleotides, which is suggestive of a redox sensing 
function. Furthermore, NmrA is able to recognize the C-terminal part of AreA (Lamb et al., 2003). 
Concomitantly, NmrA and the GATA DNA-motif compete for binding to the same C-terminal patch of AreA, 
while the GATA-containing DNA is bound preferentially (Lamb et al., 2004). NmrA thus fulfills his role as a 
co-repressor, inhibiting AreA’s activity under nitrogen-replete conditions (high glutamine). Not 
surprisingly, NmrA levels are controlled by the nitrogen status of the cell (Wong et al., 2007).  
NmrA is a capital player in the nitrogen metabolism, and recent studies even point to their involvement in the 
carbon metabolism (Macios et al., 2012). While a function in redox-sensing was prompted, the exact signals to 
which NmrA responds remain in the dark.  
 
Reinforcing this idea for a role in redox sensing, NmrA-homologues from other organisms were found to 
perfectly corroborate the intracellular NADPH/NADP+ status. For instance, three Nmr-like proteins from the 
fungus Magnaporthe oryzae appear to function as NADPH-dependent switches during the invasion of the rice 
plant. This signaling pathway involves metabolic enzymes such as trehalose-6-phosphate synthase and 
glucose-6-phosphate dehydrogenase. Here, a diminished supply of nutrients is translated into a shift towards 
NADP+. Consequently, the Nmr co-repressors form complexes with GATA-type transcriptional regulators, 
which results in a downregulation of the genes required for virulence (Wilson et al., 2010).  
In another mode of action, the human NmrA counterpart HSCARG translates changes in NADPH/NADP+ 
through impressive conformational readjustments. When NADPH levels drop, the HSCARG dimeric protein 
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will dissociate and uncover a binding site for argininosuccinate synthetase (AS), a rate-limiting enzyme in 
nitric oxide synthesis. Upon protein:protein association, the activity of AS is inhibited and the production of 
the signaling molecule NO concomitantly decreased (Zhao et al., 2008). 
1.2. Other SDR homologues participating in signaling processes 
In contrast to previously cited SDR-like proteins where the catalytic residues are missing and a 
dehydrogenase/reductase function is improbable, few examples emerge of SDRs involved in transcriptional 
control while retaining their typical activity. It is the case of the human hRoDH-E2, an abundant SDR protein 
working as a retinol or hydroxysteroid dehydrogenase/reductase in the endoplasmatic reticulum of 
keratinocytes. Remarkably, the protein can be shuttled to the nucleus, where it downregulates the activity of 
epidermal promotors. The repression is not achieved by direct binding of hRoDH-E2 to the promotor DNA, 
but through protein:protein interactions with other proteins regulating transcription. These interactions 
appear to modulate the level of acetylation of the histone and non-histone proteins, making the chromatin 
structure less accessible. As for many genes, increased acetylation is linked to transcriptional activation while 
hypoacetylation is associated with repression. In accordance with this assumption, it has been reported that 
hRoDH-E2 blocks the binding sites and/or the activity of histone acetylases, but promotes the recruitment 
and/or activity of histone deacetylases (Markova et al., 2006).. Since the hRoDH-E2 cofactor (NAD) levels 
influence the degree of acetylation, the protein may participate in redox-sensing  
2. A LTTR CLOSELY ASSOCIATED WITH SDRvv HOMOLOGUES 
Based on the nature of the residues occupying homologues positions to the Ser-Tyr-Lys active site residues in 
classical short-chain dehydrogenases, SDRvv was initially thought to be catalytically inactive. Because the 
protein retains the capacity to bind NADP(H) and differentiates between oxidized and reduced forms of the 
coenzyme, we envisaged a physiological role as a redox-sensor. In analogy to the NmrA-AreA association, 
SDRvv could interact with, and modulate the function of, the upstream-located LysR-type transcriptional 
regulator (abbreviated as LTTR). STRING, a search tool for retrieval of interacting genes/proteins (Szklarczyk 
et al., 2010) revealed that, in most cases, orthologues of SDRvv are closely associated with a divergently 
transcribed LTTR.  
2.1. The LysR-family of transcriptional regulators 
With over 60.000 potential members (EMBL-EBI website, IPR000847 HTH_LysR), the LTTR family is 
probably one of the largest families of DNA-binding proteins in bacteria. Since the discovery of its first 
members about two decades ago (Henikoff et al., 1988), LTTRs were shown to control the transcription of 
operons and regulons involved in diverse cellular responses. Among them, the oxidative stress response, 
nitrogen source utilization, the detoxification of deleterious compounds, bacterial virulence, antibiotic 
resistance, or amino acid biosynthesis and catabolism (Table 5).  
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Table 5: A diverse range of functions controlled by LysR-type transcriptional regulators 
 LTTR Target Effector molecule 
Biosynthesis of AA LysR lysA Diaminopimelate 
 MetR a.o. metE Homocysteine, methionine 
 ArgP ArgK L-arginine 
 CysB Cys-regulon N-acetyl-L-serine 
 LeuO LeuABCD Not known 
Oxidative stress OxyR katE, ahpCF, grxA, gor, trxC, dsbG, fur, gor, 
hemH, sufA-E, sufS  
Oxidative stress  
(hydrogen peroxide) 
N-utilization NAC hut, put, ure, dad, cod  Not known 
 NodD Nod-genes Flavonoid compounds 
 CynR cynT, cynS, cynX Cyanate 
Detoxification BenM BenABCDE Benzoate 
 CbnR cbnABCD Cis-cis muconate 
 BlaA BlaB Beta-lactam antibiotic 
 CatR Cat-regulon Catechol 
C-utilization CbbR Cbb-regulon Ribulose 1,5-biphosphate 
Virulence QseA ler region for enterocyte effacement Autoinducer 2 (AI-2) 
 MvfR phnAB and pqsABCDE genes 2-heptylquinoline 
 
Being divergently oriented with respect to the genes they regulate, most of LTTRs will repress their own 
expression while activating the expression of the target genes. This can easily be achieved since LTTR 
promotors lie very close to, or even overlap with the promotor of the regulated genes (Schell, 1993). The vast 
majority of LTTRs need the presence of a small signal molecule, the ‘co-inducer’, to fully activate or repress 
the expression of the target operon. The absence of the effector, however, will not abolish the specific binding 
of the LysR transcriptional regulator to the promotor-DNA (Rosario et al., 2010). When present, 
conformational changes in the protein will occur, permitting different interactions with the DNA and 
allowing transcription levels to rise between 6- and 200-fold. LTTRs have thus different footprints, depending 
on the absence or presence of the inducer. 
 
LTTR membership is defined by some characteristics that distinguish them from other transcriptional 
regulators. Having a molecular mass around 35kDa, size exclusion chromatography of LTTRs revealed that 
their overall oligomeric state is either homotetrameric or homodimeric. In every subunit, two domains can be 
distinguished: the C-terminal co-inducer binding domain and N-terminal promotor binding domain 
(Maddocks & Oyston, 2008).  
2.2. The helix-turn-helix DNA binding domain 
The primary structure of the N-terminal domain is highly conserved (in the central region up to 40% 
identical!) and folds into the characteristic DNA-binding secondary structure, the helix-turn-helix motif 
(HTH motif). This typical signature allows interactions with the nucleotide bases of the major groove. 
Displaying a wing-like β-sheet between the second and third helix, all LTTRs belong to the ‘winged’ subfamily 
of HTH-bearing proteins. 
Generally, LTTRs can choose between different LTTR boxes to which they can bind with different affinities. 
The current literature distinguishes the dissimilar regulatory binding sites (RBS) and activation binding sites 
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(ABS). The first one is the primary binding site of LTTRs (necessary for both activation and repression) and is 
hallmarked by a palindromic T-N11-A motif, usually situated around position -65 relative to the start codon 
of the controlled gene and overlapping the LTTR promotor. The second site, the activation binding site (ABS), 
lies between the RBS and the activated promotor, mostly around position -35. As its sequence is less 
predictable compared with the RBS, DNAse I protection assays are often used to determine this zone (Porrua 
et al., 2007, Tropel & van der Meer, 2004, Schell, 1993).  
 
According to the sliding dimer theory, each dimer of the tetrameric LTTR interacts with the RBS and ABS 
respectively. Binding the promotor region this way causes a high-angle bending of the DNA strand and 
prevents the RNA polymerase to start transcription. Upon binding of the effector, the LTTR undergoes 
conformational changes in the C-terminal domain that will reposition the DNA-binding domains around the 
ABS. The protein will adopt a more compact structure. Instead of spanning a region of five helical turns, the 
DNA will be more relaxed, exposing the promotor and allowing RNA polymerase recruitment (Fig 13) 
(Porrua et al., 2007, Maddocks & Oyston, 2008).  
2.3. The ligand-binding C-terminal domain 
The C-terminal part of LTTR proteins is much more variable and shows little conservation at the primary 
structure level, a feature that corresponds with the diverse range of ligands that can be recognized by LTTRs. A 
very diverse range of substrates -including amino acids, mono- and oligosaccharides, oligopeptides, 
inorganic anions and xenogenic compounds- can indeed be recognized by LTTRs. These effector molecules 
typically bind in a pocket (inducer binding cavity, IBC) formed by two adjacent subdomains, conventionally 
referred to as RD1 and RD2 (Stec et al., 2006). Like the periplasmatic binding proteins (PBP) of Gram-
negative bacterial importers, both subdomains are built up by a central β-sheet surrounded by α-helices and 
joined by a hinge region consisting of a rigid α-helix. The overall shape of the formed cavity and the 
differences in electrostatic distribution of the pocket allow high-affinity binding and selectivity.  
Working like clamps, RD1 and RD2 close the cleft when the cognate substrate is bound. Moreover, structure 
determinations of C-terminal domains in the absence and presence of the inducer revealed that this closing 
movement is followed by a significant rotation of RD2 towards RD1, up to 21° (Devesse et al., 2011, Ezezika et 
al., 2007). This impressive change is mainly triggered by interactions with the inducer at the base of the cavity, 
which results in rearrangements of nearby helices. 
2.4. Full-length structures of LTTRs 
Most structural studies on LTTRs are limited to the crystal structure of the cofactor-binding domains. As the 
wHTH-domain is particularly unstable in the absence of its corresponding promotor DNA, full-length 
LTTRs are difficult to keep in solution and to crystallize. To date, only a couple of examples are known of the 
successful determination of full-length LTTR X-ray structures, but none of them being bound to DNA or 
interacting with RNA polymerase: i) the cis,cis-muconate responsive CbnR from Ralstonia eutropha NH9 
(Muraoka et al., 2003), ii) the product of the contact-regulated gene A CrgA from Neisseria meningitis, 
implicated in host-pathogen interactions (Sainsbury et al., 2009), iii) a lysR transcriptional regulator of 
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Pseudomonas aeruginosa, iv) ArgP for arginine outward transport (Zhou et al., 2009), v) BenM, one of the 
regulators for benzoate consumption (Ruangprasert et al., 2010), vi) TsaR, a LysR transcriptional regulator 
from Comamonas testosteroni strain T-2, regulating the degradation of para-toluenesulfonate (TSA) 
(Monferrer et al., 2010) , and vii) AphB, a virulence gene activator from Vibrio cholerae (Taylor et al., 2011).  
With a lower degree of pairwise sequence conservation and the formation of octameric rings, CrgA is 
regarded as an outsider among the structurally determined LTTRs. However, the three other characterized 
LTTRs also demonstrate differences when superposing their quaternary structures. Montferrer et al. explained 
this phenomenon with a theory in perfect agreement with the sliding dimer model. Analysis of the ligand-free 
CbnR and LTTR from Pseudomonas on the one hand, and the TSA-bound TsaR on the other led to the 
conclusion that binding of inducer molecules leads to drastic conformational changes of vicinal loops, 
disrupting intra-helical contacts at the dimer interface. The C-terminal domains of the tetramer will then 
adopt a more extended conformation, while the DNA-binding domains will come more in the proximity of 
each other. The concomitant release of the ABS is accompanied by a relaxation of the intergenic DNA and an 
increased transcription. This theory furthermore clarifies why only the fully occupied LTTR exhibits the 
totally open conformation and how variable degrees of DNA bending can be achieved (Monferrer et al., 2010, 
Devesse et al., 2011). 
 
Fig 13. The LTTR mechanism – 
The sliding dimer theory 
(Top left) Two polypeptide chains 
(green and blue) build up every 
LTTR dimer, forming an effector-
binding domain (C-terminal part) 
and a DNA-binding domain (N-
terminal part).  
(Top right) LTTRs interact with  
DNA at two dissimilar sites: the 
RBS containing the LTTR consensus 
motif, and the activator binding site 
(ABS). In absence of inducer, the 
LTTR interacts with the ABS1 
region (high angle DNA bending). 
Upon binding of the inducer ligand, 
conformational changes of the 
bound LTTR will incite interactions 
with the ABS2-site (DNA 
relaxation).  
(Bottom)  Schematic representation 
of the effector- and DNA-binding 
domains of LTTRs, reorganizing 
from a closed to an open 
conformation upon inducer binding.  
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3. RESULTS 
 
Expression and stabilization of the purified V.vulnificus LysR-type transcriptional regulator 
Analyzing the expression of the recombinantly produced proteins, by loading expressing cells at different 
time intervals on an SDS-PAGE gel, showed that high levels of GST-LysRvv and 6xHis-LysRvv could be 
reached. The molecular mass of both induced proteins, as estimated on the polyacrylamide gel, coincided 
perfectly with the predicted molecular mass of the LysRvv amino acid sequence plus the GST-tag or the 
hexahistidine-tag sequence.  
Instability issues, however, which are often encountered when producing LysR transcriptional regulators in 
their completeness, could not be prevented. As expected, problems were more important when the DNA-
binding domain was not stabilized by the fused GST-protein. Confirming this stabilizing action, the removal 
of the GST-tag by treatment with thrombin instantly led to protein loss. 
In order to improve the solubility of LysRvv, we attempted to slow down the production of LysRvv and to 
allow the cell to fold the produced proteins properly. However, lowering the temperature to 28°C after 
induction, transforming other strains for T7-promotor-based expression than BL21(DE3), or using low-copy 
vectors were not helpful.  
Another approach consisted in performing thermofluor-based thermal assays to rapidly establish stabilizing 
conditions for the purified LysRvv. Such a strategy furthermore potentially allows the identification of a 
ligand. The experiment revealed that the addition of glycerol or sulfobetaines (NDSB195) reduces the 
aggregation of the proteins. In conclusion, to control precipitation of LysRvv, our actions consisted in 
limiting the time of expression to four hours and adding glycerol up to 35%, depending on the concentration 
of the sample. 
 
The intergenic region between LysRvv and the downstream operon contains elements for LTTR 
binding 
Similar to what has been described for other LTTRs, the gene coding for LysRvv is divergently transcribed 
from the VVA1599-VVA1600-VVA1601 operon, strongly suggesting that LysRvv controls the expression 
of the latter. These three downstream-located ORFs are predicted to encode a short-chain dehydrogenase 
(SDRvv), a homologue of E.coli Grx2 (Grx2vv) and NADPH-dependent Old Yellow Enzyme (OYEvv) 
respectively.  
The transcriptional start of LysRvv and the first operon gene, SDRvv, are separated by a 115bp-intergenic 
region, likely containing promotors and other regulatory sequences such as the ribosome-binding sites 
preceding the ATG codons. Another cis-acting sequence could easily be recognized as the regulatory binding 
site (RBS), hallmarked by a conserved palindromic T-N11-A motif. Bordered by inverted repeats (underlined), 
the TTCAGCTCAGATGAA motif stretches from position -93 to -73 relative to the transcriptional start of 
SDRvv.  
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Fig 1. The intergenic region between the open reading frames VVA1598 (LysRvv) and VVA1599 
(SDRvv). Nucleotide sequence with the deduced amino acid sequence of the intergenic region located on the 
Vibrio vulnificus genome between ORF’s VVA1598 and VVA1599 (sequence used for gel mobility shift 
assays). The putative ribosomal binding sites are shown in red, the T-N11-A palindromic sequence recognized 
by LysRvv is highlighted in cyan. Arrows indicate the direction of transcription.  
 
LysRvv has affinity for the intergenic region  
To investigate whether LysRvv regulates the expression of SDRvv and the other downstream located genes of 
the operon, DNA electrophoretic mobility shift assays (EMSA) were performed. A 300bp probe, spanning the 
intergenic region between LysRvv and SDRvv as well as significant portions of both flanking genes (Fig 1), 
was PCR-generated, biotin-labeled, and subsequently incubated with serial dilutions of purified LysRvv-GST 
protein. Binding of the fusion protein caused a band-shift in a concentration-dependent manner (Fig 2, top). 
However, the protein appeared to have a higher affinity for the promotor region when thrombin was included 
in every reaction and the GST-tag was cleaved off. This observation suggests that the tag confers steric 
hindrance at the N-terminus of LysRvv. To mimic the in vivo conditions, future EMSA experiments were 
executed with His-tagged instead of GST-tagged protein (Fig 2, bottom). 
The apparent Kd of LysRvv for the promotor region was estimated to be 25nM, indicating high-affinity 
binding. To rule out aspecific binding, an arbitrary DNA-probe lacking the operator sequences was included 
in the assay as a control. Addition of LysRvv up to 550nM did not provoke a DNA-shift, confirming that the 
interaction between LysRvv and the intergenic region was specific. 
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Fig 2. Electrophoretic mobility shift 
assay for the binding of LysRvv to 
the intergenic region. (Top) The 
300bp-probe was end-labeled by the 
introduction of 5’-biotinylated 
primers in the PCR and incubated at 
room temperature with increasing 
concentrations of purified LysRvv. 
Based on the intensity of the shifted 
bands, the Kd is estimated to be 25nM. 
 
 
 
(Bottom) Incubation of the labeled promotor-
containing DNA (300bp) with increasing 
concentrations of DNA, in the left panel, in the 
absence of thrombin, in the right panel in the 
presence of thrombin. The difference in intensity 
of the shifted bands indicates that the fused GST-
tag confers steric hindrance when binding to the 
promotor region. Consequently, a 10-fold 
increase (from 20nM to 2nM, see arrows) in 
affinity can be expected upon removal. 
 
 
LysRvv does not form a ternary complex with DNA and SDRvv 
The search tool for the retrieval of interacting genes/proteins (STRING) revealed that, similarly to Vibrio 
vulnificus, the limited number of species carrying a homolog of LysRvv also possess a divergently transcribed 
SDRvv-homolog. Unique to prokaryotes, the majority of bacteria bearing a LysRvv-SDRvv couple appear to 
be prevalent in human pathogens such as Pseudomonas aeruginosa, Yersinia enterolitica, Stenotrophomonas 
maltophila and Burkholderia pseudomallei. Interestingly, the genome of Klebsiella pneumoniae shows up to 
three copies of this particular association. 
In our study we investigated whether SDRvv is able to form a ternary complex with the promotor-bound 
LysRvv, and as such, to participate in translational control. Because SDRvv is extraordinary sensitive and 
selective for NADPH, it can in principle perfectly communicate the redox status to the transcriptional 
regulator and influence gene expression. However, while protein-protein interactions with transcriptional 
regulators are common in bacteria (e.g. the two-component signal transduction systems for quorum sensing, 
changes in osmolarity, antibiotics, temperature, pH, etc.), those involving LTTRs are limited to modulatory 
contacts with subunits of the RNA polymerase (Park et al., 2002, Lochowska et al., 2004). 
To visualize the eventual formation of a complex, the EMSA with the biotin-labeled intergenic fragment was 
repeated using 20nM LysRvv and increasing concentrations of purified SDRvv. Experiments were similarly 
performed in the presence and absence of NADPH, to investigate the eventual effect of an SDRvv-bound 
ligand. While the sole presence of LysRvv displaces the promotor DNA, no second shift –indicative of the 
formation of a LysRvv:SDRvv interaction- was observed, even not at concentrations of SDRvv= 1.5μM (75-
fold excess). To rule out the importance of an unknown parameter, gel shift assays with crude lysate were 
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performed in parallel. From these results, the formation of a supercomplex comprising LysRvv, promotor 
DNA and SDRvv seems not plausible. LysRvv thus responds to other, yet unknown, stimuli to regulate the 
expression of its cognate operon. 
4. CONCLUSION 
The basis of this work is the observation that some members of the short-chain dehydrogenases participate in 
the control of gene expression. Since no in vivo function could be attributed to SDRvv, we wanted to verify 
whether the latter can communicate the monitored changes in NADPH/NADP+ status by direct interaction 
with LysRvv. 
We showed that locus tag VVA1598 encodes a LysR transcriptional regulator, which binds a DNA sequence 
adjacent to its transcription start with specificity and high affinity. Since the formation of a ternary complex 
with SDRvv can be excluded, the regulatory features of the association seen at the genetic level remain to be 
established.  
 
5. EXPERIMENTAL PROCEDURES 
 
Bacterial strains, media and growth conditions 
All bacterial cells were grown at 37°C, in a shaker (180rpm) in Luria Bertani medium, supplemented with 
50μg/ml carbenicillin or 25μg/ml chloramphenicol. 
  
Cloning of V. vulnificus LysRvv 
Gene VVA1598, coding for a LysR-type transcriptional regulator, was PCR-isolated from the genomic DNA 
of Vibrio vulnificus using Expand Long Template polymerase (Roche Applied Science) in combination with 
following designed forward and reverse primers: 5’- CA GAC GAA TTC CC  ATG GAT AAG TTT TCC-3’ 
and 5’- AA TTA  CTC GAG  TCA CGA GGC GGG AAA TCG-3’ respectively. The introduced EcoRI and 
XhoI restriction sites (underlined) at both ends of the amplified gene permitted an easy cloning step in the 
opened pGEX-4T-2 (Amersham) vector. It should be noted that the N-terminal initiation codon was omitted 
to attain the recombinant expression of the protein in fusion with an N-terminal GST-tag. This strategy was 
adopted to stabilize the otherwise unstable winged HTH-domain. Scientific literature describing the efforts to 
produce LysR-type transcriptional regulators frequently report difficulties when the DNA-binding domain is 
included in the expressed sequence. Beside the truncation of the transcriptional regulator, the recombinant 
expression of a fusion protein is one way to tackle this problem.  
Therefore a second construct, based on pET15b (Novagen), was produced to allow the formation of LysRvv 
having a N-terminal 6xhis-tag. The PCR-product was obtained using primers (Forward: 5’-CA GAC CAT 
ATG GAT AAG TTT TCC GAT ATG-3’ and Reverse: 5’-AA TTA GGA TCC TCA CGA GGC GGG AAA 
TCG-3’ containing NdeI and BamHI restriction sites, underlined. The resulting constructs were verified by 
restriction and sequencing analyses. 
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Expression and purification of recombinant GST-tagged and 6xHis-tagged LysRvv 
E. coli BL21(DE3) transformants carrying the constructs were cultured overnight in 100ml of Luria-Bertani 
medium supplemented with carbenicilllin. The precultures were transferred to fresh medium in a ratio 1/100. 
Cells were induced by addition of 1mM IPTG when the exponential phase (optical density at 600nm between 
0.6 and 0.8) was reached, and were further grown for 4 hours. After harvesting the cells by centrifugation, 
pellets were resuspended in PBS-buffer, pH 7.4, and ultrasonicated. Cleared supernatans, containing GST-
LysRvv or 6xHis-LysRvv, was obtained after another round of centrifugation, and was loaded on a 
Glutathione Sepharose-4B column (GE Healthcare) or TALON affinity matrix (Clontech), respectively. 
After binding on the glutathione-containing matrix, due to the high affinity of GST for the immobilized GSH, 
and a washing step with PBS-buffer, the GST-LysRvv fusion protein was retrieved using 10mM glutathione. 
The eluate of nearly pure GST-LysRvv was dialyzed overnight against 50mM Tris, pH 7.5, 150mM NaCl and 
5% glycerol. 
6xHis-LysRvv was separated from other contaminants on the basis of the association between the tag and the 
Co2+-metal. The column was concomitantly washed with PBS-buffer, followed by elution of the fusion-
protein with 500mM imidazole. Due to the high instability of the purified protein, high percentages of 
glycerol (40%) were needed to keep 6xHis-LysRvv in solution.  
The proteins were pooled and stored at -80°C. The concentrations were determined according to the method of 
Bradford with BSA as a standard, or by using the Nanodrop method for absorption at 280nm and a computer-
calculated extinction coefficient of ε=25.900M-1cm-1. 
 
Electro-mobility shift assays (EMSA)  
Electromobility shift assays (synonyms: gel shift or gel retardation assay), abbreviated as EMSA, are 
commonly performed to study the interactions of proteins with DNA. The technique is based on the slower 
migration of protein:DNA complexes compared to free DNA during the separation on a non-denaturing 
polyacrylamide gel. The promotor-containing intergenic region between LysRvv and SDRvv was thus PCR-
amplified from the genomic DNA of V.vulnificus using primers carrying a biotin label at the 5’-terminus. 
Both forward (5’!GAT ATC GTG ACG GTG GCC GGC GAT AA-3’) and reverse (5’"TCC TTT GCT AGC 
CAT CAC GAT GGT ATG CTC ACT 3’) primers were complementary to sequences of the coding region of 
LysRvv and SDRvv respectively, to ensure that all DNA-binding regions for LysRvv were present. The DNA 
concentration was determined spectrophotometrically at 260nm using a Nanodrop and a computer-calculated 
extinction coefficient of ε= 4.958.697M-1cm-1. 
All EMSA reactions were carried out in 20μl containing binding buffer (10mM Tris-HCl, pH7.5, 50mM 
KCl, 1mM DTT), 5ng/μl poly(dI-dC), BSA, 2ng labeled DNA and LysRvv-concentrations between 2 and 550 
nM. Reaction mixtures were incubated at room temperature during 30 minutes and then subjected to gel 
electrophoresis (7.5% polyacrylamide gel in 0.5x TBE running TBE buffer at 100V). The DNA was 
concomitantly electro-transferred onto nylon membranes (Hybond, Pierce) and visualized by capturing the 
chemiluminescence with an X-ray film (LightShift Chemiluminescent EMSA kit, Pierce). 
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4. 
GLUTAREDOXIN 
 
Besides SDRvv, the divergently transcribed LTTRvv also regulates a member of the glutaredoxin family, called 
Grx2vv. Blast analysis reveals the protein as a close homologue of E.coli Grx2 (33% pairwise sequence 
identity), the atypical Grx-product of the grxB gene. Most organisms reckon upon a glutaredoxin repertoire to 
catalyze the reversible reduction of disulphide bonds. Being involved in stability (e.g. BSA), catalytic activity 
(e.g. PAPS and ribonucleotide reductase) and biological function (e.g. OxyR), disulphide bridges are crucial for 
proteins. Glutaredoxins achieve their role of oxidoreductase in interplay with GSH, NADPH and glutathione 
reductase (GR). These components –forming the glutaredoxin system- will be discussed in detail in the 
following paragraphs. 
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1. THE GLUTATHIONE REDOX COUPLE 
The most important low-molecular thiol in the cell was discovered in 1888 by the French scientist J. de-Rey-
Pailhade, who called the substance philothion  (from the Greek ‘sulfur-loving’) for its property to react with 
elemental sulfur (J. de Rey-Pailhade, 1888).  Nobel Prize winner Sir Frederick Gowland Hopkins isolated and 
characterized the molecule in 1921 and renamed it glutathione. His work, and independently that of Kendall et 
al., concluded that the structure corresponds to a tripeptide composed of glutamic acid, cysteine and glycine, 
with an unusual gamma-linkage between the first two amino acids (Hopkins, 1929; Kendall, 1929).  
Glutathione is synthesized in two closely linked ATP-dependent steps involving the enzymes γ-
glutamylcysteinyl synthetase (gshA) and glutathione synthetase (gshB). First, L-glutamate and cysteine are 
combined to form γ-glutamylcysteine, followed by a second step consisting of the addition of glycine.  The first 
synthesis step, catalyzed by γ-glutamylcysteinyl synthetase, is subject to feedback inhibition by GSH and is 
considered to be the rate-limiting step as it is dependent on the free cysteine pool in the cell. Mutants of gshA 
indeed demonstrated an increased sensitivity to a large number of chemicals (Apontoweil & Berends, 1975b, a).  
 
Noteworthy, an enzyme was discovered by Vergauwen and coworkers (Vergauwen et al., 2006), unifying the 
activities of the two separate ligases gshA and gshB. This protein, GshF, is present in a number of pathogens and 
free-living bacteria and achieves its bifunctionality through a fusion between γ-glutamylcysteinyl synthetase 
and glutathione synthetase. The crystal structures of GshF-representatives show that an intricate network of 
highly conserved interactions and a shared helix allow the two entities to communicate (Stout et al., 2012). 
 
Degradation of GSH is not an easy process, due to the γ-linkage. The catabolic pathway is under control of γ-
glutamyl transpeptidases (GGT), a family of membrane-bound enzymes transferring the γ-glutamyl moiety of 
glutathione to diverse acceptors such as amino acids, peptides or water. The resulting cysteinylglycine is further 
cleaved at the cell surface to free glycine and cysteine (Griffith et al., 1978). 
L-Glu + L-Cys + ATP ! γ-Glu-Cys + ADP + Pi 
γ-Glu-Cys + Gly + ATP ! GSH + ADP + Pi 
 
Glutathione is found in almost all eukaryotes, while in prokaryotes its synthesis is restricted to cyanobacteria 
and proteobacteria as well as to a couple of strains of Gram-positive bacteria (Masip et al., 2006). The cytosolic 
concentration of reduced glutathione fluctuates among species between 1 and 11mM (Fahey et al., 1978), which 
is much higher than for other redox active compounds. Due to its thiol functional group, the molecule can adopt 
a reduced and oxidized state, respectively abbreviated as GSH and GSSG. In its reduced state, GSH is recognized 
to be a crucial player in the first-line defense against reactive species and oxidative stress. By scavenging 
directly a wide variety of deleterious compounds (superoxide anion, hydroxyl radical, singlet oxygen, protein- 
and DNA radicals) their electron donation leads to the formation of a thyil radical (GS"), which can recombine 
with a second GS" radical resulting in GSSG.  
GSH + R" ! GS" + R 
GS" + GS" !GSSG 
Geraldine Buysschaert - Glutaredoxins 77 
Under normal conditions, i.e. in absence of oxidative stress, the oxidized glutathione concentration is 
approximately two orders of magnitude lower than the GSH concentration. Furthermore, the ratio of 
GSH/GSSG is a measure for the redox state of the cell. Indeed, the absolute concentrations of the components of 
the GSSG/2GSH redox pair have an impact on the reduction potential (GSSG +2H+         2e- + 2GSH). As 
glutathione is differently distributed over the cell, various redox compartments can be created (e.g. cytosol, 
nucleus, ER, mitochondria). The cytosol -the principal site of synthesis of GSH- is thus primarily a reducing 
environment.  
2. GLUTATHIONE REDUCTASE 
The reduction of oxidized glutathione is nearly entirely attributed to glutathione reductase (GR; EC 1.6.4.2), the 
product of the gor gene. The GSH-recycling and maintenance of a reduced environment in the cell is 
accomplished using the reducing equivalents of NADPH. Being a member of the pyridine nucleotide disulphide 
oxidoreductase family, GR carries a (yellow) FAD cofactor in its binding site to facilitate the transfer of two 
electrons from NADPH to oxidized glutathione.  
GSSG + NADPH + H+ !2GSH + NADP+ 
The crystal structure of glutathione reductase from a variety of sources is known in detail (Karplus & Schulz, 
1987, Ermler & Schulz, 1991, Berkholz et al., 2008). It reveals a homodimeric organization in which both 
subunits of approximately 50kDa are positioned in a head-to-tail manner. While OxyR is the transcriptional 
regulator of gor in the exponential phase, it was demonstrated that RpoS is the regulator in the stationary phase 
(Becker-Hapak & Eisenstark, 1995). 
3. THE GLUTAREDOXIN FAMILY 
With the discovery of glutaredoxin, an alternate hydrogen donor for ribonucleotide reductase, Holmgren and 
coworkers (1976) found the first member of a protein family represented in nearly all living organisms. 
Existing in prokaryotes (E.coli), plants (A. thaliana, rice, poplar), viruses (bacteriophage T4, vaccinia, HIV) and 
eukaryotes (P. falciparum, yeast, rabbit, calf, pig and human), glutaredoxins are indispensable oxidoreductases 
performing fast and reversible thiol-disulphide exchange reactions.  
3.1.  Structure of glutaredoxins 
Except for a number of outliers, glutaredoxins are generally small proteins with molecular weights varrying 
between 9 and 12kDa. Today, around 80 three-dimensional structures of glutaredoxins, from bacteria, yeast and 
higher eukaryotes, are deposited in the Protein Databank. These structures reveal that all glutaredoxins share a 
common denominator, the so-called ‘thioredoxin fold’, a well-conserved scaffold of about 80 residues 
consisting of a central β-sheet, on both sides surrounded by α-helices. This motif (Fig 14) appears to be the 
hallmark of proteins specialized in cysteine- or glutathione-binding, such as the GSTs (Reinemer et al., 1991), 
thioredoxins (Katti et al., 1990), PDIs (Kemmink et al., 1996), members of the bacterial Dsb family (Martin et 
al., 1993), glutathione peroxidases (Epp et al., 1983), peroxiredoxins (Choi et al., 1998), and members of the 
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CLIC1 (Harrop et al., 2001). The homology between those antioxidant enzymes is rather limited and can vary 
enormously between two members (Fig 14). The highest degree of conservation, however, is concentrated 
around the CxxC or CxxS active site motif, situated in a connecting loop between strand β1 and helix α1 (Martin, 
1995). 
 
 
Fig 14. The thioredoxin fold topology. Based on (Martin, 1995). As seen in several antioxidant enzymes, the 
thioredoxin fold seems effective in fighting oxidative stress conditions. The fold was named after the first 
protein in which it was first observed, E.coli Trx1 (Holmgren et al., 1975). However, the structure of E.coli 
Grx1 represents the most basic variant of this fold, composed of a four-stranded β-sheet and three flanking α-
helices. Upon superposition of the α-carbon traces of different Trx-fold bearing proteins, we can note that the 
conserved active site motif is located at similar locations (Martin, 1995). Another conserved characteristic is the 
cis-XP peptide bond in the loop between α2 and β3. 
 
                                                                  
1 CLIC: nuclear chloride channel proteins 
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Fig 15. Multiple sequence alignment of glutaredoxins. Amino acid sequence alignment (Multalin) of 
glutaredoxins from E.coli, baker’s yeast and human. The arrow indicates the glutaredoxin dicysteine active site. 
Representation made with ESPript. 
 
3.2. Classification of glutaredoxins 
In accordance to their phylogeny, sequence conservation and domain organization, Grxs are classified in three 
main groups. Initially, only two groups were defined and belonging to the dithiol (class I) or monothiol (class 
II) glutaredoxins was simply based on the presence of a CPYC or CGWS active site signature, respectively. 
However, the great diversity of Grx sequences in plant genomes urged for the introduction of a third class, 
grouping glutaredoxins containing CCxx active site motifs. This family of class III glutaredoxins is thus plant-
specific, since no counterparts are present in nonphotosynthetic organisms or lower photosynthetic eukaryotes. 
CC-type glutaredoxins constitute a relatively new family and were to date not characterized biochemically 
(Zaffagnini et al., 2012).  
Depending on whether they contain one or more domains, monothiol glutaredoxins can be further divided into 
single- and multidomain monothiol proteins. In last case -only found in eukaryotes- the enzyme is built up by 
an N-terminal Trx-like domain and one to three C-terminal monothiol Grx domains, or PICOT homology 
domains (Isakov et al., 2000, Xia et al., 2001). 
After the elucidation of the structure of E.coli Grx2 (Xia et al., 2001), dithiol glutaredoxins are also subdivided 
in two main groups. The largest branch, called ‘classical’ glutaredoxins, comprise the small (9-12kDa) dithiol 
(2-Cys) glutaredoxins, such as E. coli Grx1 and Grx3, yeast Grx1 and Grx2, and human Grx1. They are mainly 
known as important electron donors for a number of enzymes (e.g. RNR, PAPS reductase and methionine 
sulfoxide reductase). Exemplified by E.coli Grx2, a smaller subset of glutaredoxins appears to be twice the size 
of that for classical glutaredoxins (24-30kDa). The larger molecular weight of these atypical glutaredoxins is 
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explained by the presence of an extra GST-like C-terminal domain,  in addition to the N-terminal Grx domain 
(Fig16) (Xia et al., 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 16. Crystal structures of classical and atypical glutaredoxins. (Left) E.coli Grx1 (PDB-code: 1GRX) 
(Right) E.coli Grx2 (PDB-code: 1G7O). The additional GST-like domain of Grx2 is shown in light blue. 
(Cartoon representation, made in Pymol) 
 
 
 
 
3.3. Properties of the active site 
In glutaredoxins, as in other proteins bearing the thioredoxin motif, the active site is composed of two cysteines 
separated by two other residues. The nature of the intervening amino acids can vary between, but usually not 
within subfamilies (e.g. Trx -> GP; Grx -> PY; PDI -> GH; DsbA -> PH) (Kortemme et al., 1996). In those 
proteins, the surface-exposed N-terminal active site cysteine has an unusual low pKa compared to what is 
normally expected for side chain of this amino acid (≈ 8.7). On the other hand, the more buried C-terminal 
cysteine, when present, has a much more basic pKa value. 
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Table 6. Proteins of the thioredoxin superfamily and their associated active site motif, the pKa-value of 
the N-terminal active site cysteine and observed redox potential. 2 Underlying table emphasizes the close 
correlation between the pKa of the N-terminal active site cysteine and the redox potential of the enzyme. The 
latter determines directly the capability of each protein to participate in redox reactions, from very reducing  
(-270mV) to very oxidizing (-124mV). Respecting the rule ‘the lower the redox potential, the greater the 
tendency to act as a reductans’, the different enzymes can be ordered as follows from their ability to act as a 
reductans: Trx> Grx > PDI > DsbA. This observation is evidently directly related with protein function. While 
Trx is a reductant of protein disulphide bonds (formation of a strong active site C-C), DsbA and PDI are 
oxidants (formation of a weak active site C-C). 
 
 
 
 
 
 
 
 
 
Modulation of the pKa value of a residue is generally achieved by electrostatic interactions with other charged 
groups. In proteins, most electrostatic effects cause a modulation from the intrinsic value of less than 1 pH unit, 
although greater shifts are known (Kortemme et al., 1996, Anderson et al., 1990). 
The driving force behind the cysteine pKa-lowering, which has an effect on both the nucleophilicity and the 
leaving group properties of the formed thiolate, is not clear. Studies performed in this regard show that 
different factors contributes to this effect. First, the identities of the intervening –xx- residues in the active site 
can significantly affect the pKa of the N-terminal cysteine. Site-directed mutagenesis demonstrated that a change 
in the intervening residues of Trx (Joelson et al., 1990, Krause et al., 1991, Mossner et al., 1998), Grx (Joelson et 
al., 1990) or DsbA (Grauschopf et al., 1995) leads to an altered pKa. For instance, obliterating the proline in 
thioredoxin and replacing it by histidine, as seen in the active site signature of PDI, increases the redox potential 
of Trx to come closer to that of PDI (Krause et al., 1991). According to several authors the effect of the 
intervening residues on the pKa is linked to the number of hydrogen bonds that these amino acids can provide 
to stabilize the charge of the thiolate (Nordstrand et al., 1999, Foloppe et al., 2001). Mutations in the active site 
showed that the formation of an additional H-bond to the thiolate sulfur is beneficial for pKa-lowering. Beside 
the intervening residues, the thiolgroup of the C-terminal cysteine can also donate a hydrogen bond to the N-
terminal counterpart and consequently participate in the stabilization of the thiolate (Foloppe et al., 2001).  
Secondly, the stabilization of the negative charge of the nucleophilic cysteine is reinforced by the C-terminally 
located α-helix (Hol, 1985, Nelson & Creighton, 1994, Katti et al., 1990, Madzelan et al., 2012). The alignment 
of the dipolar peptide bonds in such an α-helix engenders an electrostatic field, called a helix dipole, where the 
positive end points towards the N-terminus and the negative end towards the C-terminus. Based on this 
                                                                  
2 The redox potential at pH 7.0 and 25°C, E0’ (expressed in V), is a measure of the reducing capacity of a 
redox couple. The redox potential can be calculated using the equilibrium constant of the redox reaction 
involving a reference with known redox potential, using the Nernst equation: ΔE = (RT/nF) ln Keq 
Protein Active site motif pKa Redox potential (E°) 
E. coli Trx1 CGPC 7.1 -270 mV 
E. coli Grx1 CPYC ≈5 -233 mV 
E. coli Grx3 CPYC ≈5 -198 mV 
hGrx1 CPYC 3.5 -232mV 
yGrx1 CPYC 4.0  
yGrx2 CPYC 3.5  
hPDI CGHC 4.5 -175mV 
E. coli DsbA CPHC 3.2 -124 mV 
E. coli DsbC CGYC  -130mV 
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reasoning, the following correlation could indeed be seen in model peptides folding into α-helices: a decrease of 
the pKa is noted when the cysteine thiol is situated at the N-terminus, whereas an increase is observed for C-
terminal cysteines (Kortemme & Creighton, 1995). This phenomenon also harmonizes with the well-conserved 
position of a proline residue (Richardson & Richardson, 1988) next to the surface-exposed cysteine. Proline, 
introducing a mild kink in the protein chain, ensures that the negative charge of the thiolate is ideally positioned 
with respect to the helix dipole. 
The fact that E.coli Grx1 and Grx3 show different redox potentials, despite identical intervening residues in the 
active site and comparable positions of the nucleophilic cysteine with respect to the α-helix, proves that other 
parameters contribute to the pKa-value of the thiol functional group. Molecular dynamics simulations, a tool to 
explore the structural dynamics of a given protein, showed the importance of the residues in the vicinity of the 
active site. For instance, the presence of a peripheral Arg or Lys at position 8 in respectively E.coli Grx1 and 
Grx3, forming transient hydrogen bonds with the thiolate, can significantly affect the catalytic properties of the 
enzyme (Foloppe & Nilsson, 2004). 
 
 
 
Fig 17.  Factors influencing the pKa of 
the N-terminal active site cysteine in 
glutaredoxins. (Top) The consensus 
conformation of Cys9 and Cys12 in 
reduced E. coli glutaredoxin 2 (PDB-code: 
1G7O) shows interactions between Cys9 
and the intervening residues. The latter are 
thought to stabilize the thiolate by 
hydrogen bonding. (Bottom) Effect of the 
helix dipole moment on the pKa-lowering 
of Cys9. 
 
 
3.4. Monothiol versus dithiol reaction mechanism 
Glutaredoxins perform their function through one of the following distinct, but functionally connected, reaction 
schemes: the monothiol and dithiol reaction mechanism (Fig 18) (Lillig et al., 2008). 
In the dithiol mechanism, both active site cysteines are involved in the reduction reaction. This mode of action, 
necessitating a second cysteine, is particularly important for the reduction of protein disulfides. Here, the 
thiolate group of the N-terminal cysteine first performs a nucleophilic attack on the target disulfide, followed 
by the formation of a mixed disulfide intermediate between the two proteins. Next, the second active site thiolate 
frees the reduced protein substrate, which leaves the glutaredoxin with an oxidized active site. The local 
environment around the C-terminal cysteine will, under normal circumstances, not lead to deprotonation. To 
lower the pKa of the second cysteine and to increase its nucleophilicity, the electrostatic potential around this 
residue needs to be reshaped. Therefore, the formation of the mixed disulphide is accompanied by 
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conformational changes of the α-helices, which will lead to the replacement of positively charged residues and 
quenching of the negative charge on the N-terminal cysteine (Berardi & Bushweller, 1999). The cysteine couple 
of the glutaredoxin can retrieve its reduced state using a GSH-molecule. Upon subsequent formation of a mixed 
disulfide intermediate, a second GSH-molecule enters the active site, liberating the N-terminal cysteine and 
leaving the Grx as GSSG.  
 
Fig 18. The reaction 
mechanism of glutaredoxins.  
When reducing protein 
disulfides, glutaredoxins 
utilize both active site residues 
(dithiol mechanism, left panel). 
The reaction starts with a 
nucleophilic attack on one of 
the sulfur atoms of the 
disulfide target. The C-
terminal Cys participates 
during the reaction by 
attacking the formed mixed 
disulfide with the target 
protein. Protein-GSH mixed 
disulfides are reduced by 
glutaredoxins following a 
monothiol mechanism. This 
results in the formation of a 
covalent Grx-SG mixed 
intermediate (right panel). The 
GSSG formed, released upon 
reduction of the oxidized active 
site, is reduced by the common 
action of glutathione reductase 
and NADPH 
 
 
 
When following the monothiol mechanism, only the reactive N-terminal active site cysteine is required. This 
scheme applies for the reduction of mixed disulfides with GSH or small molecular weight compounds. During 
such a catalytic cycle, a mixed disulphide between the N-terminally located cysteine and GSH is generated, 
while the non-GSH molecule acts as leaving group (Yang et al., 1998). A reduced active site is retrieved in a 
similar way as for dithiol glutaredoxins: a second GSH-molecule is needed to reallocate the glutathione 
participating in the formation of the mixed disulphide. In both cases, the resulting oxidized glutathione is 
regenerated by glutathione reductase, at the expense of NADPH. 
3.5. Glutaredoxin distribution 
With genome sequencing projects following up each other rapidly, the glutaredoxin family did not stop 
growing over the last years. As previously stated in the introduction, glutaredoxins are present in nearly every 
life form, from viruses to human. Table 7 briefly summarizes the wide distribution of glutaredoxin isoforms. 
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Table 7. Glutaredoxin occur in every life form, and display a highly conserved active site motif.  
Organism Gene Protein MW (kDa) Active site 
E.coli grxA Grx1 9.7 CPYC 
E.coli grxB Grx2 24,3 CPYC 
E.coli grxC Grx3 9.1 CPYC 
E.coli grxD Grx4 12,8 CGFS 
S.cerevisiae GRX1 Grx1 12,4 CPYC 
S.cerevisiae GRX2 Grx2 15.8 CPYC 
S.cerevisiae GRX3 Grx3 32.4 CGFS 
S.cerevisiae GRX4 Grx4 27.5 CGFS 
S.cerevisiae GRX5 Grx5 16.9 CGFS 
S.cerevisiae GRX6 Grx6 25.8 CPYS 
S.cerevisiae GRX7 Grx7 22.6 CSYS 
S.cerevisiae GRX8 Grx8 12.5 CPDC 
T4 bacteriophage nrdC T4 Grx1 10,0 CVYC 
T4 bacteriophage Y55.7 T4 Grx2 12 CPGC 
Human GLRX1 Grx1 11.8 CPYC 
Human GLRX2 Grx2 18.7 CSYC 
Human GLRX3 Grx3 37.4 CGFS 
Human GLRX5 Grx5 16.6 CGFS 
A.thaliana 14 Grx genes CxxC 
A.thaliana 17 Grx genes CxxS 
 
4. THE E.COLI GENOME ENCODES FOUR GRXs AND ONE GRX-LIKE 
PROTEIN, NrdH  
4.1. The dithiol glutaredoxins 1, 2 and 3 
The 9.7kDa Grx1, the product of the grxA gene, counts 85 amino acids, including the signature sequence CPYC. 
Grx1 protein levels vary between 285ng/mg (0.0285% of total protein) to 600ng/mg (0.06% of total protein) 
during the stationary and the exponential growth phase, respectively (Potamitou, Holmgren et al., 2002), which, 
by comparison, represents approximately only 1/10th of the protein levels of Trx1, Grx2 and Grx3. Despite a 
lower concentration in the cell, Grx1 is the best characterized of all glutaredoxins and its biological function as a 
glutathione-dependent hydrogen donor for class Ia ribonucleotide reductase3 is now quite well understood (see 
further). Measuring the incorporation of labeled thymidine in newly synthesized DNA strongly suggests that 
Grx1, and not Trx1, is the most important contributor in the rescue of RNRIa. From this point of view it is not 
surprising that the Grx1 levels are upregulated during the exponential phase, where the need for DNA building 
blocks is the highest (Potamitou, Holmgren et al., 2002). Null mutants for Grx1 are perfectly viable (Russel & 
                                                                  
3 Three classes of ribonucleotide reductases -the protein catalyzing the conversion of nucleotides to 
deoxynucleotides- exist. All three function through a free radical mechanism, but differ in the way the radical is 
generated: class I depends on oxygen, class II uses adenosylcobalamin (vit B12), and the anaerobic class III needs 
adenosylmethionine and an iron-sulphur cluster. Class I can further be divided into two subclasses based on 
differences in regulation. The canonical RNRs (class Ia) are found in almost all eukaryotes, and also in 
eubacteria, bacteriophages and viruses. The Ib class is restricted to eubacteria and some bacteriophages.  
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Holmgren, 1988), proving the existence of back-up mechanisms for the important process of ribonucleotide 
reduction. 
 
Grx2 and Grx3 were purified from an E.coli mutant lacking Grx1 and Trx1 more than 20 years ago (Aslund et 
al., 1994). To date there is yet no consensus about their in vivo function. With a molecular weight of 24,3kDa, 
Grx2 has twice the mass of conventional glutaredoxins. Due to the addition of a highly helical domain to the N-
terminal Trx-fold, Grx2 has little homology with other glutaredoxins (Vlamis-Gardikas et al., 1997) and 
resembles more the glutathione S-transferases (Xia et al., 2001). The existence of close homologues to this 
outlier in the glutaredoxin family appears to be restricted to bacteria, mainly to pathogens such as Shigella 
dysenterica (seq.id. 99%), Salmonella enterica (seq.id. 86%), Ecetinobacillus actinomycetemcomitans (seq.id. 
50%) and Vibrio cholerae (30% seq.id.). In contrast with a narrow distribution between species, Grx2 of E.coli 
appears to be very abundant in the cell. Levels climbing up to 10μg/mg  (1% of total protein) in the stationary 
phase are observed when the Trx system is knocked out.  Strikingly, Grx2 displays the highest catalytic activity 
against the synthetic HED substrate (Vlamis-Gardikas et al., 1997) and contributes to 80% of total glutaredoxin 
activity of the cell (Vlamis-Gardikas et al., 2002). While Grx1 is an exponential phase protein, Grx2 appears to 
be mainly upregulated in the stationary phase. The protein is indeed under positive control of two factors 
(ppGpp and RpoS) controlling the transcription of genes in the stationary phase and genes participating in the 
antioxidant response, while cAMP inhibits Grx2 expression in the exponential phase (Potamitou, Neubauer et 
al., 2002). This is in accordance with the fact that strains missing Grx2 are more sensitive to hydrogen peroxide 
in catalase deficient strains and more prone to protein carbonylation, a phenomenon mainly occurring during 
the stationary phase.(Table 8). 
 
Being an 82 amino acid-long protein with a CPYC active site demonstrating in vitro activity against RNRIa, 
Grx3 shows an analogous architecture and catalytic profile to Grx1. However, with a catalytic turnover that is 
only 5% of that of Grx1, it is very unlikely that Grx3 reduces RNRIa in vivo (Aslund et al., 1994). Grx3 is also an 
abundant protein, existing in the cell in amounts as high as 0.5% of total protein (3.5 μg/mg), while their levels 
remain constant during every growth stage (Potamitou, Holmgren et al., 2002). Strains missing Grx3 show an 
increased sensitivity to organic peroxides such as cumene hydroperoxide and superoxide-generating 
compounds as for example menadione (Vlamis-Gardikas et al., 2002) (Table 8). 
4.2. The monothiol Glutaredoxin 4 
The availability of the E.coli genome revealed the existence of grxD, the gene encoding a glutaredoxin isoform 
with a monothiol active site (CGFS). Remarkably, Grx4 appeared to be the first glutaredoxin as a substrate for 
the selective TrxR. Like Grx2 and Grx3, this glutaredoxin is present in the cell at high concentrations (2 μg/mg), 
and predominantly in the stationary phase. Therefore, it is not surprising that Grx4 expression is controlled by 
the stationary phase transcription factor ppGpp (Table 8). More importantly, the upregulation of Grx4 is 
closely associated with the iron metabolism in the cell. Initial studies (Fernandes et al., 2005, Fladvad et al., 
Geraldine Buysschaert - Glutaredoxins 86 
2005) indeed showed a dramatic increase of Grx4 under iron limiting conditions, especially in fur4 null 
mutants. The synthetic lethality of the grxD mutant when combined with mutations in the isc5 operon on one 
hand (Butland et al., 2008), and the high-resolution crystal structure of dimeric Grx4 (Iwema et al., 2009) -
unveiling two monomeric Grx4 molecules bridged by a [2Fe-2S] cluster at the dimer interface and two non-
covalently bound GSH molecules, on the other hand, directly connect the corresponding protein to FeS 
biosynthesis. Co-purification studies recently denoted that, except as a homodimeric complex, Grx4 also exists 
as a heterodimer linking Grx2 through the [2Fe-2S] cluster to BolA, a transcription factor influencing cell 
morphology under stress conditions. The same study showed that the homodimer is much more potent in 
transferring the FeS cluster to an acceptor protein than the Grx4-BolA heterodimer. BolA can thus modulate the 
activity of Grx4, as increasing levels of BolA will lead to the sequestration of more Grx4 and a diminished 
donation of FeS clusters (Yeung et al., 2011). 
 
Table 8. Summary of the events leading to expression, and the key players involved in the upregulation, of 
the glutaredoxin system. 
 
Gene Protein Regulation Sensitivity 
gor Glutathione reductase OxyR, ppGpp H2O2, CHP, tBHP, diamide 
         grxA Grx1 OxyR Diamide, H2O2 
grxB Grx2 Acid stress, osmosis,  
RpoS, ppGpp, cyclic 
AMP 
Diamide, H2O2 
grxC Grx3  Menadione, CHP 
grxD Grx4 ppGpp, Fur  
 
4.3. The glutaredoxin-like NrdH, a hybrid between Grx and Trx 
E.coli, and bacteria lacking glutathione in particular, appear to contain small (9kDa) glutaredoxin-like proteins: 
the NrdH-redoxins (Jordan et al., 1996). Having the greatest sequence homology with glutaredoxins (27% 
seq.id. with Grx3), they carry the characteristic dicysteine motif CxxC in their active site, but with Val and Gln  
as intervening residues. However, NrdH behaves functionally as a thioredoxin: it is not reduced by GSH but it 
is by thioredoxin reductase, it has a low redox potential and it can reduce the disulphide bridges in insulin 
(Jordan et al., 1997, Gon et al., 2006). These observations are in agreement with the crystal structure, which 
shows an overall glutaredoxin-like fold, the absence of a GSH-binding site and the occurrence of a large 
hydrophobic patch at the surface to dock on TrxR (Stehr et al., 2001). It was also demonstrated (Gon et al., 2006) 
that NrdEF, a class Ib RNR, is specifically reduced by NrdH in vivo and that Grx1 can manage the NrdH 
                                                                  
4 The bacterial Fur, or ferric uptake regulator, is a global regulator that controls iron homeostasis and 
other cellular processes such as oxidative stress. The sensor exerts its function by forming a complex 
with Fe2+ ions and concomitantly binding to a consensus sequence, known as the fur box, upstream genes 
that are related to iron uptake. This interaction leads to the repression of transcription (Braun, V. (2003). 
Front Biosci 8, s1409-1421. 
5 In E.coli, FeS cluster biosynthesis is controlled by two operons: Isc (an iron-sulfur cluster) and Suf (a 
sulphur utilization factor). 
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recycling in TrxB mutants. While the in vivo role of the NrdEF-NrdH couple remained obscure for a long time, 
a recent study claims that their induction depends on Fur, an iron-dependent repressor. The manganese-
dependent NrdEF will thus sustain the production of dNTPs in periods of iron starvation to function as a back-
up mechanism for the iron-dependent class Ia RNR (Martin & Imlay, 2011). 
5. GLUTAREDOXIN FUNCTIONS 
5.1. Glutaredoxins and thioredoxins: overlapping and complementary redox systems 
It is impossible to address the many biological roles of glutaredoxins without mentioning the parallel redox 
system of the thioredoxins. The first member of this family of small oxidoreductases was discovered 13 years 
before the glutaredoxins (Laurent et al., 1964). Both enzyme families share a lot of common features. Being 
widely distributed among eukaryotic and prokaryotic species, thioredoxins also display the characteristic Trx-
fold and a conserved catalytic site (CGPC) that undergoes reversible oxidation to a cystine disulphide trough 
the transfer of reducing equivalents to a disulphide substrate. Despite similarities in structure and activity, 
glutaredoxins and thioredoxins show nearly no pairwise sequence similarity, which facilitates classification.  
Moreover, the two families retrieve their activity through the action of different systems: Grxs are reduced non-
enzymatically by glutathione, whereas Trxs are dependent of NADPH-dependent thioredoxin reductase, the 
only enzyme known so far to be able to reduce the active site of Trx. The homodimeric flavoenzyme, the gene 
product of TrxB, belongs to the same family as GR and shuttles electrons from NADPH via its FAD cofactor to 
the active site disulphide of thioredoxins. In plants, fungi and bacteria such as E. coli, the electron transfer is 
accompanied by dramatic conformational changes, which explains the narrow substrate specificity and 
selectiveness of TR (Lennon et al., 2000). Higher eukaryotes, having larger TR counterparts (55kDa/subunit 
versus 35kDa/subunit), are less picky concerning their substrates. This observation is a direct consequence of 
the presence of a selenocysteine residue in the active site motif GC(SeC)G, and a different catalytic mechanism 
(Sandalova et al., 2001, Williams et al., 2000). 
In E.coli, two thioredoxins were identified thus far: Trx1 and Trx2, encoded by trxA and TrxC  respectively. The 
highly expressed Trx1 (12kDa) was discovered as an electron donor for ribonucleotide reductase, a major 
player in DNA synthesis and repair (Laurent et al., 1964). Eliminating trxA gene did not affect the phenotype 
and revealed the presence of Grx1 as an alternate hydrogen donor for ribonucleotide reductase (Holmgren, 
1976). The construction of a viable triple mutant lacking Trx1, Grx1 and Grx3 led to the assumption that an 
additional reductor of ribonucleotide reductase exists (Prinz et al., 1997). Trx2 (15.5kDa) was only identified 
and characterized when the genome sequence of E.coli became available. The latter was then shown to have lower 
expression levels and lower activities in comparison with Trx1 (Miranda-Vizuete et al., 1997).  
The following paragraphs will describe that a considerable overlap exists in the functions of both redoxins. Yet, 
there is generally little cross-reactivity between the redoxins and their corresponding NADPH-dependent 
reductases, allowing them to work and to be regulated independently. In their review, Fernandes and Holmgren 
depicted the thioredoxin pathway as the evolutionary most ancient and more robust system to maintain a 
reduced state in the cell. The glutaredoxin pathway probably evolved later and is assumed to be more 
sophisticated since its substrates are not limited to protein disulphides but also comprise mixed disulphides 
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with glutathione. This explains why the glutaredoxin system can, in most of the following reactions, operate as a 
back-up when the thioredoxin pathway is switched off (Fernandes & Holmgren, 2004). 
5.2. Working as electron donors 
Glutaredoxins were originally discovered as a proton donor for ribonucleotide reductase (RNR), as said 
before a vital enzyme providing the building blocks for DNA synthesis. The genome of E.coli encodes three 
types of ribonucleotide reductases (RNR I, II and III). The membership of a class is based on the mechanism used 
to create an active site tyrosyl or glycyl radical, which precedes the formation of the active site cysteinyl radical. 
The latter directly abstracts a hydrogen atom from the ribose ring to yield deoxy ribonucleotides and to form an 
oxidized redox-active cysteine pair in the active site of RNR. While the regeneration of RNRIa (NrdAB) is 
largely attributed to Trx1 (Laurent et al., 1964), Grx1 was found to operate as back-up mechanism for the supply 
of hydrogen atoms in strains without detectable levels of thioredoxin (Holmgren, 1976). Since the mutation of 
the buried C-terminal Cys to Ser results in a completely inactive protein towards RNR, one can assume that 
Grx1 performs its action trough a dithiol mechanism (Bushweller et al., 1992, Aslund et al., 1994). Later, it 
appeared that E.coli Grx1 is not the only glutaredoxin able to reduce the active site disulfide of RNR: a grxAtrxA 
double mutant overexpressing Grx3 can apparently compensate for the loss of both proteins, nonetheless, 
demonstrating much lower (5%) activity compared to E.coli Grx1 (Aslund et al., 1994).  
RNRIb (NrdEF), under normal growth conditions, is specifically reduced by NrdH, a glutaredoxin-like protein. 
Despite a structural similarity with glutaredoxins, NrdH is reduced by thioredoxin reductase and not by the 
glutathione/glutaredoxin system. In mutant strains lacking thioredoxin reductase, E.coli Grx1can also perform 
the reduction of NrdEF. In this situation, the weak affinity of Grx1 for NrdH is compensated by the massive 
upregulation of Grx1(Gon et al., 2006).  
 
Like ribonucleotide reductase, glutaredoxins were found to be alternative electron donors for PAPS reductase 
(Lillig et al., 1999), one of the enzymes enabling bacteria, fungi and plants to utilize inorganic sulfate as a 
sulphur source in the synthesis of cysteine, methionine and other sulfur-containing compounds. In this 5-step 
process, the so-called ‘sulphate assimilation pathway’, the very stable sulphate ion is activated and reduced to 
sulfide, which can subsequently be incorporated in a precursor like O-acetylserine to form cysteine. PAPS 
reductase catalyzes the first reductive reaction of PAPS to sulfite (SO23-) and thereby follows a two-step 
mechanism. First, PAPS undergoes a nucleophilic attack by the only cysteine residue in the active site of the 
enzyme to release and form an enzyme S-sulfocysteine intermediate. Next, the sulfite is released in a reaction 
depending on the electron-donating thioredoxin. This last step involves a nucleophilic attack of the thioredoxin 
on the S-sulfocysteine intermediate and the formation of a mixed disulphide between Trx and PAPS reductase 
(Carroll et al., 2005, Chartron et al., 2007). While the preferred provider of reducing equivalents is Trx1 
(Gonzalez Porque et al., 1970), it was demonstrated  that E. coli Grx1 and Trx2 support identical rates of sulfite 
formation than Trx1(Carroll et al., 2005, Lillig et al., 1999). E. coli Grx2 and Grx3 had no activity. Beside a role 
as electron donor to PAPS reductase, E. coli glutaredoxins were shown to regulate their activity through 
reversible S-glutathionylation (see further) (Lillig et al., 2003). 
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The observed resistance to arsenite (As3+) and arsenate (As5+), seen in both Gram-positive and Gram-negative 
bacteria, is associated with the presence of plasmid-encoded arsenical resistance (ars) operons. This operon of 5 
genes in E.coli (arsRDABC) provides a transport system to extrude the toxic arsenite outside the cell. The arsC 
gene product plays a key role in arsenate tolerance by catalyzing the reduction of arsenate to arsenite (Carlin et 
al., 1995). Initial studies on ArsC unveiled that in vitro assays monitoring the reduction of arsenate work 
independently of thioredoxins, but require all the components of the glutaredoxin system, i.e. E. coli Grx1, 
NADPH, GR and GSH. Upon binding of arsenate in the enzyme’s binding pocket, the reduction to arsenite 
proceeds through the transfer of one electron from the active site thiolate of ArsC and one from the thiolate of 
GSH. After release of the product, the glutaredoxin will reduce the resulting ArsC-SG mixed disulphide. This 
modus operandi is in perfect agreement with the conserved activity of CysC-term->Ser mutants (Shi et al., 1999). 
The authors investigated the relative contribution of each glutaredoxin to serve as a hydrogen donor for the 
reduction of arsenate and showed that, of all glutaredoxins in E.coli, Grx2 was the most effective one (the 
relative efficiencies were:  Grx2 > Grx3 > Grx1).  
 
Like the sulfhydrylgroups of cysteines, the methionine residues are very susceptible to oxidation. Upon reaction 
with ROS, methionine sulfoxide (MetSO) is formed and the biological activity of the protein can be lost (Brot & 
Weissbach, 1991). E. coli, however, possesses at least two methionine sulfoxide reductases (MsrA and MsrB) 
which make methionine oxidation a reversible process. Both enzymes follow a similar three-step mechanism. 
First, a sulfenic acid is formed on the catalytic Cys with the concomitant release of Met. In the second step the 
nucleophilic attack of the second cysteine on the sulfenic acid leads to the formation of a disulphide bridge, 
while in the last phase of the process the latter is reduced by thioredoxin (Boschi-Muller et al., 2008). Recent 
research demonstrated that, of both thioredoxins, only Trx1 is able to take part in the recycling process of Msr’s 
(Jacob et al., 2011). On the other hand, a methionine auxotrophe lacking Trx1 could be rescued when Grx1, but 
not Grx3, is expressed at high levels from a plasmid (Stewart et al., 1998). 
 
In E. coli, the transcription factor OxyR becomes directly activated under oxidative stress conditions (especially 
by peroxides) through intramolecular disulphide bond formation. When the cell needs to cope with reactive 
oxygen species and the cysteine couple in OxyR becomes oxidized, the expression of several antioxidant genes is 
induced, among them glutathione reductase (gorA), hydroxyperoxidase I (katG), alkylhydroxyperoxide 
reductase (ahpCF), a regulatory RNA (oxyS) and glutaredoxin 1 (grxA). Upon reduction of the cysteine bond, 
OxyR becomes inactivated. Zheng et al. demonstrated that both glutaredoxin 1 and thioredoxin can trigger this 
reaction in vitro. Nonetheless, Grx1 is thought to be the primary reductant of OxyR in vivo, since mutants 
lacking Grx1, glutathione reductase or glutathione, show a prolonged expression of the downstream antioxidant 
product OxyS. Mutants missing thioredoxin and thioredoxin reductase do not. The OxyR response is thus 
autoregulated since Grx1 can catalyze OxyR deactivation at the expense of GSH, and thereby guarantees that the 
activation by OxyR is not permanent but only for a defined period (Zheng et al., 1998).  
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5.3. Involvement in iron metabolism 
The previous paragraph shows a direct link between the glutaredoxin system and the first-line defense against 
the deleterious effects of reactive oxygen species and other dangerous compounds. While the enumerated 
reactions are mainly the work of dithiol glutaredoxins, their monothiol namesakes are strongly connected to 
potential roles in iron-sulfer cluster assembly and iron homeostasis. Since free ferrous iron catalyzes the Fenton 
reaction with the concomitant production of reactive hydroxyl radicals, its presence in high amounts in the cell 
is unwanted. Monothiol glutaredoxins were shown to be one of the players preventing iron dysregulation and 
thus to contribute indirectly to the defense against oxidative stress. 
Purification of monothiol Grxs from a broad range of species revealed that, beside a monomeric form, they also 
exist as dimers, where a bridging [2Fe-2S] cluster coordinates the cysteines of two glutathione molecules and 
the active site cysteines of the monothiol glutaredoxins (Picciocchi et al., 2007).  
This finding is consistent with the role of monothiol glutaredoxins as donors of Fe-S clusters to Fe-S cluster 
requiring proteins. Yeast strains missing the monothiol Grx5, for instance, were found to accumulate iron in the 
cell and to be subsequently more sensitive to oxidative stress. This phenotype could nonetheless be suppressed 
by overexpressing genes participating in Fe-S cluster assembly, indicating that Grx5 can transfer Fe-S clusters 
to apo-proteins. Since Grx5 is located in the mitochondrial matrix, it is not surprising that mitochondrial 
proteins such as aconitase or succinate dehydrogenase are among the targets (Rodriguez-Manzaneque et al., 
2002). Yet, recent studies indicate that cytosolic proteins can also be affected (Kim et al., 2010). 
 
Monothiol glutaredoxins also operate in iron sensing, informing iron regulators of the iron status of the cell. 
This process is illustrated in yeast by the protein:protein interaction of Grx3 and Grx4 with the transcriptional 
regulator Aft1 (Ojeda et al., 2006, Pujol-Carrion et al., 2006). This transcription factor is the principal regulator 
of a subset (±20) of genes –called the high affinity iron-uptake regulon- involved in iron uptake and storage in 
S. cerevisiae. The control of expression depends on Aft1 localization: under iron-replete conditions Aft1 resides 
in the cytosol, but under conditions of iron starvation Aft1 translocates to the nucleus to bind specific promotor 
regions (Yamaguchi-Iwai et al., 2002). It was also shown that Grx3 and Grx4 modulate the subcellular 
localization of Aft1. Confirming this key function for Grx3 and Grx4, double mutants missing both genes were 
highly sensitive to oxidative stress and constitutively expressed the genes of the iron regulon (Pujol-Carrion et 
al., 2006). However, the mechanism controlling the nucleus-cytoplasm switch of Aft1 involves multiple steps, 
and its complexity is not totally understood until today.  Rather than responding to the iron levels, Aft1 would 
be linked to the mitochondrial Fe-S cluster biosynthesis, using the cytosolic proteins Fra16 and Fra2 (the 
homologue of E.coli BolA) as intermediates in the signaling pathway (Kumanovics et al., 2008, Li et al., 2009). 
When iron is abundant and Fe-S biosynthesis can be sustained, Aft1 should be directed towards the cytosol in a 
process mediated by the Fra2-Grx3/Grx4 heterodimeric complex and based on a conformational change of Aft1. 
When iron is depleted and Fe-S biosynthesis put on hold, the Fra2-Grx3/Grx4 can not be formed and Atf1 
accumulates in the nucleus to activate iron uptake systems (Li et al., 2009, Li et al., 2010). 
                                                                  
6 Fra = Fe repressor of activation 
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5.4. Defense against oxidative stress 
5.4.1. Reducing low-molecular weight compounds 
Glutaredoxins appear to be one of the proteins having the ability to reduce dehydroascorbic acid (DHA) or 
vitamin C. Besides a role as an essential antioxidant, reduced ascorbic acid (AA) is also an indispensable 
coenzyme for at least eight hydroxylases involved in collagen, carnitine and neurotransmitter biosynthesis. The 
Grx-mediated reaction mechanism for DHA reduction involves the nucleophilic attack of the N-terminal active 
site thiolate on the 2’-carbon of DHA, leading to a thiohemiketal intermediate which can be reduced in a 
following step by the second active site cysteine (‘dithiol’-like) or using GSH-molecules (‘monothiol’-like) 
(Washburn & Wells, 1999). 
 
5.4.2. S-Glutathionylation 
Oxidative stress is a biological phenomenon typified by an imbalance between the production of ROS and the 
inability of the cell to detoxify the reactive intermediates and/or to repair the damage made to lipids, proteins or 
nucleic acids. Scientific reports established a strong correlation between oxidative stress and numerous disease 
states such as cancer (Halliwell, 2007), atherosclerosis (Bonomini et al., 2008), malaria (Becker et al., 2004), and 
age-related degenerative disorders (Berlett & Stadtman, 1997).  
With respect to proteins, the sulfhydryl group of cysteines is particularly susceptible to oxidative 
modifications. Inter- or intramolecular disulphides between proteins can be formed and lead to aggregation. 
Furthermore, the reaction with ROS or RNS may result in sulfenic (P-SOH), sulfinic (P-SO2H), sulfonic (P-
SO3H) acids as well as S-nitroso groups (P-SNO). While oxidations to sulfenic acids are reversible, those 
leading to sulfinic and sulfonic acids are considered irreversible. However, the sulfinic acid causing inactivation 
of the mammalian peroxiredoxin I can be reduced to its active thiol form (Woo et al., 2003). Two major 
determining factors make cysteinyl residues more or less prone to redox reactions, namely their solvent 
accessibility within the three-dimensional structure and their reactivity, which is influenced by vicinal amino 
acids. Evidently, if a cysteine of catalytic or structural importance is struck, the function of the corresponding 
protein is compromised. Nature thus evolved a protective mechanism based on the reversible formation of a 
mixed disulfide between protein thiols and GSH. However, S-glutathionylation is not strictly associated with 
oxidative stress and can also occur under basal (i.e. physiological) conditions. When the modified cysteine 
involves key residues in the active site or that determine the fold, the activity of the proteins can be modulated in 
a controlled way, much like reversible phosphorylation. This implies a possible role in cellular signaling and 
redox regulation of protein functions (Dalle-Donne et al., 2008).  
 
Until today, it remains unclear how protein S-glutathionylation occurs in vivo. However, several mechanisms 
are recognized which lead to the formation of mixed disulphides between protein sulfhydryl groups and GSH in 
vitro. Among them is the spontaneous thiol/disulphide exchange reaction between a protein thiol group and 
GSSG. Yet, mixed disulphides are unlikely to be produced through this path in vivo, as the redox potential of 
protein cysteines does not favor this type of reaction (Dalle-Donne et al., 2003, Dalle-Donne et al., 2008). Indeed, 
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for most cysteines the GSH/GSSG ratio at which 50% of the protein is in the glutathionylated form (Kox) 
balances around 1. This mode of S-glutathionylation thus relies on a dramatic increase of the cellular GSSG 
concentration. Such elevated levels are physiologically not realizable, since the GSH/GSSG ratio is normally 
tightly regulated by the combined action of GR and GSSG exporters. Furthermore, to illustrate this point, no 
increase in GSSG concentration was observed during the oxidative burst in human neutrophils while a massive 
increase in S-glutathionylated proteins was recorded (Chai et al., 1994). 
The second route leading to S-glutathionylation is more likely to occur in vivo and involves an activation step to 
form more reactive derivatives, such as sulfenic acids (-SOH), thyil radicals (-S"), S-nitrosylated thiols (-SNO) 
or thiosulfinates (-S(O)SR).  
 
Under conditions of oxidative stress, the protein thiol can be primed to a sulphenic acid (a 2-electron oxidation) 
or a protein-thyil radical (a 1-electron oxidation) that can react with GSH. Inversely, the sulfhydryl group of 
GSH can be activated to a glutathione thyil radical that can attack the protein thiol. This 1-electron theory 
gained evidence, since glutaredoxins were found to scavenge and stabilize glutathione thyil radicals to form a 
glutaredoxin-S-S-glutathione disulphide anion radical (Grx-SSG-"). This intermediate can then abstract a 
hydrogen atom from the protein-SH, resulting in the formation of GSH and a protein-S" radical. The latter will 
result in a glutathionylated protein upon reaction with a second Grx-SSG-" molecule or, alternatively, with 
molecular oxygen, releasing respectively GSH and two reduced Grxs, or a superoxide radical. Starke and 
coworkers successfully demonstrated the Grx-facilitated mode of action in vitro on actin, GAPDH and protein-
tyrosine phosphatase 1B (Starke et al., 2003). 
 
Alternatively, conditions of nitrosative stress also promote S-glutathionylation. Protein nitrosothiols will 
react with glutathione or, vice versa, GSNO will react with a protein thiol. The ability to trigger S-
glutathionylation via GSNO was proved for many proteins, such as c-Jun (Klatt et al., 1999), GAPDH (Mohr et 
al., 1999), or PDI (Townsend et al., 2009). While GSNO is a stable molecule, its decomposition yields the highly 
reactive thiosulfinate GSH derivative, GS(O)SG. The mixed disulfides of rat brain neurogranin, tyrosine 
hydroxylase and matrix metalloproteases were found to originate from the reaction of this thiosulfinate with 
protein thiols. 
 
Such as the mechanism leading to S-glutathionylation, the factors influencing the specificity of the reaction 
remain vague. Indeed, not all cysteine residues appear to be destined to mixed disulfide formation. The 
accessibility, the reactivity and the microenvironent of the cysteine are elements determining the sensitivity to 
S-glutathionylation. Today, a lot of protein targets are known to be up- or downregulated by S-
glutathionylation, and their number is increasing (Table 9). 
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Table 9. Protein targets from human origin, known to be regulated by glutathionylation (Fratelli et al., 
2004) 
Cytoskeletal proteins Energy metabolism and glycolysis Transcription factors 
Actin GAPDH E.coli OxyR 
Vimentin KGDH c-Jun 
Tropomyosin Aconitase Ras 
Cofilin Complex I Keap 1 
Profilin Complex II p53 
Myosin Complex IV NFκB 
Β-tubulin ATP synthase (F1α) 1κK and 1κB 
Annexin Hemoglobin  
   
Antioxidant enzymes Protein folding and degradation Ion channels 
Peroxiredoxin 1 20S proteasome SERCA 
Protein disulphide isomerase HSP70 RyR1 
  RyR2 
  Na+/K+ exchanger pump 
Signalling   
Creatine kinase   
PTP1B   
MEKK1   
PKA   
PKC-alpha   
5.4.3. Deglutathionylation 
S-glutathionylation is fully reversible. In a process called ‘deglutathionylation’, glutaredoxins catalyze the 
reduction of the mixed disulfide. While glutaredoxins are generally accepted as the main ‘deglutathionylators’, 
literature reports that other thiol/disulfide oxidoreductases (PDI, Trx/TR, sulfiredoxin) can sometimes replace 
for Grx in this reaction (Dalle-Donne et al., 2008). 
 
The reaction operates through a thiol/disulfide exchange mechanism for which only the reactive N-terminal 
cysteine of Grx is required. The thiolate moiety of Grx performs a nucleophilic attack on the mixed disulfide, 
resulting in a glutathionylated Grx (Grx-SSG) and a reduced protein (Protein-SH). The specificity of this 
reaction is largely dependent on the unusual peptide bond in GSH linking the γ-carboxylate of glutamic acid to 
the α-amino group of cysteine (Peltoniemi et al., 2006). In the second, rate-limiting, step Grx is reduced by 
displacement by GSH and the oxidized glutathione is recycled by GR.  
 
Dithiol Grxs of human, yeast and E.coli were indeed found to function through this monothiol mechanism since 
their mutant monocysteinic counterparts (CxxC -> CxxS) were also active in deglutathionylation assays. In 
some cases, the recorded deglutathionylase activity of the mutant was even higher compared to the wild-type 
(Gallogly et al., 2008, Discola et al., 2009, Johansson et al., 2004). This observation is not surprising because the 
removal of the second cysteine abolishes a possible side reaction in which both active site cysteines form an 
intramolecular disulfide. When this side-reaction competes with the turn-over of the Grx-SSG intermediate, 
the catalytic rate of the deglutathionylation reaction decreases. For E.coli Grx1 and Grx3, however, the C->S 
substitution is detrimental for its activity. Here the C-terminal cysteine actively participates in the recognition 
of the γ-linkage in the second step of deglutathionylation. Yet, discerning this atypical peptide bond in the 
second step is not a common feature of glutaredoxins: human Grx1 shows no preference towards a γ-linked or 
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normal bond, and yeast Grx1 has an even higher turnover with ECG than with GSH. The reasons for this 
different behavior of glutaredoxins in the second step remain unclear but must be explained by differences in the 
structures of the Grx-GSH intermediates (Saaranen et al., 2009). 
6. UNDERSTANDING THE FUNCTION OF E.COLI GRX2 AND OTHER 
ATYPICAL GRXs 
6.1. VvGrx2 
VvGrx2 shares 33% and 31% sequence identity respectively, with the atypical glutaredoxins of E.coli and 
S.typhimurium, the only atypical glutaredoxins characterized by X-ray crystallography. Comparable values for 
pairwise sequence conservation were observed with close homologues such as the Grx2-proteins from N. 
meningitides and Shigella dysenterica.  
VvGrx2 will likely adopt the same conformation as EcGrx2 as StGrx2. The crystal structure of the atypical 
E.coli Grx2 revealed a two-domain organization, where the N-terminal moiety has the typical glutaredoxin fold 
and the C-terminal domain predominantly consists of α-helices. Both domains are kept together by an 11-
residue linker and hydrophobic contacts at the interface. The N- and C-terminal parts are unstable on their own 
and can not be produced as separate entities (Xia et al., 2001). 
On the basis of sequence alignments, one can note that the sequence conservation between atypical members is 
very high N-terminally. On the other hand, the homology with classical glutaredoxins is limited to the active 
site containing domain. The Trx-fold is well conserved, but in the classical Grxs the α1- and α3- helices are more 
tilted and the active site is more surface-exposed. Strikingly, when considering the overall fold, atypical Grxs 
resemble the mammalian cytosolic GSTs. Especially members of the θ- and ω- class were singled out by 
structural homology search engines as DALI (Xia et al., 2001). 
6.2. Properties of Omega and Theta GSTs  
Glutathione S-transferases play fundamental roles in the detoxification of endogenous and xenobiotic 
compounds. GSTs are phase II enzymes and catalyze the conjugation of glutathione to the electrophilic center of 
deleterious, nonpolar molecules to form a derivative that can more easily be secreted or compartmentalized by 
the cell. Other GSTs have functions beyond this scope and operate as peroxidases, isomerases, thiol transferases 
or as modulator of signaling processes (Frova, 2006, Hayes et al., 2005). The vast presence of GSTs across all 
taxa, and especially in aerobic organisms, reflects the evolutionary response of the cell for protection against the 
noxious effects of oxidative stress.  
The GSTs can be classified in three main subfamilies: (i) the cytosolic and mitochondrial (Kappa-class) GSTs, 
(ii) the microsomal GSTs, or MAPEGs (membrane-associated proteins in eicosanoid and glutathione 
metabolism), and (iii) the plasmid-encoded fosfomycin resistance proteins FosA and FosB. The cytosolic GSTs 
represent by far the largest branch. Their members can be attributed to one of the existing 14 subclasses based 
on amino acid/nucleotide sequence similarities, the intron-exon organization of their genes, and their 
immunological cross reactivity. While some classes are widely distributed, others are organism-specific (e.g. 
the Beta-class is bacteria-specific, the Delta-class is insect-specific, the Phi- and Tau-class is plant-specific). 
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Mammalian cytosolic GSTs cluster into 7 classes: Alpha, Mu, Pi, Sigma, Theta, Omega and Zeta (Hayes et al., 
2005, Frova, 2006, Mannervik & Danielson, 1988).  
 
Cytosolic GSTs display a strictly conserved architecture, despite low pairwise sequence similarities. Being 
mostly biologically active as dimers of approximately 50kDa, each monomer is built up by two domains. The 
N-terminal domain is constituted of alternating α-helices and β-strands, folding into the Trx-fold. The C-
terminal region forms an all α-helical domain and is attached to the first domain through a short linker 
sequence. The active site resides in a solvent-accessible cleft between both domains and is characterized by two 
ligand-binding pockets: the G-site, which has a high specificity for reduced GSH, and a more variable, 
hydrophobic H-site to accommodate a variety of substrates. In cytosolic GSTs, three residues can fulfil the role 
of essential catalytic residue: Ser (Theta), Tyr (Alpha, Mu and Pi) or Cys (Omega and Beta). Being responsible 
for the pKa-lowering of GSH and the stabilization of the corresponding thiolate group by hydrogen bonding, 
these residues were found to be indispensable since mutations lead to complete inactive GSTs (Sheehan et al., 
2001, Board et al., 1995).  
 
Theta and Omega GSTs were among the more recently discovered GST-subfamilies, despite a more ancestral 
origin. Differences between both classes are situated around the active site (Ser in the Theta-class vs. Cys in the 
Omega-class). While conserved in almost all organisms investigated, Theta and Omega GSTs are not retained 
on glutathione affinity matrices and do not (or poorly) metabolize the typical GST-substrate 1-chloro-2,4-
dinitrobenzene (CDNB). With regard to function and catalysis, Omega GSTs have some activities in common 
with glutaredoxins. First, they were proven to be efficient in the thioltransferase (HED) and dehydroascorbate 
reductase assay. Secondly, they can catalyze the reduction of monomethylarsonate, one of the steps of the 
arsenate biotransformation process (Whitbread et al., 2005).  
6.3. An evolutionary intermediate in GST development 
Comparison of amino acid sequences and crystal structures of glutaredoxins, thioredoxins, GSTs and other 
proteins exhibiting the Trx-fold enabled scientists to set up a model explaining the evolutionary relationships 
between these protein families. As a consensus, the proteins all derive from a common ancestor where Grx 
demonstrates the most basic representation of the Trx architecture. By incorporation of structural variations on 
this ancestral fold, new functions will have developped over time. Proteins displaying the Trx-fold have indeed 
a broad field of activity. Among these, the catalysis of thiol-disulfide reactions (Grx, Trx, PDI, DsbA), the 
reduction of peroxides (Prx), the GSH-conjugation to toxic compounds (GST), the occurrence as intracellular 
ion channel (CLIC) and the binding of calcium ions (calsequestrins). 
Starting from the progenitor gene, Ladner and coworkers (2004) thus described two parallel pathways for the 
evolution of the canonical (route 1) and Kappa-class (route 2) GSTs (Fig 19). The first route, leading to the 
cytosolic GSTs, is characterized by the addition of an all α-helical C-terminal domain, resulting into the basic 
Trx-fold. Exemplifying the recruitment of this additional domain, E.coli Grx2 probably acts as a key 
intermediate. Further steps in evolution include a dimerization event and the mutation of the active site Cys to 
Ser and later to Tyr. The second route, generating the Kappa-class GSTs, passes over a DsbA-like intermediate 
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where the helical domain is inserted into the thioredoxin fold between the α2-helix and β3-strand. Alternatively, 
DsbA could have derived from E.coli Grx2 if the extra domain underwent a repositioning to a more internal 
position (Ladner et al., 2004, Frova, 2006). 
 
 
Fig 20. Kappa class and classical glutathione S-transferases emerging from a common Trx/Grx ancestor. 
Kappa class GSTs result from a domain insertion in the Grx/Trx ancestor or by circular permutation of Grx2 
via a DsbA-like intermediate. Classical GSTs evolved by domain addition, via a Grx2-like intermediate. From 
this point, the first steps in evolution were a dimerization event and changes in active site residues. Based on 
(Frova, 2006, Ladner et al., 2004) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Geraldine Buysschaert - Glutaredoxins 97 
REFERENCES 
 
Anderson, D. E., Becktel, W. J. & Dahlquist, F. W. (1990). Biochemistry 29, 2403-2408. 
Apontoweil, P. & Berends, W. (1975a). Biochim Biophys Acta 399, 1-9. 
Apontoweil, P. & Berends, W. (1975b). Mol Gen Genet 141, 91-95. 
Aslund, F., Ehn, B., Miranda-Vizuete, A., Pueyo, C. & Holmgren, A. (1994). Proc Natl Acad Sci U S A 91, 
9813-9817. 
Becker, K., Tilley, L., Vennerstrom, J. L., Roberts, D., Rogerson, S. & Ginsburg, H. (2004). Int J Parasitol 
34, 163-189. 
Becker-Hapak, M. & Eisenstark, A. (1995). FEMS Microbiol Lett 134, 39-44. 
Berardi, M. J. & Bushweller, J. H. (1999). J Mol Biol 292, 151-161. 
Berkholz, D. S., Faber, H. R., Savvides, S. N. & Karplus, P. A. (2008). J Mol Biol 382, 371-384. 
Berlett, B. S. & Stadtman, E. R. (1997). J Biol Chem 272, 20313-20316. 
Board, P. G., Coggan, M., Wilce, M. C. & Parker, M. W. (1995). Biochem J 311 ( Pt 1), 247-250. 
Bonomini, F., Tengattini, S., Fabiano, A., Bianchi, R. & Rezzani, R. (2008). Histol Histopathol 23, 381-390. 
Boschi-Muller, S., Gand, A. & Branlant, G. (2008). Arch Biochem Biophys 474, 266-273. 
Braun, V. (2003). Front Biosci 8, s1409-1421. 
Brot, N. & Weissbach, H. (1991). Biofactors 3, 91-96. 
Bushweller, J. H., Aslund, F., Wuthrich, K. & Holmgren, A. (1992). Biochemistry 31, 9288-9293. 
Butland, G., Babu, M., Diaz-Mejia, J. J., Bohdana, F., Phanse, S., Gold, B., Yang, W., Li, J., Gagarinova, A. G., 
Pogoutse, O., Mori, H., Wanner, B. L., Lo, H., Wasniewski, J., Christopolous, C., Ali, M., Venn, 
P., Safavi-Naini, A., Sourour, N., Caron, S., Choi, J. Y., Laigle, L., Nazarians-Armavil, A., 
Deshpande, A., Joe, S., Datsenko, K. A., Yamamoto, N., Andrews, B. J., Boone, C., Ding, H., 
Sheikh, B., Moreno-Hagelseib, G., Greenblatt, J. F. & Emili, A. (2008). Nat Methods 5, 789-795. 
Carlin, A., Shi, W., Dey, S. & Rosen, B. P. (1995). J Bacteriol 177, 981-986. 
Carroll, K. S., Gao, H., Chen, H., Stout, C. D., Leary, J. A. & Bertozzi, C. R. (2005). PLoS Biol 3, e250. 
Chai, Y. C., Ashraf, S. S., Rokutan, K., Johnston, R. B., Jr. & Thomas, J. A. (1994). Arch Biochem Biophys 
310, 273-281. 
Chartron, J., Shiau, C., Stout, C. D. & Carroll, K. S. (2007). Biochemistry 46, 3942-3951. 
Choi, H. J., Kang, S. W., Yang, C. H., Rhee, S. G. & Ryu, S. E. (1998). Nat Struct Biol 5, 400-406. 
Dalle-Donne, I., Milzani, A., Gagliano, N., Colombo, R., Giustarini, D. & Rossi, R. (2008). Antioxid Redox 
Signal 10, 445-473. 
Dalle-Donne, I., Rossi, R., Giustarini, D., Colombo, R. & Milzani, A. (2003). Free Radic Biol Med 35, 
1185-1193. 
Discola, K. F., de Oliveira, M. A., Rosa Cussiol, J. R., Monteiro, G., Barcena, J. A., Porras, P., Padilla, C. A., 
Guimaraes, B. G. & Netto, L. E. (2009). J Mol Biol 385, 889-901. 
Epp, O., Ladenstein, R. & Wendel, A. (1983). Eur J Biochem 133, 51-69. 
Ermler, U. & Schulz, G. E. (1991). Proteins 9, 174-179. 
Fahey, R. C., Brown, W. C., Adams, W. B. & Worsham, M. B. (1978). J Bacteriol 133, 1126-1129. 
Fernandes, A. P., Fladvad, M., Berndt, C., Andresen, C., Lillig, C. H., Neubauer, P., Sunnerhagen, M., 
Holmgren, A. & Vlamis-Gardikas, A. (2005). J Biol Chem 280, 24544-24552. 
Fernandes, A. P. & Holmgren, A. (2004). Antioxid Redox Signal 6, 63-74. 
Fladvad, M., Bellanda, M., Fernandes, A. P., Mammi, S., Vlamis-Gardikas, A., Holmgren, A. & 
Sunnerhagen, M. (2005). J Biol Chem 280, 24553-24561. 
Foloppe, N. & Nilsson, L. (2004). Structure 12, 289-300. 
Foloppe, N., Sagemark, J., Nordstrand, K., Berndt, K. D. & Nilsson, L. (2001). J Mol Biol 310, 449-470. 
Fratelli, M., Gianazza, E. & Ghezzi, P. (2004). Expert Rev Proteomics 1, 365-376. 
Frova, C. (2006). Biomol Eng 23, 149-169. 
Gallogly, M. M., Starke, D. W., Leonberg, A. K., Ospina, S. M. & Mieyal, J. J. (2008). Biochemistry 47, 
11144-11157. 
Gon, S., Faulkner, M. J. & Beckwith, J. (2006). Antioxid Redox Signal 8, 735-742. 
Gonzalez Porque, P., Baldesten, A. & Reichard, P. (1970). J Biol Chem 245, 2371-2374. 
Grauschopf, U., Winther, J. R., Korber, P., Zander, T., Dallinger, P. & Bardwell, J. C. (1995). Cell 83, 947-
955. 
Griffith, O. W., Bridges, R. J. & Meister, A. (1978). Proc Natl Acad Sci U S A 75, 5405-5408. 
Halliwell, B. (2007). Biochem J 401, 1-11. 
Geraldine Buysschaert - Glutaredoxins 98 
Harrop, S. J., DeMaere, M. Z., Fairlie, W. D., Reztsova, T., Valenzuela, S. M., Mazzanti, M., Tonini, R., Qiu, 
M. R., Jankova, L., Warton, K., Bauskin, A. R., Wu, W. M., Pankhurst, S., Campbell, T. J., Breit, S. 
N. & Curmi, P. M. (2001). J Biol Chem 276, 44993-45000. 
Hayes, J. D., Flanagan, J. U. & Jowsey, I. R. (2005). Annu Rev Pharmacol Toxicol 45, 51-88. 
Hol, W. G. (1985). Prog Biophys Mol Biol 45, 149-195. 
Holmgren, A. (1976). Proc Natl Acad Sci U S A 73, 2275-2279. 
Holmgren, A., Soderberg, B. O., Eklund, H. & Branden, C. I. (1975). Proc Natl Acad Sci U S A 72, 2305-
2309. 
Isakov, N., Witte, S. & Altman, A. (2000). Trends Biochem Sci 25, 537-539. 
Iwema, T., Picciocchi, A., Traore, D. A., Ferrer, J. L., Chauvat, F. & Jacquamet, L. (2009). Biochemistry 48, 
6041-6043. 
Jacob, C., Kriznik, A., Boschi-Muller, S. & Branlant, G. (2011). FEBS Lett 585, 1905-1909. 
Joelson, T., Sjoberg, B. M. & Eklund, H. (1990). J Biol Chem 265, 3183-3188. 
Johansson, C., Lillig, C. H. & Holmgren, A. (2004). J Biol Chem 279, 7537-7543. 
Jordan, A., Aslund, F., Pontis, E., Reichard, P. & Holmgren, A. (1997). J Biol Chem 272, 18044-18050. 
Jordan, A., Pontis, E., Aslund, F., Hellman, U., Gibert, I. & Reichard, P. (1996). J Biol Chem 271, 8779-
8785. 
Karplus, P. A. & Schulz, G. E. (1987). J Mol Biol 195, 701-729. 
Katti, S. K., LeMaster, D. M. & Eklund, H. (1990). J Mol Biol 212, 167-184. 
Kemmink, J., Darby, N. J., Dijkstra, K., Nilges, M. & Creighton, T. E. (1996). Biochemistry 35, 7684-7691. 
Kim, K. D., Chung, W. H., Kim, H. J., Lee, K. C. & Roe, J. H. (2010). Biochem Biophys Res Commun 392, 
467-472. 
Klatt, P., Molina, E. P. & Lamas, S. (1999). J Biol Chem 274, 15857-15864. 
Kortemme, T. & Creighton, T. E. (1995). J Mol Biol 253, 799-812. 
Kortemme, T., Darby, N. J. & Creighton, T. E. (1996). Biochemistry 35, 14503-14511. 
Krause, G., Lundstrom, J., Barea, J. L., Pueyo de la Cuesta, C. & Holmgren, A. (1991). J Biol Chem 266, 
9494-9500. 
Kumanovics, A., Chen, O. S., Li, L., Bagley, D., Adkins, E. M., Lin, H., Dingra, N. N., Outten, C. E., Keller, 
G., Winge, D., Ward, D. M. & Kaplan, J. (2008). J Biol Chem 283, 10276-10286. 
Ladner, J. E., Parsons, J. F., Rife, C. L., Gilliland, G. L. & Armstrong, R. N. (2004). Biochemistry 43, 352-
361. 
Laurent, T. C., Moore, E. C. & Reichard, P. (1964). J Biol Chem 239, 3436-3444. 
Lennon, B. W., Williams, C. H., Jr. & Ludwig, M. L. (2000). Science 289, 1190-1194. 
Li, H., Mapolelo, D. T., Dingra, N. N., Keller, G., Riggs-Gelasco, P. J., Winge, D. R., Johnson, M. K. & 
Outten, C. E. (2010). J Biol Chem 286, 867-876. 
Li, H., Mapolelo, D. T., Dingra, N. N., Naik, S. G., Lees, N. S., Hoffman, B. M., Riggs-Gelasco, P. J., Huynh, 
B. H., Johnson, M. K. & Outten, C. E. (2009). Biochemistry 48, 9569-9581. 
Lillig, C. H., Berndt, C. & Holmgren, A. (2008). Biochim Biophys Acta 1780, 1304-1317. 
Lillig, C. H., Potamitou, A., Schwenn, J. D., Vlamis-Gardikas, A. & Holmgren, A. (2003). J Biol Chem 278, 
22325-22330. 
Lillig, C. H., Prior, A., Schwenn, J. D., Aslund, F., Ritz, D., Vlamis-Gardikas, A. & Holmgren, A. (1999). J 
Biol Chem 274, 7695-7698. 
Madzelan, P., Labunska, T. & Wilson, M. A. (2012). FEBS J 279, 4111-4120. 
Mannervik, B. & Danielson, U. H. (1988). CRC Crit Rev Biochem 23, 283-337. 
Martin, J. E. & Imlay, J. A. (2011). Mol Microbiol 80, 319-334. 
Martin, J. L. (1995). Structure 3, 245-250. 
Martin, J. L., Bardwell, J. C. & Kuriyan, J. (1993). Nature 365, 464-468. 
Masip, L., Veeravalli, K. & Georgiou, G. (2006). Antioxid Redox Signal 8, 753-762. 
Miranda-Vizuete, A., Damdimopoulos, A. E., Gustafsson, J. & Spyrou, G. (1997). J Biol Chem 272, 30841-
30847. 
Mohr, S., Hallak, H., de Boitte, A., Lapetina, E. G. & Brune, B. (1999). J Biol Chem 274, 9427-9430. 
Mossner, E., Huber-Wunderlich, M. & Glockshuber, R. (1998). Protein Sci 7, 1233-1244. 
Nelson, J. W. & Creighton, T. E. (1994). Biochemistry 33, 5974-5983. 
Nordstrand, K., Aslund, F., Meunier, S., Holmgren, A., Otting, G. & Berndt, K. D. (1999). FEBS Lett 449, 
196-200. 
Ojeda, L., Keller, G., Muhlenhoff, U., Rutherford, J. C., Lill, R. & Winge, D. R. (2006). J Biol Chem 281, 
17661-17669. 
Geraldine Buysschaert - Glutaredoxins 99 
Peltoniemi, M. J., Karala, A. R., Jurvansuu, J. K., Kinnula, V. L. & Ruddock, L. W. (2006). J Biol Chem 281, 
33107-33114. 
Picciocchi, A., Saguez, C., Boussac, A., Cassier-Chauvat, C. & Chauvat, F. (2007). Biochemistry 46, 15018-
15026. 
Potamitou, A., Holmgren, A. & Vlamis-Gardikas, A. (2002). J Biol Chem 277, 18561-18567. 
Potamitou, A., Neubauer, P., Holmgren, A. & Vlamis-Gardikas, A. (2002). J Biol Chem 277, 17775-
17780. 
Prinz, W. A., Aslund, F., Holmgren, A. & Beckwith, J. (1997). J Biol Chem 272, 15661-15667. 
Pujol-Carrion, N., Belli, G., Herrero, E., Nogues, A. & de la Torre-Ruiz, M. A. (2006). J Cell Sci 119, 4554-
4564. 
Reinemer, P., Dirr, H. W., Ladenstein, R., Schaffer, J., Gallay, O. & Huber, R. (1991). EMBO J 10, 1997-
2005. 
Richardson, J. S. & Richardson, D. C. (1988). Science 240, 1648-1652. 
Rodriguez-Manzaneque, M. T., Tamarit, J., Belli, G., Ros, J. & Herrero, E. (2002). Mol Biol Cell 13, 1109-
1121. 
Russel, M. & Holmgren, A. (1988). Proc Natl Acad Sci U S A 85, 990-994. 
Saaranen, M. J., Salo, K. E., Latva-Ranta, M. K., Kinnula, V. L. & Ruddock, L. W. (2009). Antioxid Redox 
Signal 11, 1819-1828. 
Sandalova, T., Zhong, L., Lindqvist, Y., Holmgren, A. & Schneider, G. (2001). Proc Natl Acad Sci U S A 98, 
9533-9538. 
Sheehan, D., Meade, G., Foley, V. M. & Dowd, C. A. (2001). Biochem J 360, 1-16. 
Shi, J., Vlamis-Gardikas, A., Aslund, F., Holmgren, A. & Rosen, B. P. (1999). J Biol Chem 274, 36039-
36042. 
Starke, D. W., Chock, P. B. & Mieyal, J. J. (2003). J Biol Chem 278, 14607-14613. 
Stehr, M., Schneider, G., Aslund, F., Holmgren, A. & Lindqvist, Y. (2001). J Biol Chem 276, 35836-35841. 
Stewart, E. J., Aslund, F. & Beckwith, J. (1998). EMBO J 17, 5543-5550. 
Stout, J., De Vos, D., Vergauwen, B. & Savvides, S. N. (2012). J Mol Biol 416, 486-494. 
Townsend, D. M., Manevich, Y., He, L., Xiong, Y., Bowers, R. R., Jr., Hutchens, S. & Tew, K. D. (2009). 
Cancer Res 69, 7626-7634. 
Vergauwen, B., De Vos, D. & Van Beeumen, J. J. (2006). J Biol Chem 281, 4380-4394. 
Vlamis-Gardikas, A., Aslund, F., Spyrou, G., Bergman, T. & Holmgren, A. (1997). J Biol Chem 272, 
11236-11243. 
Vlamis-Gardikas, A., Potamitou, A., Zarivach, R., Hochman, A. & Holmgren, A. (2002). J Biol Chem 277, 
10861-10868. 
Washburn, M. P. & Wells, W. W. (1999). Biochemistry 38, 268-274. 
Whitbread, A. K., Masoumi, A., Tetlow, N., Schmuck, E., Coggan, M. & Board, P. G. (2005). Methods 
Enzymol 401, 78-99. 
Williams, C. H., Arscott, L. D., Muller, S., Lennon, B. W., Ludwig, M. L., Wang, P. F., Veine, D. M., Becker, 
K. & Schirmer, R. H. (2000). Eur J Biochem 267, 6110-6117. 
Woo, H. A., Chae, H. Z., Hwang, S. C., Yang, K. S., Kang, S. W., Kim, K. & Rhee, S. G. (2003). Science 300, 
653-656. 
Xia, B., Vlamis-Gardikas, A., Holmgren, A., Wright, P. E. & Dyson, H. J. (2001). J Mol Biol 310, 907-918. 
Yamaguchi-Iwai, Y., Ueta, R., Fukunaka, A. & Sasaki, R. (2002). J Biol Chem 277, 18914-18918. 
Yang, Y., Jao, S., Nanduri, S., Starke, D. W., Mieyal, J. J. & Qin, J. (1998). Biochemistry 37, 17145-17156. 
Yeung, N., Gold, B., Liu, N. L., Prathapam, R., Sterling, H. J., Willams, E. R. & Butland, G. (2011). 
Biochemistry 50, 8957-8969. 
Zaffagnini, M., Bedhomme, M., Marchand, C. H., Morisse, S., Trost, P. & Lemaire, S. D. (2012). Antioxid 
Redox Signal 16, 567-586. 
Zheng, M., Aslund, F. & Storz, G. (1998). Science 279, 1718-1721. 
 
 
Géraldine Buysschaert – Comparative kinetic study on classical and atypical glutaredoxins 100!
Manuscript 3:  
 
Comparative kinetic study of classical and atypical glutaredoxins 
Buysschaert G., Wen Y., Savvides S.N., Vergauwen B. 
 
 
Manuscript in preparation. 
GB carried out the recombinant expression and purification of the proteins. With contributions of BV, GB 
performed all kinetic experiments and data analysis. Mass spectrometric data were gathered by YW. I 
gratefully aknowledge BV and Prof.Dr. Irwin H. Segel for their tremendous contribution in determining the 
rate equation for glutaredoxins. 
 
 
1. INTRODUCTION 
All biological systems on earth have to face stress conditions, mostly provoked by harmful (electrophilic) 
xenobiotics, heavy metals, and reactive oxidative or nitrosative species. Present in millimolar concentration in 
living cells (E. coli: 3.5-6.6 mM (Apontoweil & Berends, 1975), up to 20mM in P. Multocida (Vergauwen et al., 
2006); S. cerevisiae: 10 mM (Penninckx, 2002); plant cells: 1-4.5 mM (Noctor & Foyer, 1998); mammalian 
cells: 1-10mM (Kosower & Kosower, 1978)), the low molecular weight thiol glutathione (GSH; !-Glutamyl-
Cysteinyl-Glycine) appears to play an essential role in the antioxidant defence network (Vergauwen et al., 
2003). Using its reducing sulfhydryl moiety, GSH will not only scavenge and neutralize radicals but also 
operate as an important redox buffer (GSH/GSSG) to monitor and signal intracellular changes. Moreover, it is 
not surprising that, due to its versatility and ubiquity, nature evolved to make glutathione a pivotal cofactor 
for different thiol-based enzyme systems.  
 
One of these enzyme systems, the glutaredoxin family (Grx), covers a group of thiol-disulphide 
oxidoreductases found in all kingdoms of life. Usually small (9-12kDa), like their representative E.coli Grx1, 
these enzymes are characterized by a thioredoxin (Trx) fold architecture and a highly conserved N-terminal 
Cxx(C/S) motif that constitutes an active site (Xia et al., 1992, Fernandes & Holmgren, 2004). With a 
molecular weight of around 24kDa, E.coli Grx2 can be regarded as an outlier among the family representatives 
described till now. The high resolution solution structure from EcGrx2 explains the very low sequence 
similarity with other Grxs and reveals a two-domain arrangement: a small N-terminal Trx-domain 
comprising the active site, linked to a larger C-terminal GST-like domain absent in classical glutaredoxins 
(Xia et al., 2001). 
 
Since the discovery of Grxs in the late 70’s as a donor of reducing equivalents to ribonucleoside-diphosphate 
reductase (RNR) (Holmgren, 1976), a plethora of biological functions were attributed to glutaredoxins: 
participation in sulphate assimilation (PAPS reductase) (Lillig et al., 2003), draining oxidative stress (arsenate 
reductase (Shi et al., 1999), methionine sulfoxide reductase (Couturier et al., 2012), OxyR, peroxiredoxins 
(Vergauwen et al., 2001, Rouhier et al., 2002), reducing dehydroascorbic acid (DHA) (Washburn & Wells, 
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1999), controlling iron homeostasis (formation of Fe-S clusters, influencing Fe uptake (Rouhier et al., 2010)) 
and catalyzing (de)glutathionylation. The latter is a post-translational process protecting Cys-containing 
proteins from inactivation caused by oxidative damage. Thereby, a single glutathione molecule is temporarily 
attached to the protein by disulphide bonding, thus preventing fatal alterations to sulfhydrylgroups, such as 
sulfinic and sulfonic acid formation.  
 
However, the complete picture is not clear and it remains difficult to attribute distinct in vivo roles to 
glutaredoxins. This is especially the case for atypical glutaredoxins whose physiological function remains 
enigmatic. Nonetheless, prominent roles in the cell should be attributed to this Grx subfamily as they are 
exceedingly upregulated during the stationary phase and make up to 1% of the total protein content (Potamitou 
et al., 2002).  
 
This study aims to establish of a kinetic-based framework to disentangle the mechanistic properties of 
classical and atypical glutaredoxins and to provide a better understanding of their physiological roles. To 
achieve this goal, we first optimized a fluorescence-based assay (Peltoniemi et al., 2006) allowing the analysis 
of Grx-catalyzed deglutathionyation in real-time. Secondly, we strived to fine-tune the kinetic models for 
data-fitting, taking side reactions into account involving the active site dicysteine.  
While two-substrate kinetics with EcGrx1 and EcGrx2 revealed that other unknown parameters hamper the 
analysis of the data, we found that both classical and atypical glutaredoxins have similar IC50 values for GSSG. 
Mass spectrometry, however, showed that the N-terminal cysteine of EcGrx1 and EcGrx2 behave differently 
in the presence of an excess oxidized glutathione: while in classical glutaredoxins an intramolecular disulfide 
is formed, a glutathionylated active site is retrieved in atypical glutaredoxins. The implications of this 
particular conduct at the physiological level remain to be established and should be the subject of future 
research. 
 
2. RESULTS AND DISCUSSION 
Substrate specificity: atypical glutaredoxins are selective for glutathione-containing mixed disulfides 
Scanning a number of characteristic Grx-substrates can underline catalytic similarities among proteins. Based 
on this, we prepared protein solutions of a representative of the classical glutaredoxins (Escherichia coli Grx1 
or EcGrx1) as well as two atypical glutaredoxins (Escherichia coli Grx2 or EcGrx2 and Vibrio vulnificus Grx2 
or VvGrx2) and tested them in terms of substrate recognition. The results are listed in  Table 1. 
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Table 1. Overview of the substrates tested on representatives of a classical Grx (EcGrx1) and two atypical 
Grxs (EcGrx2 and VvGrx2). A “+” sign denotes substrate recognation and subsequent conversion by the 
given glutaredoxin. A “-“ sign indicates that no reaction with the proferred substrate could be detected. 
Atypical glutaredoxins can thus not sustain the reduction of intramolecular disulfide bridges (dithiol 
mechanism). 
 
First, EcGrx1, EcGrx2 and VvGrx2 all mediate the enzymatic recycling of the intracellular antioxidant 
dehydroascorbic acid (DHA) to ascorbic acid (AA, vitC). Glutaredoxins are thought to be the major DHA 
reductases in the cell (Park & Levine, 1996). However, to date the reaction mechanism is not fully understood. 
The proposed route for Grx-catalyzed reduction is thought to proceed through the formation of a 
thiohemiketal intermediate with DHA (Washburn & Wells, 1999). With insulin as a substrate, only EcGrx1 
provoked an increased turbidity at 650nm due to precipitation of the insulin B-chain. In the presence of the 
atypical EcGrx2 and VvGrx2, the intermolecular disulfide bond in insulin remained intact, indicating that they 
can not sustain the dithiol reaction mechanism. On the other hand, they are all active in the reduction of mixed 
disulfides with glutathione, whether the glutathione moiety is attached to β-ME (HED), Cys or a Cysteine-
containing peptide. 
 
These results confirm previous studies, showing that many protein-SSG’s and small molecule-SSG’s  are 
substrates for deglutathionylating glutaredoxins, independent of the nature of the non-glutathionyl component 
of the mixed disulfide substrate (Johansson et al., 2004, Gallogly et al., 2008, Gladyshev et al., 2001, Lundberg 
et al., 2001, Gravina & Mieyal, 1993). Studies on EcGrx1 indicated that the orientation of the glutamyl moiety 
of the coupled GSH (the γ-linkage) plays a determining role in its specificity (Peltoniemi et al., 2006, Saaranen 
et al., 2009). 
 
Towards a better analysis of the Grx-catalyzed reaction 
Scientific publications reported previously that the EcGrx1-catalyzed reaction shows a sigmoid shape when 
the [GSH]-dependence is investigated (Peltoniemi et al., 2006, Saaranen et al., 2009). The observed lag-phase is 
probably due to a kinetic partitioning effect of the glutathione mixed disulfide intermediate. Indeed, when the 
C-terminal cysteine performs a nucleophilic attack on the mixed disulphide, Grx-GSH releases the 
sequestered glutathione and is converted into the oxidized, inactive form of the protein. 
This side reaction affects considerably the kinetic analyses on glutaredoxins and thwarts affinity (Km) 
determinations for GSH at fixed concentrations of the peptide-SG substrate. Application of the King-Altman 
method (King & Altman, 1956, Segel, 1973) is one of the possible tools to circumvent this problem and will 
result in a strong model to accurately derive the rate laws of the Grx-catalyzed reaction. 
 
 Classical Grx Atypical Grx 
Substrate EcGrx1 EcGrx2 VvGrx2 
DHA + + + 
Insulin +  -  - 
HED + + + 
Cys-SG + + + 
Peptide-SG + + + 
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Fig 1. Schematic representation of the steady state mechanism followed by glutaredoxins. Glutaredoxins 
operate through a nucleophilic, double-displacement catalytic mechanism with both steps displaying high 
commitment to catalysis. The efficiency of Grxs in performing the deglutathionylation reaction is attributed to 
the unusually low pKa of the N-terminal cysteine. A Ping-Pong model is given in which Grx primarily cycles 
between a fully reduced state and the glutathionylated intermediate. From this Grx-SSG state, the intermediate 
can follow two different reactions: the first one leading to reduced Grx, the other to an inactive, intramolecular 
disulfide form of Grx. 
 
A. Kinetic scheme for the reaction related conformational changes 
Based on a Ping-Pong mechanism, which is hallmarked by the formation of a covalent intermediate between 
the enzyme and a portion of the substrate (Segel, 1973), we set up a King Altman graph (Fig 2) including the 
non-productive route leading to oxidized Grx. We thus defined 5 enzyme states, 5 links between those states 
and 10 kinetic rate constants (ki for the forward reaction, k-i for the reverse reaction). One assumption of the 
model is that the Grx enzyme bears only one GSH recognition site. 
 
 
Fig 2. The King-Altman method. (Left). Ping-Pong kinetics for Grx, involving a glutathionylated 
intermediate. A and B respectively denote peptide-SG and GSH, P and Q stand for peptide-SH and GSSG. The 
figure shows 5 enzyme states: fully reduced Grx (E), peptide-bound Grx (EA + FP), glutathionylated Grx (F), 
oxidized Grx (F’) and glutathionylated Grx being reduced by a second GSH molecule. Forward and reverse 
kinetic rate constants are shown. (Right). The geometrical diagrams depict all possible King-Altman patterns, 
directly connecting all enzyme forms without forming closed patterns. 
 
Based on Fig.2, the following concentrations can be rewritten as: 
 E:  k-3k-2Pk-1k-5B + k4k-5Bk-2Pk-1 + k-1k-5Bk3Bk4 + k2k-5Bk3Bk4 
 EA+FP:  k1Ak-3k-5Bk-2P + k4k1Ak-5Bk-2P + k-5Bk3Bk4k1A + k-4Qk-3k-2Pk-5B 
 F+F’B:  k1Ak2k-3k-5B + k4k1Ak2k-5B + k-1k-4Qk-3k-5B + k-4Qk-3k2k-5B 
 FP + EQ: k1Ak2k3Bk-5B + k-5Bk-2Pk-1k-4Q + k-1k-4Qk3k-5B + k-4Qk2k-5Bk3B 
 F’:  k1Ak2k-3k5 + k4k1Ak2k5 + k-1k-4Qk-3k5 + k-4Qk-3k2k5 
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When no P or Q is present: 
 E:   k-1k-5k3k4B2 + k2k-5k3k4B2 = k3k4k-5(k-1+k2) B2 
 EA + FP: k-5k3k4k1AB2 
 F+F’P:  k1k2k-3k-5AB + k4k1k2k-5AB 
 FP + EQ: k1k2k3k-5AB2  
 F’:  k1k2k-3k5A + k4k1k2k5A = k1k2k5(k-3 + k4)A 
 
The rate equation v= k1[E][A] – k-1[EA + FP] can be rewritten as: 
 
v =                             Vmax [A][B]            
                KmA [B] + KmB [A] + [A][B] + (KmB [A] KF/[B]) 
 
 
B. A robust assay for activity measurements 
Choosing an assay adapted to study every aspect of the Grx-catalyzed reaction, is obviously essential. 
Conventionally, the deglutathionylation reaction is traced using the synthetic "-hydroxyethyl disulfide (HED) 
substrate in a coupled spectrophotometric assay following NADPH consumption. To mimick in vivo 
conditions, however, the latest publications investigating the kinetic properties of glutaredoxins rely on the 
use of glutathionylated proteins (BSA-SG) or peptides. 
Apart from the fact that these substrates resemble more their natural counterparts, this approach offers more 
control on the substrate concentrations presented to glutaredoxins. In the HED assay, the glutaredoxin 
substrate is spontaneously formed between HED and GSH, a reaction that is presumed to take place in the first 
minutes after mixing. The experimentator assumes that all HED molecules reassemble to form β-ME-SSG, 
while the glutathione pool is slightly being modified. 
 
To avoid the possible effect of steric hindrances, leading to a difference in reactivity of EcGrx1 and EcGrx2 
towards the substrate, we preferred to include a peptide-SG substrate over a glutathionylated protein in our 
assay. Furthermore, the method developed by Peltoniemi and coworkers allows the measurement of the Grx-
catalyzed rate of deglutathionylation by means of a fluorometric assay (Peltoniemi et al., 2006). The catalytic 
activity of glutaredoxins can thus be studied in real-time, rather than indirectly by the expenditure of NADPH, 
which offers a tremendous advantage over other substrates (Fig 3). 
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Fig 3. Rationale of the fluorimetric Grx-
assay. (Top). The reaction mix contains a 
tryptophanyl-peptide-SSG, in which the 
fluorescence of the aromatic residue becomes 
unquenched when the adjacent mixed disulfide 
bridge is reduced. The increase in fluorescence 
signal is a direct effect of the Grx-mediated 
removal of the glutathione group. (Bottom) 
Superposition of the fluorescence signals 
obtained during the EcGrx2-catalyzed reaction 
with four different peptide concentrations 
(5μM, 10μM, 25μM and 50μM; 1mM GSH, 
100nM EcGrx2). 
 
In the original set-up, glutathione reductase and NADPH are incorporated in the reaction mixture. However, 
the presence of NADPH appeared to be a major pitfall of the assay, as the molecule is blue-fluorescent and 
characterized by an emission wavelength of 460nm. The cofactor of GR, therefore, absorbs light in the UV 
spectral range, more exactly at 280nm and 340nm, which corresponds to the excitation wavelengths of the 
adenine nucleotide ring and the nicotinamide group, respectively. Since tryptophan fluorescence is monitored 
through its emission spectrum at 356nm, the physical properties of NADP(H) interfere with the experiment. 
On the other hand, discarding the GR/NADPH couple from the reaction mixture is problematic as 
glutaredoxins can be inactivated by the accumulated GSSG (Peltoniemi et al., 2006). Taking these features into 
account, all reactions were executed in the absence of NADPH and GR, and were evaluated in the first seconds 
of the deglutathionylation, i.e. when the produced GSSG levels are too low to play a role in the performance of 
the enzyme.  
Moreover, it appears that stock solutions (60-100mM) made from commercially available glutathione 
powder, after dissolvement in water and adjustment of the pH, contain 0.5-0.7% GSSG. To avoid bias, 
equivalent amounts of NADPH and appropriate concentrations of GR were added to the GSH stock to allow 
the removal of any contaminating GSSG. Briefly, 3g of reduced GSH was dissolved into 10ml demineralized 
water to obtain a solution ≈ 100mM, which was titrated to a pH between 6.0 and 6.3 with NaOH. A sample of 
this GSH-stock was used to trace residual GSSG in a spectophotometric coupled assay including 200μM 
NADPH and 0.6μg/ml baker yeast glutathione reductase. The recorded difference in absorbance at 340nm 
upon addition of the enzyme is indicative of the GSSG concentration in the sample. Based on this, we added 
equimolar amounts of NADPH to the 100mM GSH-stock and 0.6μg/ml baker yeast glutathione reductase. The 
solution was allowed to stand during 2 hours at room temperature, before aliquoting and storage at -80°C. 
This mode of action was cross-validated using E.coli Grx1, whose IC50 for GSSG was determined and appeared 
to be slightly higher than the previously reported value (Peltoniemi et al., 2006) 
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The mechanistic properties of classical and atypical glutaredoxins 
The Frieden two-substrate-kinetic approach (Frieden, 1959) was used to identify the catalytic mechanism of 
the recombinantly expressed atypical glutaredoxins. In these experiments the concentration of the 
glutathionylated peptide was varied in function of three fixed concentrations of glutathione -the second 
substrate- and vice versa.  
Despite the availability of a more accurate rate equation, the plots could not be fitted and a Ping-Pong double 
displacement mechanism for classical and atypical glutaredoxins can not be confirmed by our kinetic 
approach. One of the reasons for this problem could be related directly to the configuration of the active site 
Cys. If we assume that the enzyme bears an oxidized active site at the start of the reaction, we won’t operate 
under steady state conditions and consequently, initial velocities will not be measured. 
 
However, there are strong indications from published work that classical and atypical glutaredoxins exist in a 
stable, covalently modified, enzyme state (the glutathionylated intermediate), which is a hallmark of the Ping-
Pong double displacement mechanism. Indeed, mass spectrometric analysis on human and prokaryotic (E. coli) 
glutaredoxins revealed that the first step of the deglutathionylation reaction exclusively yields the Grx-GSH 
mixed disulfide (Peltoniemi et al., 2006). NMR and crystallographic structures of classical and atypical 
glutaredoxins provide further evidence for a covalently bound GSH molecule (Yang et al., 1998, Nordstrand et 
al., 1999). Comparison of the X-ray structure of a classical Grx and a recent crystal structure of an EcGrx2 
homologue, from the pathogen Salmonella typhimurium, furthermore shows that the glutathionyl moiety is 
stabilized in equivalent ways. These residues, making ion pairs of hydrogen bonds with the bound GSH, 
appear to be highly conserved in many glutaredoxins, including the atypical members. In accordance with the 
amino acid numbering in EcGrx1, we distinguish the overall conserved V52 residue for the coordination of 
the CysGSH, a charged K45 residue for the stabilization of the negative GlyGSH side chain, and D74 for 
interactions with the GluGSH charges (Fig 4). 
 
Fig 4. The stabilization of the covalent complex between 
Grx and GSH is conserved among classical (E.coli Grx1; 
PDB-code 1GRX) and atypical glutaredoxins (EcGrx2-like 
protein from Salmonella typhimurium; PDB-code 3IR4). 
While the backbone of the Cys residue makes antiparallel 
hydrogen bonds with the backbone amide and carbonyl groups 
of a highly conserved Val residue, complementary groups 
coordinate the Glu charges (not shown). 
 
 
 
 
Yet, one conclusion can be made from the two-substrate kinetics experiment. While we confirm the 
sigmoidality characterizing the GSH-dependent traces in EcGrx1, no lag-phase can be observed in the 
corresponding traces using EcGrx2 as deglutathionylating enzyme.  This different shape indicates that, at low 
GSH concentrations, the N-terminal active site cysteine of EcGrx1 is involved in a partitioning reaction, while 
the same amino acid in EcGrx2 is probably not. 
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Fig 5. Two-substrate kinetic analysis of the EcGrx1 and EcGrx2 catalyzed deglutathionylation. The rate of 
reaction was determined using the fluoresence-based assay. Reactions were initiated by addition of 100nM 
enzyme. Data points represent the average of at least two experiments. A) The traces (dashed lines) result from 
the application of the Michaelis-Menten (EcGrx2) or Hill equation (EcGrx1) and are only represented to 
facilitate the presence (EcGrx1) and absence (EcGrx2) of sigmoidality in the GSH-dependent reactions. B) The 
corresponding Lineweaver-Burke plots. 
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GSSG inhibition 
The principal point of recognition for glutaredoxins is attributed to the γ-linked glutamyl moiety of the GSH 
added. In line with this, GSSG can also serve as a substrate. Oxidized glutathione being one of the released 
products of the Grx-catalyzed reaction, this substrate competition adds another level of complexity to the 
analysis.  
We performed deglutathionylation reactions in the fluorescence mode with EcGrx1 and EcGrx2, in the 
presence of 0 to 0.5 mM GSSG and in the absence of NADPH and glutathione reductase. We showed that both 
the EcGrx1- and EcGrx2-catalyzed reactions slow down with increasing concentrations of GSSG (Fig 6). IC50s 
were estimated using the equation y= Vmax (1-(X/(IC50 +X)), where y is the % remaining activity, Vmax the 
activity in absence of inhibitor, and X the GSSG concentration. IC50-values for GSSG were calculated to be 
75.68 μM and 111.6 μM for EcGrx1 and EcGrx2, respectively. 
Being so sensitive for inactivation by GSSG, EcGrx1 and EcGrx2 can not operate during periods of oxidative 
stress. Indeed, these conditions -whether they are provoked by xenobiotics or are part of a signal transduction 
pathway- imply an important shift of the glutathione redox buffer towards the oxidized state. 
 
 
 
Fig 6. The deglutathionylation reaction catalyzed 
by EcGrx1 and EcGrx2 is inhibited by GSSG.  The 
reactions were performed with 20μM peptide-SG, 
1mM GSH and 100nM Grx in the absence of GR and 
NADPH. The data yields IC50-values of 111.6 μM and 
75.68 μM for EcGrx2 and EcGrx1, respectively. 
 
 
 
 
EcGrx1 and EcGrx2 display a different behavior in the presence of GSSG 
To investigate the susceptibility of glutaredoxins to undergo either glutathionylation or intramolecular 
disulfide formation, we examined the behavior of these proteins in the presence of GSSG by mass 
spectrometry. Noteworthy, EcGrx1 and EcGrx2 contain only 2 cysteines, located in the active site. Their 
eukaryotic counterparts usually possess additional cysteines, positionned outside the active site. Those prone 
to oxidative modifications are tought to be involved in the regulation of activity. 
 
Freshly prepared solutions containing EcGrx1 did not contain any free thiol groups. This result is in 
accordance with the lag-phase, typically observed in assays with low GSH concentrations and oxidized Grx-
enzymes at the start. Remarkably, EcGrx2 appeared to be exclusively in a fully reduced state following 
overexpression and purification.  
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When treated with the reducing agent DTT, EcGrx1 and EcGrx2 had the expected molecular weight of 9682.4 
Da ± 0.4 and 24350.2 ± 0.2 Da respectively, which corresponds to a fully reduced active site. Incubation with an 
excess of GSSG induced the formation a new peak of 24656.3 ± 1.3 for EcGrx2. The calculated difference 
exactly fits the molecular weight of one glutathione molecule (305.5 Da), meaning that the N-terminal cysteine 
forms a mixed disulfide. EcGrx1, however, does not demonstrate such a shift in mass, corresponding to the 
addition of GSH. When incubated at GSSG concentration of 10mM, the catalytic cysteines are engaged in a 
disulphide bridge (Table 2). 
 
Table 2: Summary of the results obtained by mass spectrometry. For both proteins and for each condition 
(reducing or oxidizing), the theoretically calculated and experimentally acquired molecular masses are shown.  
The corresponding values are in accordance and the noted difference between DTT- and GSSG-treated samples 
fits the presence of either an intramolecular disulfide (EcGrx1) or a glutathione molecule (EcGrx2). 
 
The mass spectrometric analysis demonstrates that EcGrx1 and EcGrx2 react differently at elevated GSSG 
concentrations. While EcGrx2 resides in a glutathionylated state, EcGrx1 will favor the formation of an 
intramolecular disulfide. Likewise, both human Grx1 and Grx2 were shown to display disulfide pairing in the 
active site upon exposure to GSSG. 
  
A possible explanantion for the odd outcome for EcGrx1 and EcGrx2 can be attributed to a difference in 
accessibility of the active site surface. Alternatively,  this phenomenon can be directly related to the nature of 
the second active site cysteine. Previous studies have already shown that the physical properties of the C-
terminal cysteine can not be generalized. Mutation of this amino acid in glutaredoxins from different species 
results in marked differences in terms of activity. While some mutants display higher activities than the wild-
type, others exhibit lower activities than their non-mutated counterpart (Bushweller et al., 1992, Peltoniemi et 
al., 2006, Discola et al., 2009). These observations point towards a different role for the second thiolgroup in 
the return of the Grx-SG intermediate to the active, reduced state. Similarly, the C-terminal active site cysteine 
can influence the behavior of the active site N-terminal cysteine in the presence of GSSG. 
 
4. CONCLUSION 
The remarkable difference between EcGrx1 and EcGrx2 in the presence of GSSG most likely reflects 
adaptations to different physiological functions. However, care should be taken when making conclusions as 
the oxidative treatment undergone by EcGrx1 and EcGrx2 is supraphysiological: concentrations of 10mM 
GSSG in the absence of GSH are indeed never reached in vivo. Nonetheless, the atypical behavior of EcGrx2 is 
unexpected and should be the subject of further research. 
 
  + DTT + GSSG Difference 
+DTT/+GSSG 
EcGrx1 Theoretical 
Experimental 
9682.8 
9682.4±0.4 
9684.8 
9684.5±0.3 
 
2.1 
EcGrx2 Theoretical 
Experimental 
24350.3 
24350.2±0.2 
24656.3 
24656.5±1.3 
 
306.3 
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As EcGrx1 and EcGrx2 demonstrate similar IC50s for GSSG, it is very unlikely that these enzymes are active 
during overt oxidative stress. Under these conditions, the free GSH concentrations drop and the equilibrium 
of the glutathione pool shifts towards GSSG, the latter potently inhibiting the two glutaredoxins under study.  
When returning to normal in vivo conditions, GSH levels will increase steadily. As seen for EcGrx1, the 
sigmoid shape of the GSH-dependent deglutathionylation reaction indicates that low GSH concentrations are 
associated with partitioning effects that will significantly interfere with EcGrx1’s activity. Under identical 
conditions, EcGrx2’s activity is not hampered by the formation of an intramolecular disulfide involving the 
active site cysteines. Indeed, no sigmoidality of the GSH-dependent reaction was observed and no 
intramolecular disulfide could be traced when EcGrx2 samples were incubated with an excess of GSSG. 
 
This observed difference between EcGrx1 and EcGrx2 at low GSH concentrations offers a net advantage to the 
atypical glutaredoxins in the first stages following oxidative stress. Upon recovery to a more favorable 
reduced intracellular medium, the intermolecular reaction proceeds faster and a glutathionylated enzyme state 
is favored. EcGrx1 will then retrieve its full activity and reach catalytic efficiencies equivalent to EcGrx2.  
 
This different effect of GSSG on classical and atypical glutaredoxins is unforseen and could potentially reflect 
different roles in redox regulation. While atypical glutaredoxins seem to be evolutionary adapted to work 
during the first moments following oxidative stress (i.e. when the GSH concentrations are still low), EcGrx1 
and homologues are fully functional when GSH-to-GSSG ratio’s have sufficiently increased. At this point 
only, it is considered to exert it’s activity on recognized glutathionylated substrates like ribonucleotide 
reductase, the enzyme providing the building blocks for DNA. 
 
Nonetheless, the aberrant behavior of EcGrx2’s active site upon GSSG exposure adds another particularity to 
this already very atypical glutaredoxin subtype. With the C-terminal cysteine not being involved, EcGrx2 can 
be considered to be mechanistically related to the monothiol human GSTO1-1, a GST homologue belonging to 
the recently identified Omega GST-subclass, nowadays regarded as one of the oldest branches of the GST-
family. While its in vivo function remains uncertain, polymorphisms of the corresponding gene were shown to 
be a risk factor in the incidence of different types of cancer and to modulate the age-at-onset of Alzheimer and 
Parkinson disease. 
This correlation between atypical glutaredoxins and hGSTO1-1 is endorsed by common deglutathionylating 
activities (DHA, HED) and structural resemblances (Xia et al., 2001). Futhermore, we found that the atypical 
VvGrx2 is inhibited, just as other GSTs, by alkyl-GSH derivatives (the longer the alkyl chain, the more 
effective the inhibition) and that EcGrx2 has a very low but detectable activity towards 4-
nitrophenacylglutathione, a specific substrate of hGSTO1-1 (data not shown).  
The conservation of the active site cysteine in Omega-GSTs (as most GSTs evolved to carry a Tyr or Ser 
catalytic residue) and the presence of an additional α-helical domain to the C-terminal end of the thioredoxin 
domain led to the premise that all soluble GST subfamilies derive from an E.coli Grx2-like intermediate 
(Ladner et al., 2004). The Kappa class of GSTs forms an exception, evolving via a dsbA-like intermediate where 
the extra domain is inserted into the Trx-domain.  
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BLAST searches revealed that atypical glutaredoxins are almost exclusively allocated to the Gamma-
Proteobacteria. Especially members of the enterobacteria, Vibrionales, the Pseudomonadales and the 
Pasteurellaceae appear to have the closest homologues to E.coli Grx2. Contrary to conventional glutaredoxins, 
eukaryotes and archaea do not seem to possess atypical glutaredoxins. This clustering of atypical 
glutaredoxins in bacterial taxa can coincide with the prokaryotic-eukaryotic evolutionary split, leading to the 
arising of GSTs and the need of cells to cope with oxidative stress (Fig 7). 
 
Fig 7 Atypical glutaredoxins and Omega GSTs share a common ancestor. 22 primary structures of 
EcGrx1, EcGrx2, hGSTO1-1 and their homologues were retrieved and reduced to their N-terminal Trx-
domain. All amino acid sequences were compiled and subsequently aligned using the MultAlin multiple 
sequence alignment online software (http://multalin.toulouse.inra.fr/multalin). Evolutionary relationships 
were visualized by building a phylogenetic tree, using the UPGMA clustering method and the Jukes-Cantor 
genetic distance model as implemented in the Geneious 5.3.4. software. Jack-knifing with 100 resamplings 
statistically assessed the result. Since related proteins generally cluster in clades, we can deduce from this 
phylogenetic tree that atypical glutaredoxins and Omega-GSTs share a common ancestor. 
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5. EXPERIMENTAL PROCEDURES 
 
Materials 
Reduced glutathione, oxidized glutathione, baker yeast glutathione reductase, DTT, insulin, S-methyl 
glutathione, S-hexyl glutathione, S-decyl glutathione, 1-chloro-2,4-dinitrobenzene (CDNB), 
dehydroascorbate (DHA) were obtained from Sigma; NADPH was from Merck, pET20b and pACYC Duet-I 
expression plasmids were purchased at Novagen; Escherichia coli BL21(DE3) was obtained from Stratagene; 
EcGrx1 was purchased from IMCO Corp. (Stockholm, Sweden) 
 
Molecular cloning of EcGrx2 and VvGrx2 
The protein-coding sequences for EcGrx2 and VvGrx2 were PCR-amplified from Escherichia coli and Vibrio 
vulnificus genomic DNA, respectively. The NdeI/XhoI restriction sites were PCR-incorporated using the 
following forward and reverse primers: 5'-ATCTATCAACACTGCCCATTTAGTGCTCGCGTTC-3' and 5'-
GAACGCGAGCACTAAATGGGCAGTGTTGATAGAT-3' for VvGrx2, 5’-
CATATGAAGCTATACATTTAC-3’ and 5’-CTCGAGTTAAATCGCCATTGATG-3’ for EcGrx2. The 
amplicons of EcGrx2 and VvGrx2 were introduced into the first multicloning site of pACYC Duet-I 
(Novagen) and the resulting contructs were verified by DNA sequence analysis (Cogenics).  
The cloned expression constructs were transformed into the BL21(DE3) Escherichia coli strain (Stratagene).  
 
Growth conditions, bacterial cultures and expression 
All E.coli strains and their expression construct-harboring derivatives were grown under continuous shaking 
at 37°C, using Luria-Bertani broth supplemented with the appropriate antibiotic (pET-based constructs: 
100µg/ml carbenicillin; pACYC-DUET-I-based constructs: 25µg/ml chloramphenicol) as growth medium. 
The medium was inoculated with 1% of a seed culture. When a density (OD600) of 0.6 was reached, expression 
was induced by addition of 1mM isopropyl-"-D galactopyranoside (IPTG), followed by further growth at 
37°C for 16 hours.  
 
Purification of recombinant EcGrx2 and VvGrx2 
The non-tagged EcGrx2 was purified in two subsequent steps. After pelleting the cell debris, the cleared lysate 
was loaded on a S-Sepharose Fast Flow (Amersham Biosciences) column equilibrated with 20mM MES, pH 
6.0, using the Åkta purifier system. The resin was washed extensively with the same buffer before the bound 
proteins were eluted with increasing salt concentrations. Only the peak fractions containing EcGrx2 were 
pooled and concentrated for further purification, using the Superdex75 gel filtration column equilibrated with 
50mM Tris, pH 8.0, and 150mM NaCl. 
VvGrx2, another atypical glutaredoxin, was expressed without affinity tag and purified following a three-step 
procedure. The sample solution was applied on a column of Q-Sepharose Fast Flow, equilibrated with 50mM 
Tris-Hcl, pH 8.0. Upon washing, protein elution was achieved with a continuous gradient of 0-1M NaCl. 
Fractions containing the protein were pooled, dialysed overnight against 50mM MES buffer, pH 6.4, and 
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applied on a Source Q column. In an ultimate purification step, the concentrated protein samples were loaded 
on a 75ml Superdex75 column using 50mM Tris, pH 7.5, 150mM NaCl as running buffer. 
In all cases, protein purity was assessed by SDS-PAGE, and protein concentrations were determined by A280 
absorption (using following theoretically calcultated extinction coefficeint εEcGrx1 =  11585 M-1 cm-1 ; εEcGrx2 = 
23045 M-1 cm-1; εVvGrx2 = 38055 M-1 cm-1) or using the Bradford Coomassie reagent. 
 
Enzyme assays 
Removal of glutathione from the substrate peptide SQLWCLSN, and thus changes in tryptophan fluorescence, 
were measured with a Varian Cary Eclipse Spectrofluorimeter (excitation 280nm, emission 356nm, slit width 
5nm). The 500µl reactions typically contained 100mM Tris-Hcl, pH 7.4, 150mM NaCl, the peptide substrate 
(0-200μM) and 0-3mM GSH. The reaction was started by the addition of 100nM enzyme, whereafter the 
increase in fluorescence signal was followed during 10 minutes. Analyses were performed in duplicates and at 
room temperature. In all assays, the measured activities at each enzyme concentration were corrected by 
substracting the velocities of the control reactions without the enzyme.  
When the assay required the inclusing of GR (0.6μg/ml) and NADPH (200μM), analyses were performed on a 
Uvikon double beam spectrophotometer, measuring NADPH consumption at 340nm. 
 
Oxidation of glutaredoxins 
Recombinant EcGrx1 and EcGrx2 (20-100μM) were fully reduced with 1mM DTT in 50mM Tris, pH 7.5, 
150mM NaCl. The reaction was allowed to proceed for 30min at room temperature, after which the excess of 
DTT was removed with a desalting step using a HiPrep 26/10 column (GE LifeSciences). Exact concentrations 
of EcGrx1 and EcGrx2 were measured by A280 absorbance as measured using a Nanodrop (Isogen Life Science). 
S-glutathionylation or intramolecular disulfide formation was induced by incubation of the glutaredoxins 
with 10mM GSSG for 2hours at room temperature and overnight storage at 4°C.  
 
Mass spectrometry 
Native Electrospray ionization mass spectrometry (ESI-MS) measurements were performed on a Synapt G1 
instrument (Waters, UK) coupled to an NanoMate automated sample infusion device (Advion Biosciences Inc, 
Ithaca, NY). Before analysis, samples were exchanged to a buffer containing 100mM ammonium acetate, pH 
6.8. External calibration of mass spectra was carried out using cesium iodide. 
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CONCLUSION 
 
 
One of the operonic structures in the genome of the Gram-negative bacteria Vibrio vulnificus, has the 
particular characteristic to unite two outliers from large and well-characterized protein families, known 
as the short-chain dehydrogenases and glutaredoxins. In this thesis, we focused on the odd nature of 
SDRvv and atypical glutaredoxins, to map the structural and/or mechanistic diversity that can be 
observed within a family. In doing so, we also attempt to elucidate their physiological role and their 
importance in relation to the classic counterparts.  
 
In general, the conclusions of this work are the following: 
 
For SDRvv: 
(1) While SDRvv clearly misses some secondary structural elements and conserved motifs, a 
diverse range of biochemical techniques revealed that this enzyme fully retains the ability to 
coordinate NADPH (Kd=3.5μM). 
(2) Confirming the protein sequence alignment, structural analysis of SDRvv taught that two 
regions contain 310 helices, replacing the α2β3 structural elements and the first turn of the 
substrate binding loop respectively. While changes in such regions can have dramatic effects, the 
different structural organization does not impair the stabilization of NADPH.  
(3) The presence of a putative proton relay network and the conservation of the coordination 
distances between the key catalytic residues further supports the possibility that SDRvv is 
physiologically active. 
 
For Grx2: 
(1) We optimized the assay conditions and fitting procedure for the kinetic analysis of classical and 
atypical glutaredoxins. 
(2) While the tested rate equation could not confirm a Ping-Pong mechanism, the Frieden two-
substrate analysis revealed that atypical glutaredoxins do not demonstrate sigmoidality at low 
glutathione concentrations. From this observation we can conclude that the active site Cys of 
EcGrx2 and homologues will not have the tendency to form intramolecular disulfides. On the 
other hand, this lag-phase is always observed for classical glutaredoxins like EcGrx1, which is 
symptomatic for an abortive partitioning reaction. 
(3) Mass spectrometry confirmed the different active site behavior for classical and atypical 
glutaredoxins. We found that, upon treatment of both glutaredoxins with an excess of GSSG, 
only EcGrx1 formed an internal disulfide, while for EcGrx2 the N-terminal Cys in engaged in a 
mixed disulfide with glutathione. 
 
Both atypical proteins, as well as VvOye, are under control of a LysR transcriptional regulator. The latter 
has a strong affinity for the intergenic region, which appears to contain elements facilitating 
transcriptional control, such as the ribosome binding site and the regulatory binding site. EMSAs 
indicated that the DNA:LysRvv interaction is not modeled by SDRvv nor the SDRvv:NADPH complex. 
The regulator responds thus to yet unknown stimuli. 
 
The notable divergence of SDRvv and VvGrx2 from their corresponding protein families could be 
translated into differences at the physiological level. Unfortunately, this thesis cannot give conclusive 
answers concerning the in vivo function of the genes making up the VVA1598-1601 operon. The 
availability of a substrate for SDRvv would certainly have facilitated this task. However, there are reasons 
to believe that the proteins originating from this special operon, are expressed in response to oxidative 
stress. 
(1) The operon under study is shown to be controlled by an LTTR, a type of transcriptional 
regulator often associated with the expression of antioxidant genes. 
(2) Many SDR members are known to operate on xenobiotics. Since SDRvv is a reductase using 
reducing equivalents from NADPH, a toxic carbonyl-containing compound can be one of the 
substrates and a detoxification function is possible.  
(3) In accordance with a regulation by ppGpp and RpoS, EcGrx2 was highly expressed in the 
stationary phase, during which the effects of oxidative stress are the most notable. Moreover, we 
have seen that in presence of non-physiological concentrations of GSSG, the Grx2 active site N-
terminal cysteine tends to occur in a glutathionylated form. This behavior offers a net advantage 
over other classical glutaredoxins, as partitioning reactions will not occur.  
(4) While an in vivo function is still unknown, old yellow enzymes were shown to be associated 
with the oxidative stress response. Representatives from Shewanella oneidensis are for instance 
strongly upregulated by the addition of iron to the medium, peroxides, and radical generating 
compounds like NEM, cyclohexenone and acrolein. 
 
As observed for EcGrx2 and VvGrx2, the closest homologues of SDRvv and VvOye are recovered in 
prokaryotes, with no representatives in higher eukaryotes and human. We may thus conclude that SDRvv, 
VvGrx2 and VvOYE are prokaryote-specific tools. As they occur mainly in pathogens, they could 
participate in the virulence process that is often closely associated with oxidative stress.  
Future research on the identity of the molecular switch for the LysRvv regulator, the substrate of SDRvv 
and the field of action of atypical glutaredoxins should help us to answer this physiological questions.  
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